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Introduction 
Diabetes is a chronic disease that is characterised by chronically elevated blood 
glucose levels due to a relative or absolute insulin deficiency. Over time, diabetes 
can lead to devastating complications, such as retinopathy, neuropathy and 
nephropathy, and it strongly increases the risk of cardiovascular disease.1 Diabetes 
prevalence has increased sharply over the past decades, and will rise further 
because of the increasing prevalence of obesity and the ageing population.2 
Worldwide, approximately 415 million people have diabetes, and this number is 
expected to rise to 642 million by 2040 (figure 1).3 In the Netherlands, more than 
1 million people have diabetes, a prevalence rate of approximately 6 percent.4 
 People with diabetes are more likely to require surgery than people without 
diabetes, because of the diabetes-associated complications and co-morbidity.5 
Estimates of diabetes prevalence in surgery patients range from 20% in general 
surgery patients up to nearly 35% in cardiac surgery patients.6,7 People with 
diabetes are also more prone to develop complications after surgery, in particular 
postoperative infections.7-11 This is partly related to the complications of the 
diabetes, including coronary vascular disease and renal failure.5,8,12-14 In addition, 
there is a well-established relationship between hyperglycemia and adverse 
outcomes for various types of surgery.7,15-17 Literature suggests that hyperglycemia 
is a modifiable, independent predictor and possibly a causal factor of adverse 
outcomes in patients with diabetes.15-16,18 Hence, optimal glucose control may 
decrease the risk of complications associated with surgery. Given the increasing 
prevalence of diabetes and the increased postoperative risks associated with 
diabetes, optimal perioperative diabetes care is imperative.  
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Figure 1. Estimated number of people with diabetes worldwide and per region in 2015 and 2040 (20-
79 years)2  
 
 
Diabetes and hyperglycemia are associated with adverse outcomes of surgery 
The largest body of evidence for the negative influence of diabetes and 
perioperative hyperglycemia on postoperative outcomes is derived from critically 
ill cardiac surgery patients.18-26 The increased postoperative complication rate in 
patients with diabetes is partly related to the increased prevalence of 
comorbidities that complicate the diabetes, including obesity, renal insufficiency, 
hypertension, and peripheral vascular disease.5,8,12-14 In addition, there is a well-
established relationship between hyperglycemia and increased rates of 
postoperative complications. 20,21,23-30   
 Studies in patients with diabetes undergoing coronary artery bypass surgery 
indicate that diabetes is associated with increased rates of postoperative infections, 
mortality, and longer hospital stay.11,23,24 Doenst et al assessed the influence of 
hyperglycemia (highest glucose) during cardiopulmonary bypass on perioperative 
morbidity and mortality. In patients with diabetes, a highest glucose value >20 
mmol/l was associated with a threefold increase in in-hospital mortality.24 Golden 
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et al studied the effect of hyperglycemia (mean of six values) during the 36-h 
interval following surgery on postoperative infection rates. Mean glucose values 
>11.5 mmol/l were associated with a higher risk for infection, including wound 
infection, urinary tract infection and pneumonia (relative odds 1.17-1.86).25 Zerr et 
al demonstrated a direct relationship between elevated mean blood glucose at 48 
hours after surgery and an increased risk of deep wound infection.26 Patients with 
a mean blood glucose 13.9-16.7 mmol/l had a nearly six-fold increased risk of 
developing deep sternal wound infection compared to patients with blood glucose 
5.6-8.3 mmol/l.  
 For non-critically ill general surgery patients, there is also substantial evidence 
that links diabetes and hyperglycemia to worse postoperative outcomes.7,8,14,15,17,27-
31 Patients with diabetes undergoing general surgery have higher rates of 
postoperative complications, including infections, renal failure, myocardial 
infarction, higher mortality rates, and longer hospital length of stay than patients 
without diabetes (figure 2). Pomposelli et al assessed the influence of 
hyperglycemia on adverse complications after major cardiovascular or abdominal 
surgery.27 A single blood glucose level 12.2 mmol/l or higher on the first 
postoperative day was associated with 2.7 times higher infection rates. Kwon et al 
studied the influence of hyperglycemia on postoperative outcomes in patients who 
underwent elective colorectal or bariatric surgery.17 Hyperglycemia (glucose >10 
mmol/l) at any point during the day of surgery or postoperative day 1 or 2 was 
associated with increased postoperative infection rates, re-operative interventions 
and mortality in patients with diabetes. Another study among patients with 
diabetes undergoing colorectal surgery demonstrated that mean 48-hour 
postoperative glucose >11 mmol/l was associated with a greater than threefold 
increased risk of surgical site infection.30 Several studies in both cardiac surgery 
and non-cardiac surgery patients noted that the relationship between 
hyperglycemia and adverse outcomes of surgery was even stronger for patient 
who were not previously known to have diabetes, in particular with regard to 
postoperative mortality.7,23,24  
 Several studies have investigated the relationship between long term 
preoperative glycemic control (HbA1c) and postoperative outcomes in patients 
with diabetes.32-39 Some have reported that suboptimal preoperative glycemic 
control has a negative influence on postoperative outcomes, while others could 
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not confirm this relationship. One study demonstrated that HbA1c levels of 7% or 
more were associated with a significantly higher incidence of postoperative 
complications, including renal failure, and postoperative infections compared to 
lower HbA1c levels.34 In another study in cardiac surgery patients with diabetes 
using hypoglycemic agents, those with HbA1c of 6% to 7% (42-53 mmol/L) 
tended to have better cardiovascular outcomes than those with HbA1c <6% or 
>7%.36 Underwood et al investigated the relationship between HbA1c and length 
of hospital stay in non-cardiac surgery patients with diabetes.32 They reported that 
HbA1c levels >8% (64 mmol/L) were associated with longer hospital length of 
stay. High HbA1c level has also been shown to be associated with increased 
morbidity after spine, joint replacement, and vascular surgery.38,39  
 
Figure 2. Thirty-day mortality and in-hospital complication rates in patients with and without 
diabetes7 
Urinary tract infection (UTI), acute myocardial infarction (AMI), and ARF. *P < 0.001; †NS; ‡P <0.017 
 
What is the optimal target for perioperative glucose control? 
Although there is no doubt that perioperative hyperglycemia is associated with 
negative outcomes, it is less clear what the optimal glucose target should be. 
Earlier hallmark studies – intervention trials in critically ill surgery patients – have 
reported that very strict glucose control (glucose 4.4 -6.1 mmol/l) could result in 
lower mortality, less organ failure, bacteremia, renal insufficiency, blood 
transfusions, and shorter hospital stay compared with usual care.18,19 Subsequent 
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randomized controlled trials that investigated the benefits of such a strict glucose 
control, however, have reported conflicting results.40,41 Potential explanations for 
these conflicting results include differences in study population, trial design, and 
algorithms to control blood glucose, changes in standard of care, and differences 
in the timing of strict glucose control (i.e. initiation).42 A meta-analysis pointed to 
the increased rates of hypoglycaemia in patients receiving intensive insulin 
treatment.43 Tight glucose control was associated with a five times higher risk of 
hypoglycemia compared to conventional glucose control. Hypoglycemia in 
critically ill patients has been linked to serious neurologic events ranging from 
seizures to coma and increased mortality.44-46 In non-critically ill patients, 
hypoglycaemia is associated with increased length of hospital stay and higher 
mortality both during and after admission.47-49 It remains to be elucidated whether 
hypoglycaemia is a causal factor for mortality or a marker of more severe disease.  
 The multicenter NICE SUGAR trial compared the effects of strict glucose 
control (4.4-6.1 mmol/l) and conventional glucose control (<10 mmol/l) in 
critically ill patients.41 In the group with conventional glucose control, insulin 
administration was discontinued if the blood glucose dropped below 8 mmol/l. 
The trial demonstrated that a blood glucose target of <10 mmol/l resulted in lower 
mortality than strict glucose control. It is important to realise that the mean 
glucose in the conventional control group was 8 mmol/l, which is still quite low. 
Griesdale et al also conducted a meta-analysis and concluded that strict glucose 
control significantly increased the risk of hypoglycemia and conferred no overall 
mortality benefit among critically ill patients (figure 3).40 However, the data 
suggested a possible mortality benefit of stricter glucose for critically ill surgery 
patients.  
 There is a lack of trials that compare the results of different glucose targets 
for non-critically ill patients. Currently recommended blood glucose targets for 
non-critically ill surgery patients are based on observational data with regard to 
the relationship between hyperglycemia and postoperative complications, and 
intervention trials to lower blood glucose in critically ill patients. The National 
Health Service in the UK and the Netherlands Society of Internal Medicine 
recommend a blood glucose target of 6-10 mmol/l.50,51 The American Diabetes 
Association recommends a premeal blood glucose <7.8 mmol/l and random blood 
glucose <10 mmol/l.52 Analogous to management standards in ambulant diabetes 
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care, it is currently recommended that hyperglycemia in the perioperative period 
should be treated if this can be done safely, which means with an acceptable risk 
of hypoglycaemia.53 
 
Figure 3. Risk ratios of mortality in clinical trials comparing intensive insulin therapy (IIT) to 
conventional glycemic control stratified by type of ICU51 
Source: Dhatariya K, Levy N, Kilvert A, et al. NHS Diabetes guideline for the perioperative management of 
the adult patient with diabetes. Diabet Med 2012;29:420–433. © Canadian Medical Association. 
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Quality of current perioperative diabetes care from the professional’s 
perspective 
Daily practice shows that it is a huge challenge to achieve optimal glucose control 
in the perioperative period. Perioperative glucose control is complicated by 
continuously changing insulin secretory capability, insulin sensitivity, overall 
metabolism, and nutritional intake throughout the hospital care pathway.12,54 
Hyperglycemia can easily be overlooked and is often inadequately addressed, as 
the diabetes is generally not the primary reason for hospital admission.55-58 
Perioperative diabetes care is a complex multidisciplinary process, involving 
multiple multiprofessional teams of caregivers and multiple transitions of care 
throughout the hospital care pathway that ranges from the preoperative 
evaluation up to hospital discharge.  
 When we started this study in 2009, no national or international evidence-based 
guideline was available with perioperative diabetes care as a topic. 
Recommendations for optimal perioperative diabetes care were dispersed over 
several mono-disciplinary guidelines and scientific literature.59-64 In 2011, the NHS 
launched the first multidisciplinary guideline to guide the management of adults 
with diabetes undergoing surgery and elective procedures in daily clinical 
practice.51 The guideline covers all stages of the perioperative care pathway, from 
the referral from primary care up to hospital discharge. In 2013, the Netherlands 
Society of Internal Medicine launched a guideline for the perioperative treatment 
of diabetes mellitus.50 The guideline includes a chapter on perioperative diabetes 
care, and provides recommendations on preoperative glycemic control, 
perioperative glucose targets, the perioperative use of metformin and insulin, 
diabetes self-management in the perioperative period, and the perioperative 
management of patients with diabetes who undergo ambulatory surgery.  
 Diabetes management for hospitalized patients in daily practice is often 
perceived as suboptimal, and the available data suggest a valid basis for this 
impression.56,58,65-70 In the largest review of inpatient glycemic control in 575 US 
hospitals it was observed that hyperglycemia (glucose >10 mmol/l) occurred in 
32% of patient-days in non-critically ill hospitalised patients.68 In the UK, the 
‘Inpatient Diabetes Audit’ showed that patients with diabetes, and those admitted 
for surgery in particular, experience high levels of medication and management 
errors during hospital stay.69 There is limited information available on the quality 
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of current perioperative diabetes care in daily clinical practice. Insight into current 
care and the setting of implementation is of great importance to identify areas that 
need to be improved, and to determine which interventions need to be 
developed.71 
 It has been suggested that development and use of quality indicators can help 
define and assess the quality of care delivered.71-77 Quality indicators are 
preferably based on evidence-based guidelines. Quality indicators are measurable 
elements of practice performance for which there is evidence or consensus that 
they can be used to assess the quality, and hence change in the quality, of care 
provided.78 Three types of quality indicators can be distinguished.79 Outcome 
indicators specify the ultimate goal of the care given, process indicators refer to 
the actual care that is delivered to patients, and structure indicators refer to the 
organisational structure of a healthcare system. Outcome, process, and structure 
are the three components of the Donabedian framework for evaluating the quality 
of care. To make inferences about quality, there needs to be an established 
relationship between these three components.  
 To develop valid quality indicators, it is necessary to use a systematic procedure 
that combines available evidence and expert opinion to assess additional aspects 
of care for which evidence alone is insufficient, absent, or methodologically 
weak.74 The Modified Delphi method is a systematic procedure that has been used 
to develop quality indicators for various other healthcare settings, such as the care 
for hospitalised patients with lower respiratory tract infections, the diagnosis and 
treatment of patients with lung cancer, and the monitoring of the disease course in 
rheumatoid arthritis.72-77 Before introducing quality indicators in daily clinical 
practice, it is recommended to perform a practice test to gain insight into the 
feasibility of the proposed indicator sets in daily clinical practice.74,77 The purpose 
of such a practice test is to assess the clinimetric properties or quality criteria of 
indicators, e.g. their measurability, applicability, reliability, improvement 
potential, and case-mix stability, in daily clinical practice.73,74, 80,81  
 The quality of perioperative diabetes care depends crucially on the performance 
and teamwork of all professionals who are involved throughout the hospital care 
pathway, that ranges from the preoperative evaluation up to hospital discharge. 
So far, no quality indicators have been validated for assessment of perioperative 
diabetes care throughout the entire hospital care pathway.  
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Quality of current perioperative diabetes care from the patient’s perspective 
Person centredness is an important principle for delivering optimal quality 
diabetes care.82 Person centred care is defined as “providing care that is respective 
of and responsive to individual patient preferences, needs and values, and 
ensuring that patient values guide all clinical decisions”.83 The medical 
management of type 2 diabetes has become increasingly complex over the past 
years given both the wide range of available treatments, but also given 
uncertainties in terms of choice of treatment. Shared decision making, 
individualized treatment regimens and self-management support are corner 
stones of contemporary care in general and diabetes care in particular.84 There is 
growing evidence that person centred care contributes to improving patient 
experience, compliance with treatment, care quality and health outcomes. 
Involving patients in perioperative diabetes care is also an important part of the 
strategy to improve the safety of insulin use in the hospital.85 Many insulin-treated 
patients will have greater knowledge and experience of insulin adjustment than 
the medical and nursing staff responsible for their care. Many patients are used to 
self-management of the diabetes that includes making choices with regard to their 
diet, self-monitoring of blood glucose, self-administration of insulin and self-
adjustment of insulin dose. Therefore, people with diabetes who are used to self-
manage their diabetes at home should be facilitated to continue to self-manage 
during their stay at the hospital unless there is a specific reason why they should 
not.  
 There is limited information on the needs and preferences of patients with 
diabetes with regard to perioperative diabetes care. Guidelines on perioperative 
diabetes care provide only few recommendations for optimal perioperative 
diabetes care from the patient’s perspective.50-52 There is also limited information 
on the experiences of patients with diabetes with perioperative diabetes care. 
Studies suggest that people with diabetes feel rather disempowered with respect 
to their diabetes when admitted to hospital for intercurrent disease.69,86,87 In a 
recent audit of inpatient diabetes care in the UK, patients were surveyed for their 
experiences with diabetes care during their stay at hospital.69 Only 21% of the 
participants reported that they were involved in the diabetes care plan during 
hospital admission. Half the participants were permitted to self-administer insulin 
while in hospital, and 17% were permitted to test their own blood glucose values.  
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 The Picker Institute is a leading authority in the field of person centred care.88 
The institute defines eight universal dimensions of person centredness of hospital 
care that appear to be central aspects of hospital care for people in Europe and the 
USA.89 These dimensions include ‘access to care’, ‘information’, ‘communication 
and education’, ‘respect for patient values, preferences, and needs’, ‘physical 
comfort’, ‘coordination and integration of care’, ‘emotional support and alleviation 
of fear and anxiety’, ‘involvement of family and friends’, and ‘transition and 
continuity’. The Picker dimensions and surveys can be used as a basis for 
describing patient needs and preferences with hospital care, and to evaluate their 
experiences with hospital care in other settings. Picker surveys have been used to 
evaluate patient experiences with hospital care since 1987 in hospitals in the USA 
and since 1998 in several European countries. Modified versions of the Picker 
dimensions and surveys have been used to assess the level of person centeredness 
of the care for people with Parkinson’s disease, and the care for people with 
cancer.90-92 In this thesis we use the Picker adult inpatient experience survey as a 
basis to develop a survey to assess patient experiences with current perioperative 
diabetes care.  
 
Improving perioperative diabetes care 
To achieve optimal diabetes care in the perioperative period, all professionals 
involved should provide –as a team- evidence or consensus based care while 
taking the specific needs of the person with diabetes into account at all stages of 
the hospital care pathway. Insight into the quality of current care and the setting 
of implementation is of great importance in order to know how improvement 
strategies should be designed and to understand what kind of activities should be 
developed and tested to improve care.71  
 In this thesis, we followed the model of Grol and Wensing who developed a 
stepwise, practically applicable model for improving care.71 Various theories and 
approaches related to the effective implementation of change are integrated into 
this model. Applied to the topic of perioperative diabetes care, the steps in this 
model are: 
1. the clear description of optimal diabetes care by developing quality indicators;  
2. performance of a diagnostic analysis, i.e. the analysis of current practice and the 
setting for implementation (barriers for the delivery of optimal care); 
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3. development of a strategy to improve care, based on the insights from the 
diagnostic analysis;  
4. execution of the improvement strategy as developed, and  
5. evaluation of the results: have the goals been met?  
 
In this thesis, we use this stepwise implementation model to develop a strategy to 
improve the quality of perioperative diabetes care throughout the hospital care 
pathway.  
 
Conclusions 
In summary, many patients that undergo surgery suffer from diabetes. Diabetes 
and hyperglycemia are associated with increased rates of post-operative 
complications, mortality, and longer hospital stay. Although guidelines have been 
developed for optimal perioperative diabetes care, implementation in real practice 
seems insufficient. In addition, while person centred care is highly recommended, 
it is less well described in guidelines and unclear how person centredness is 
achieved in daily clinical practice. To achieve optimal diabetes care in the 
perioperative period, all professionals involved should take the specific needs of 
the person with diabetes into account, while providing evidence or consensus 
based care at all stages of the hospital care pathway.  
 In this thesis, we define optimal perioperative diabetes care from both the 
professional and patient’s perspective, we assess the quality of current 
perioperative diabetes care and the level of person centredness in current 
perioperative diabetes care, and use this information to develop and test a strategy 
to improve the quality of perioperative diabetes care throughout the hospital care 
pathway.  
 
Outline of this thesis and research questions 
In Chapter 2 we aimed to develop a valid set of quality indicators for optimal 
perioperative diabetes care throughout the hospital care pathway. For this 
purpose, we searched for recommendations on optimal perioperative diabetes care 
in international guidelines and literature, and conducted a systematic procedure to 
achieve consensus on a set of quality indicators. To gain insight into the feasibility 
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of the indicator set in daily practice, we performed a practice test to assess 
clinimetric properties or quality criteria of the quality indicators.  
 In chapter 3, our objective was to assess the quality of current perioperative 
diabetes care throughout the hospital care pathway. We used the quality 
indicators as developed in chapter 2 to assess the quality of perioperative diabetes 
care for patients with diabetes who underwent major surgery in six hospitals.  
Next, we investigated the level of person centredness of current perioperative 
diabetes care. For this purpose, we explored needs and preferences of patients 
with diabetes with regard to perioperative diabetes care, and used this 
information to develop a survey to assess patient experiences with current 
perioperative diabetes care. The survey was administered to patients with diabetes 
who underwent major surgery in six hospitals. The results are provided in chapter 
4.  
 In chapter 5 our objective was to describe blood glucose levels throughout the 
perioperative period, and to examine potential determinants of perioperative 
glucose control, including adherence to the quality indicators as developed in 
chapter 2. In chapter 5, we also identified barriers for optimal perioperative 
diabetes care among professionals involved in perioperative diabetes care.  
 Based on the assessments of current care as described in chapters 3 and 4, and 
the analysis of barriers for optimal care as described in chapter 5, we developed a 
strategy to improve perioperative diabetes care throughout the hospital-care 
pathway. The effectiveness of this strategy was tested in a controlled before and 
after trial in six hospitals and described in chapter 6.  
 In chapter 7 we summarise our main findings and put these in perspective.   
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ABSTRACT 
Background In this study, we aim to develop a set of quality indicators for 
optimal perioperative diabetes care throughout the hospital care pathway and to 
gain insight into the feasibility of the indicator set in daily clinical practice by 
assessing the clinimetric properties of the indicators in a practice test. 
Methods A literature-based Modified Delphi method was used to develop a set of 
quality indicators. To assess clinimetric properties of each indicator 
(measurability, applicability, reliability, improvement potential and case-mix 
stability), a practice test was performed in six Dutch hospitals using a sample of 
389 major surgery patients with diabetes who underwent abdominal, cardiac, or 
large joint orthopedic surgery.  
Results We developed a set of 36 quality indicators for perioperative diabetes care. 
The practice test showed that one indicator was inapplicable, and nine indicators 
were unmeasurable. Interobserver reliability was good (0.61≤k≤0.8) for all 
indicators except for one with moderate (0.41≤k≤0.6) interobserver reliability. 
Improvement potential was low (<10%) for five indicators. Twenty-one indicators, 
including 3 outcome indicators, 9 process indicators, and 9 structure indicators, 
could be used to assess the quality of care delivered in our six study hospitals.  
Conclusions We developed a face and content valid set of quality indicators for 
optimal perioperative diabetes care throughout the hospital care pathway, using a 
rigorous and systematic approach. The results from our practice test show that it is 
essential to subject indicators to a practice test before applying them for quality 
improvement purposes.   
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INTRODUCTION 
Estimates of diabetes prevalence range from 20% in general surgery patients to 
nearly 35% in cardiac surgery patients.1,2 Surgery for patients with diabetes is 
associated with longer hospital stay, more use of healthcare resources and greater 
perioperative morbidity and mortality than surgery for patients without diabetes.2-
5 The greater perioperative morbidity and mortality relates, in part, to the higher 
incidence of coronary heart disease, hypertension, renal insufficiency and 
postoperative complications associated with diabetes.4 Further, the relationship 
between perioperative hyperglycemia and surgical complications is well 
established for a large range of surgical procedures.6-12 
 Perioperative care is a complex and multidisciplinary process, involving 
multiple teams of caregivers and multiple transitions of care. To achieve optimal 
diabetes care in the perioperative period, all professionals involved should take 
the specific needs of the person with diabetes into account at all stages of the 
hospital care pathway that ranges from preoperative evaluation up to hospital 
discharge.13 Several large professional organisations, such as the American 
Diabetes Association and more recently the Joint British Diabetes Societies (JBDS), 
have developed recommendations for optimal diabetes care in the perioperative 
period, but it is unknown whether this has resulted in optimal or ‘good quality’ 
care delivery.13-14 
 The development and use of quality indicators have been suggested to help 
define and assess the quality of the care delivered.15-16 Quality indicators are 
measurable elements of practice performance, for which there is evidence or 
consensus that they can be used to assess the quality, and hence change in the 
quality, of care provided.17 Three types of quality indicators can be distinguished. 
Outcome indicators specify the ultimate goal of the care given, process indicators 
refer to the actual care that is delivered to patients and structure indicators refer to 
the organisational structure of a healthcare system.18  
 This study aims to develop a set of quality indicators for optimal perioperative 
diabetes care throughout the hospital care pathway and to gain insight into the 
feasibility of the indicator set in daily clinical practice by assessing the clinimetric 
properties (quality criteria) of the indicators in a practice test.  
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METHODS 
Development of quality indicators for perioperative diabetes care 
A modified Delphi method was used to develop a set of quality indicators.19-21 
Recommendations for optimal perioperative diabetes care were extracted from the 
literature (international guidelines, websites and PubMed database), translated 
into potential quality indicators, and presented to a multidisciplinary expert panel.  
 
Selection of recommendations 
The search for recommendations for optimal perioperative diabetes care was 
based on the guidelines for Quality Indicator Development of the Dutch Institute 
for Healthcare Improvement.22 In January 2009, we searched 33 websites of 
international healthcare organisations, for example http://www.qualitymeasures. 
ahrq.gov and http://www.who.int/en/, to identify quality indicators for 
perioperative diabetes care.22 We continued by searching websites of national and 
international guideline organisations, and found 7 guidelines that contained 
recommendations on perioperative diabetes care.14,23-28 Three reviewers (IH, PvG 
and MH) extracted all recommendations for optimal perioperative diabetes care 
from the American Diabetes Association guidelines. As agreement was very high, 
one reviewer continued to extract recommendations from the guidelines (IH).  
 To complement the inventory of recommendations for optimal perioperative 
diabetes care, we used the PubMed database to review international literature for 
information about the development of quality indicators and recommendations 
for perioperative diabetes care. Supplementary Figure S1 depicts the search 
strategy, and supplementary Table S1 presents the exclusion criteria. Three 
reviewers checked the abstracts. Potentially relevant publications were checked in 
full text format.  
 All recommendations were categorised as ‘patient outcome’, ‘process’ or 
‘organisational structure’.18 Recommendations for process were categorised 
according to the various stages of the hospital care pathway: ‘preoperative 
evaluation’, ‘hospital admission’ (care that should be initiated upon hospital 
admission), ‘preoperative management’ (care that should be initiated in 
preparation for the surgery), ‘intraoperative management’, ‘postoperative 
management’, or ‘hospital discharge’. 
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Rating procedure 
The rating procedure took place between May 2009 and November 2009. Our 
expert panel consisted of 35 Dutch experts who had experience with the care for 
patients with diabetes in the perioperative period (19 endocrinologists/internists 
with special interest in diabetes care, 6 anesthesiologists, 5 intensive care 
specialists and 4 surgeons). The experts worked in 22 Dutch hospitals in the 
Netherlands. We selected the experts based on their experience with perioperative 
diabetes care (champions of diabetes care in the Netherlands), while aiming for 
sufficient diversity in hospital size (small to large size, academic and non-
academic), the various regions in the Netherlands and disciplines of the panel 
members. 
 
First questionnaire round  
All recommendations for optimal perioperative diabetes care were translated into 
potential quality indicators by defining ‘who should do what to whom and when’, 
and were worked into a written questionnaire. The experts rated the quality 
indicators anonymously. We asked the experts to rate each quality indicator while 
considering the following criteria: 
 The recommended care leads to health gain for the patient (e.g., fewer 
complications) or promotes efficiency of care 
 The recommended care is generalisable to all patients with diabetes who 
undergo a major surgical procedure 
 There is enough scientific evidence or expert consensus to justify the 
recommended care.  
A Likert scale rating ranging from 1 (not at all relevant for assessing the quality of 
care delivered) to 9 (very relevant) was added, and the answer category ‘cannot 
assess’ was made available. Supplementary Figure S2 shows an example of a 
rating scale for a quality indicator. Experts could also add quality indicators. 
Quality indicators were selected according to relevancy (median scores 7, 8, or 9) if 
there was no disagreement (30% or more of ratings in both the 1–3 and 7–9 
tertiles). Quality indicators rated ≤ 6 were discarded.  
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Expert Panel Meeting 
The analysis of the questionnaires was presented during a panel meeting, to 
discuss the quality indicators with median scores 7, 8 or 9 and disagreement, and 
to rephrase quality indicators that were not defined specific enough. All panellists 
who had participated in the first questionnaire round were invited.  
 
Second questionnaire round 
Following the meeting, all accepted and added quality indicators, rephrased if 
necessary, were presented for final remarks and approval to the panel members 
who had completed the first questionnaire. We added a ranking procedure to 
single out key recommendations for each stage of the hospital care pathway 
(‘preoperative evaluation’, ‘hospital admission’, ‘preoperative management’, 
‘intraoperative management’, ‘postoperative management’, or ‘hospital 
discharge’). For each stage that contained more than four indicators, we asked the 
experts to select the top three of most relevant indicators. We awarded an 
indicator 3 points for each number-one expert ranking, 2 points for each number-
two ranking, and 1 point for each number-three ranking. Indicators that received 
>20% of the maximum possible ranking points were included in the final indicator 
set. The maximum possible ranking points were 57 points (19 experts times 3 
points). The experts ranked the quality indicators anonymously. 
 
Practice test 
Setting  
The application of a systematic and rigorous modified Delphi method for 
developing quality indicators results in high face and content validity for the 
indicator set. To gain insight into the feasibility of the final indicator set in daily 
clinical practice, we performed a practice test, that is, a test to assess the clinimetric 
properties or quality criteria of indicators in daily clinical practice. We assessed 
the clinimetric properties of the final indicator set in six Dutch hospitals. There 
were two academic hospitals (953-1042 beds), two regional teaching hospitals (543-
576 beds), and two tertiary teaching hospitals (730-846 beds). All six hospitals 
performed orthopedic and abdominal surgery, and three of the six hospitals 
performed cardiac surgery. In one hospital, the department of abdominal surgery 
declined participation. The hospitals participated in a study to test the 
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effectiveness of an implementation strategy to improve perioperative diabetes care 
in daily clinical practice (trial no. NCT01610674). The Regional Review Board for 
Human Research Arnhem-Nijmegen (CMO, no. 2008/333), approved the study for 
all hospitals. 
 Adult patients with diabetes were included if they met our criteria of major 
surgery: (1) the person was under general anesthesia during abdominal surgery or 
cardiac surgery, or under spinal or general anesthesia during large-joint 
orthopedic surgery and (2) the minimum operation time was 1 h.29 Patients who 
underwent outpatient surgery were excluded. If a participant underwent more 
than one surgical procedure, we included the first procedure. The surgery took 
place in the period March 2009 and March 2010. We retrospectively identified the 
patients from data in the hospital prescription system, operating room 
management systems, preoperative screening records, and anesthesiology records. 
The patients were invited to participate in the study by mail and by phone.30 
Informed consent was obtained from all patients. After informed consent had been 
obtained, information regarding the inclusion criteria was verified with the patient 
record. We aimed to include a minimum of 30 patients per surgical specialty 
(abdominal surgery, cardiac surgery and large-joint orthopedic surgery) in each 
hospital, that is, 420 patients for a total of 14 departments. We invited 60 patients 
per surgical specialty if sufficient numbers were available. 
 
Data collection  
The patient data relevant to process and outcome indicators were manually 
abstracted from the patient records and entered into a computerised database. The 
data were collected from medical and nursing records, anesthesiology records, 
medication records, and laboratory reports. Four trained research assistants (EE, 
MG, ER and AV) and one researcher (IH) searched the patient records for the 
period between August 2010 and May 2011.  
 We assessed the quality indicators for the recommended organisational 
structure of perioperative diabetes care with a questionnaire. A diabetes specialist 
in each of the six participating hospitals completed the questionnaire.  
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Clinimetric properties assessed 
OUTCOME INDICATORS AND PROCESS INDICATORS 
Individual patient indicator scores (dichotomous variable with the values 0 and 1) 
were computed for each patient and for each outcome and process indicator, and 
the scores described whether or not care was delivered as recommended. We 
constructed an algorithm for each indicator to calculate the indicator outcomes. 
Supplementary Figure S3 provides an example of an indicator algorithm. We 
computed hospital indicator scores (in percentages) by dividing the number of 
patients who received the recommended care as described by the indicator 
(numerator) by the number of patients to whom the recommended care applied 
(denominator). We used these data to assess the following clinimetric properties: 
1. Measurability31,32 
 A specific indicator was considered ‘unmeasurable’ if >25% of the patients’ 
individual indicator scores could not be computed because of missing data.   
2. Applicability33 
Indicators that applied to <10% of the patients were considered ‘inapplicable’. 
3. Reliability31,34 
The interobserver reliability of the data collection was expressed in kappa 
coefficients, that is, the percentage of agreement between two data reviewers at 
the level of the patient indicator score, corrected for chance. Two independent 
data reviewers collected a sample of 30 patient records from three hospitals. 
Values of 0.41≤k≤0.6 were considered ‘moderate’, 0.61≤k≤0.8 were considered 
‘good’, and values >0.8 were considered ‘very good’. Values <0.4 were 
considered ‘poor’.  
4. Improvement potential32 
The improvement potential of a specific indicator was considered ‘low’ if the 
median potential for hospital improvement was less than 10% (hospital 
indicator score ≥90%) in >80% of the hospitals.    
5.  Case-mix stability31 
For indicators with good clinimetric properties, we explored whether the 
hospital indicator scores needed correction for case mix. We used multilevel 
analysis to study the relationship between the indicator results and the 
following patient characteristics: age, gender, insulin treatment, and type of 
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surgery. We corrected for data clustering at the hospital level. Significance for 
the multilevel analysis was set at p<0.05.  
 
STRUCTURE INDICATORS 
Individual hospital indicator scores (dichotomous variable with the values 0 and 
1) were computed for each hospital and for each structure indicator and the scores 
described whether or not care was organised as recommended. The number of 
hospitals that were included in the practice test (six) was too small to determine all 
the clinimetric properties of the indicators for organisational structure. To get an 
impression of the ‘improvement potential’ of these indicators, we computed the 
fraction of hospitals with an organisational structure of perioperative diabetes care 
as described by the indicator.  
 
RESULTS 
Quality indicators for perioperative diabetes care 
Selection of recommendations from guidelines and literature 
Figure 1 schematically presents the quality indicator development. No existing 
quality indicators for perioperative diabetes care were found on international 
websites. In total, 90 recommendations for perioperative diabetes care were 
derived from seven guidelines.14,23-28 The literature review yielded 1318 abstracts 
for 114 articles that contained recommendations for perioperative diabetes care. 
From these articles, we derived 22 recommendations that were complementary to 
the set of recommendations found in the guideline search. Further aggregation of 
the total of 112 recommendations by topic resulted in a total of 79 
recommendations that were translated into potential quality indicators. The 
evidence level, as provided in the guidelines, was D (i.e. a formal combination of 
expert views or other information, e.g., Delphi study, expert opinion or informal 
consensus.) for most quality indicators.35    
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Figure 1. Developing and testing the indicator set 
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The flowchart shows the steps involved in the indicator development. Potential quality indicators and 
recommendations for optimal perioperative diabetes care were selected from websites, guidelines and the 
international literature, and were rated by a panel of experts. A practice test was performed to assess the 
clinimetric properties of the indicators. 
 
Rating procedure 
FIRST QUESTIONNAIRE ROUND 
Twenty-seven of 35 experts returned the first questionnaire (15 internists, 5 
anesthesiologists, 4 intensive care specialists, and 3 surgeons; response rate 77%). 
The expert panel rejected 30 quality indicators, accepted 48 indicators as relevant 
for assessing the quality of perioperative diabetes care, disagreed on one indicator, 
and suggested two new quality indicators.  
 
EXPERT PANEL MEETING 
Six experts attended the panel meeting (3 internists, 1 anesthesiologist, 1 surgeon 
and 1 intensive care specialist). The panel discussed and rephrased 15 quality 
indicators, combined 2 quality indicators with similar contents and suggested 2 
new quality indicators, resulting in a total of 52 quality indicators.  
 
SECOND QUESTIONNAIRE ROUND 
Nineteen of 27 experts (10 internists, 4 anesthesiologists, 3 intensive care 
specialists and 2 surgeons, response rate 70%) completed the second 
questionnaire. The panel approved all 52 quality indicators, including 4 outcome 
indicators, 39 process indicators and 9 structure indicators (Supplementary table 
2). The experts prioritised 15 out of the 39 process indicators. The 28 indicators in 
the prioritised set (4 outcome, 15 process and 9 structure) were systematically 
operationalised by defining numerators and denominators. Five indicators (see 
supplementary table S2, indicator numbers 1, 2, 5, 15 and 27) were operationalised 
into two or more indicators. Tables 1-3 present the final set of 36 indicators that 
were tested for feasibility in the study hospitals.  
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Table 1. Clinimetric properties for the outcome indicators in six practice test hospitals  
 
  
  
INDICATOR 
 Measurability 
% patients with 
missing values 
Applicability 
% patients to whom 
the indicator applies 
Reliability 
(agreement) 
kappa 
Improvement 
potential 
median % for six 
hospitals (range) 
1. All glucose values 6-10 mmol/l in 
surgical ward 
16 100 1 95 (92-100) c 
2. All glucose values 6-10 mmol/l in the 
ICUa 
>25         
3. All glucose values 6-10 mmol/l during 
surgery 
>25         
4. Hyperglycemiaa in the surgical ward 16 100 0,87 91 (82-96) c,e 
5. Hyperglycemiab in the ICUa >25         
6. Hyperglycemiab during surgery  >25         
7. Postoperative wound infection during 
hospital stay 
0 100 1 5 (0-14) 
8. Unplanned readmission within 3 weeks 0 100 1 10 (6-14) d 
Grey bars: indicators with good clinimetric properties in our practice test hospitals  
a ICU: intensive care unit 
b ≥1 glucose >10 mmol/l 
c,d,e Case-mix correction required for: cDiabetes treatment, dType of surgery, eAge 
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Table 2. Clinimetric properties for the process indicators* in six practice test hospitals  
 
  
  
INDICATOR 
 Measurability 
% patients with 
missing values 
Applicability 
% patients to whom 
the indicator applies 
Reliability 
(agreement) 
kappa 
Improvement 
potential 
median % for six 
hospitals (range) 
Preoperative evaluation           
9. Microvascular complications evaluateda 3 88a 0,74 81 (12-92) b 
10. Macrovascular complications 
evaluateda 
1 88a  0,64 4 (0-10) 
11. Blood glucose control evaluateda 4 88a  0,78 50 (17-81) b,c 
12. Referred to ambulant diabetes 
caregiver because of poor glycemia control 
>25         
Hospital admission           
13. Diagnosis of ‘diabetes mellitus’ 
recorded on medical chart   
1 100 0,82 6 (0-32)  
14. Blood glucose measurement every 4–6 
h ordered for fasting patients 
2 100 0,51 8 (2-27) 
15. Policy specified for hypoglycemia 2 100 0,73 32 (3-82) b 
16. Policy specified for hyperglycemia 2 100 0,73 23 (3-72) b,c 
Preoperative management           
17. Oral hypoglycemic agents 
discontinued on the morning of surgery 
24 78 0,92 8 (4-25) 
18. Intravenous insulin infusion initiated 
on the morning of surgery 
5 100 0,86 42 (3-94) b,c 
19. Intravenous glucose ordered for fasting 
patients with hypoglycemia 
16 <10       
20. Basal insulin requirements covered at 
all times in case of type 1 diabetes 
>25         
Intraoperative management           
21. Blood glucose measured within 4 h 
preceding surgery 
25 100 0,71 38 (14-50) b,c 
22. Blood glucose measured every 2 h 
during surgery 
0 50 0,83 93 (26-97) c,d 
23. Blood glucose measured within 1 h 
after surgery 
11 100 0,77 38 (26-77) c 
Postoperative management           
24. Hyperglycemia in critically ill surgery 
patients treated with intravenous insulin 
>25         
25. Amount of scheduled insulin revised 
daily on the basis of patient response 
>25         
Hospital discharge           
26. Follow-up visit arranged with 
ambulant diabetes caregiver 
4 100 0,76 85 (81-98) b,c 
27. Follow-up planned for hyperglycemic 
patients who are not known to have 
diabetes 
>25         
Grey bars: indicators with good clinimetric properties in our practice test hospitals  
*The indicator definitions were abbreviated. Appendix I shows the full descriptions. 
a Emergency surgery excluded  
b, c, d Case-mix correction required for: bDiabetes treatment, cType of surgery, dSex 
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Table 3. Fractions of practice test hospitals with organisational structure as described by the 
indicator*  
 
INDICATOR Fraction of hospitals 
28. Multidisciplinary perioperative diabetes care team present 3/6 
29. Protocol for perioperative diabetes care present 6/6 
30. Dosing algorithm to guide intravenous insulin treatment present**  0/6 
31. Staff education on perioperative diabetes care provided  3/6 
32. Glucose measurement manual present 5/6 
33. Quality of perioperative diabetes care evaluated regularly  1/6 
34. Standardised order sets for perioperative glycemia management present 3/6 
35. Nutrition according to the most recent nutritional guidelines 5/6 
36. Access to glucose measurement for all caregivers provided 4/6 
 * The indicator definitions were abbreviated. Appendix I shows the full descriptions.   
**For non-critically ill surgical patients 
 
Practice test 
Setting  
We identified 1100 patients with diabetes who underwent major surgery. We 
aimed to include 30 patients per surgical specialty in each hospital, but these 
numbers were not available for the departments of orthopedic and abdominal 
surgery in all hospitals. We performed a practice test with the final set of 36 
indicators on a sample of 389 patients who underwent abdominal surgery (32%), 
orthopedic surgery (39%), or cardiac surgery (29%). Figure 2 shows the patient 
inclusion. Of these patients, 62% were men and 38% were women. More than half 
of the patients (57%) had received oral treatment with hypoglycemic agents only 
before admission to hospital. Twenty-one percent of the patients used a 
combination of oral hypoglycemic agents and insulin, 18% used insulin only, and 
4% took dietary measures only.  
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Figure 2. Flow-chart showing patient inclusion 
 
 
 
Clinimetric properties assessed 
OUTCOME INDICATORS AND PROCESS INDICATORS 
1. Measurability  
Tables 1 and 2 show the results of the practice test. Nine indicators (4 outcome 
and 5 process) were ‘unmeasurable’ in our study hospitals because the relevant 
data for computing patient indicator scores were missing at the time of data 
extraction for > 25% of the patients.  
2. Applicability 
As hypoglycemia rarely occurred, we considered the indicator ‘intravenous 
glucose ordered for fasting patients with hypoglycemia’ ‘inapplicable’ in our 
study hospitals.  
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3. Reliability 
The indicator ‘blood glucose measurement every 4–6 h ordered for fasting 
patients’ had a kappa of 0.51, which indicates moderate inter-observer 
reliability. All other indicators had kappa scores of > 0.6.  
4. Improvement potential 
The potential for improvement was low for four process indicators and one 
outcome indicator.  
5. Case-mix stability 
Case-mix stability was assessed for 12 indicators that had good clinimetric 
properties (no. 1, 4, 8, 9, 11, 15, 16, 18, 21-23, 26). All these indicators needed 
correction for case mix. The most important determinants that influenced 
several indicator scores were diabetes medication and the type of surgery 
(cardiac, orthopedic, or abdominal). One indicator ‘blood glucose measured 
every 2 h during surgery’ was influenced by sex.  
 
STRUCTURE INDICATORS 
Table 3 presents the fractions of hospitals with organisational structures as 
described by the indicators. Supplementary table S3 presents the details for these 
results, which indicate that there is plenty of room for improving most structure 
indicators. For example, perioperative diabetes care protocols lacked clear 
descriptions of the tasks and responsibilities of the caregivers in five of the six 
hospitals. None of the multidisciplinary teams to coordinate perioperative 
diabetes care included all the professionals who should participate in such a team. 
  
DISCUSSION 
In this study, we developed a set of 36 quality indicators describing optimal 
perioperative diabetes care throughout the hospital care pathway, based on 
international literature and a systematic modified Delphi procedure. The 
application of this systematic and rigorous method for indicator development 
resulted in indicators with high face and content validity. The results from the 
practice test showed that 21 indicators, including 3 outcome indicators, 9 process 
indicators, and 9 structure indicators, could be used to assess the quality of care 
delivered in our six study hospitals.  
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Our study has several strengths. First, to our knowledge, this is the first study to 
develop and appraise quality indicators for optimal perioperative diabetes care 
throughout the entire hospital care pathway using a rigorous and systematic 
approach. In the UK, the JBDS put audit standards in place as part of their 
guidelines for perioperative diabetes care.13 There is overlap between our quality 
indicator set and the audit standards in the JBDS document. However, the 
selection procedure for the audit standards and how they were appraised is 
unclear. We used a modified Delphi method to develop a set of quality 
indicators.18 This method has been used in other studies, and combines scientific 
evidence with the opinions of experts.15,16,32,36,37 Our procedure for quality 
indicator development follows the common steps of guideline-based quality 
indicator development that were recommended by Kötter et al38 Boulkedid et al 39 
reviewed the use and reporting of the Delphi method for quality indicator 
selection. They noted considerable variability across studies in the characteristics 
of the Delphi method, and formulated practical guidelines for using this method 
for selecting healthcare quality indicators. Our procedure using the modified 
Delphi method is compatible with these guidelines.  
 Second, our indicator set includes indicators for patient outcome, process and 
organisational structure of perioperative diabetes care; all three components of the 
Donabedian quality of care framework.18 To make inferences about quality, there 
needs to be an established relationship between these three components. To get an 
indication of the criterion validity of the quality indicators in our set (i.e. were the 
outcomes more favourable for patients who received care as described with the 
quality indicators?), we analysed the relationship between the process indicator 
scores and the length of hospital stay. Preliminary results suggest a trend towards 
shorter hospital stay for patients whose blood glucose was measured according to 
the recommended frequency.  
 A limitation of our study is that the indicator set was developed in a Dutch 
setting; so the results do not automatically translate to other healthcare systems. 
As our set of quality indicators is based on international literature, we are 
convinced that the indicators are useful for other countries as well. For example, 
our set could be used as an extension to the requirements for inpatient diabetes 
care that were formulated by the Joint Commission in the USA, as part of their 
disease-specific programme on inpatient diabetes care.40 However, we strongly 
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advise to test the clinimetric properties of the quality indicators to determine the 
feasibility of the indicator set in other settings. A practice test will also facilitate 
acceptance of the indicators. We provided an example of how to perform such a 
practice test. A second limitation is that nurses and people with diabetes were not 
represented in the procedure to develop indicators. We aimed to include experts 
that had both experience in the care of people with diabetes who have to undergo 
surgery and up-to-date knowledge of the international literature on perioperative 
diabetes care. The latter may apply less to nurses and people with diabetes. In a 
different sub-study of a PhD study, we defined optimal perioperative diabetes 
care from the patients’ view.30  
 In this study, we developed a set of 36 face and content valid quality indicators. 
The results from our practice test show that it is essential to subject indicators to a 
practice test before applying them for quality improvement purposes in a specific 
setting; only 21 could be used to assess the quality of perioperative diabetes care in 
our six hospitals. Nine indicators were unmeasurable, which is quite a high 
number compared with other studies.32,36 This was primarily caused by poor 
availability of medical data and the lack of adequate data resources. Poor 
availability of medical data and the lack of adequate data resources are common 
problems in quality assessment efforts.41 As these problems can be solved by 
changes in administrative policy and data registration, this should not lead to a 
rejection of these indicators. For example, the introduction of electronic patient 
records may facilitate the multidisciplinary sharing of relevant patient information 
and the collection of data to fill the indicators. Similarly, hospital improvement 
potential was low for five indicators in our six hospitals. These indicators are less 
sensitive to detecting differences in the quality of care. These indicators are 
probably not suitable to be used as quality measures in Dutch hospitals. However, 
again, this should not lead to a rejection of these indicators, as a practice test in a 
different setting may yield different outcomes. It should be monitored regularly 
whether adherence continues to be high. 
 The indicator set consists mainly of indicators regarding the structures and 
processes of care, and only few regarding patient outcome. This reflects the ratios 
of these types of recommendations in guidelines. Insurers, policymakers and 
consumers may be more interested in outcome indicators; however, there are 
several disadvantages to the use of outcome indicators. Outcome indicators are 
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sensitive to case mix and the methods of data collection.42,43 In addition, good 
outcomes do not necessarily indicate that care delivery is optimal. Indicators 
regarding the process and structure of care are more valuable in quality 
improvement initiatives, because, unlike outcome measures, they offer a concrete 
starting point for improvement. The practice test in our six hospitals showed that 
there was ample room for improvement regarding many indicators. An 
improvement strategy was developed to address these problem areas.  
 In conclusion, we developed a face and content valid set of quality indicators 
that defines optimal patient outcome, professional performance and organisational 
structure of perioperative diabetes care throughout the hospital care pathway. We 
showed that it is essential to subject indicators to a practice test before applying 
them for quality improvement purposes in a specific setting. Future studies must 
prove the value of the indicator set as a tool to guide and monitor an improvement 
strategy for perioperative diabetes care.  
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SUPPLEMENT 
 
Supplementary Figure 1. Search Strategy 
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Supplementary Figure 2. Example of a Rating Scale for a Recommendation 
 
Potential 
indicator 
Preoperative evaluation To what extent is this item relevant for assessing the 
quality of perioperative diabetes care delivered? 
2.4 The anesthesiologist/surgeon 
should measure glycated 
hemoglobin (HbA1c) in all 
patients with diabetes who 
undergo major surgery if no 
recent value (<3 months old) is 
available 
                                     
                      1     2     3     4     5     6     7     8    9 
 Not at all [------------------------------------------------] Very 
 Cannot assess 
            
 
 
Supplementary Figure 3. Example of an algorithm to calculate the indicator outcome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 1. Exclusion Criteria for the Literature Search 
 
Reasons for exclusion N = 1318 
Articles that did not specifically address perioperative diabetes care or diabetes care for in-
patients 
1107 
Articles studying children 13 
Articles with publication types other than systematic reviews, meta-analysis, clinical trials, 
or guidelines 
39 
Articles with neither abstracts nor full text  10 
Articles addressing diabetes care in a very specific subtype of diabetic patients (kidney 
transplantation) or very specific surgical techniques (diabetic foot surgery) 
9 
Articles containing guidelines that were already retrieved or containing older versions of 
the retrieved guidelines 
24 
Guidelines that were not Dutch or English 2 
 
 
 
Indicator definition:  
The anesthesiologist/surgeon should evaluate preoperative glycemic control prior to planned 
procedures in patients with diabetes who undergo major surgery 
Indicator algorithm:  
Numerator  
The number of patients with diabetes that underwent elective “major surgery”, in whom the 
anesthesiologist/surgeon evaluated preoperative glycemic control  
Denominator  
Total number of patients with diabetes that underwent elective “major surgery” 
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Supplementary Table 2. 52 quality indicators for perioperative diabetes care 
 
INDICATORS Median 
panel rating 
Priority 
score 
Practice 
test 
OUTCOME INDICATORS    
1.      Percentage of patients with all blood glucose values within target 
range (6.0–10.0 mmol/l)  
In the surgical ward  
In the intensive care unit  
During surgery  
7 NA* Yes 
2.      Percentage of hyperglycemic patients (glucose value >10 mmol/l) 
In the surgical ward  
In the critical care unit  
During surgery 
7 NA Yes 
3.      Percentage of patients who developed postoperative wound 
infection during the hospital stay 
7 NA Yes 
4.      Percentage of patients needing unplanned re-admission within 3 
weeks after discharge 
7 NA Yes 
PROCESS INDICATORS       
Preoperative evaluation       
5.      Evaluate and record any metabolic and vascular complications 
prior to planned procedures  
8 53 Yes  
6.      Evaluate preoperative glycemic control prior to planned 
procedures  
7 35 Yes  
7.      Refer patient to his/her ambulant diabetes caregiver when 
diabetes control is poor  
8 26 Yes 
8.      Measure glycated hemoglobin (HbA1c) if no recent value (<3 
months old) is available 
7 12 No 
9.      Delay elective procedures if HbA1c is >75 mmol/mol 7 19 No 
10.    Delay elective procedures if preoperative glucose is >20 mmol/l  7 18 No 
11.    Develop a glycemic management plan and inform the involved 
caregivers about this plan  
8 18 No 
12.    Establish an individualized plan for treating hypoglycemia  7 12 No 
Hospital admission       
13.    Record “diabetes mellitus” on the medical chart if the diagnosis of 
diabetes mellitus is known  
9 51 Yes 
14.    Order blood glucose measurement every 4–6 h for patients who 
are fasted 
7 25 Yes 
15.    Specify policy for hypoglycemia or hyperglycemia 8 51 Yes 
16.    Order blood glucose measurement at mealtimes and at bedtime 
for patients who can eat  
7 2 No 
17.    Order correction dose insulin for patients receiving scheduled 
insulin 
8 19 No 
18.    Treat patients who are not known to have diabetes with the same 
glycemic goals as patients with known diabetes  
8 18 No 
19.    Take precautions to prevent decubitus ulcers in patients with 
diabetic neuropathy 
8 12 No 
20.    Order blood glucose measurement for patients without diabetes 
when risk of hyperglycemia is high 
8 14 No 
21.    Order blood glucose measurement for all patients who are 
admitted for a major surgical procedure and who are not known to 
have diabetes.  
 
8 7 No 
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INDICATORS Median 
panel rating 
Priority 
score 
Practice 
test 
22.    Schedule and/or administer basal insulin in accordance with meal 
planning  
8 2 No 
Preoperative management       
23.    Discontinue oral hypoglycemic agents on the morning of surgery 8 NA Yes 
24.    Order intravenous glucose-insulin-potassium infusion on the 
morning of surgery 
7 NA Yes 
25.    Order administration of intravenous glucose in case of 
hypoglycemia when a patient is fasted  
8 NA Yes 
26.    Cover basal insulin requirements of patients with type 1 diabetes 
at all times 
8 NA Yes 
Intraoperative management       
27.    Measure blood glucose at the following times: 
Within 4 h preceding surgery 
Every 2 h during surgery 
Within 1 h after surgery 
8 NA Yes 
Postoperative management       
28.    Treat critically ill surgery patients who have hyperglycemia with 
intravenous insulin 
8 21 Yes 
29.    Revise amounts of scheduled insulin at least daily on the basis of 
patient response  
8 30 Yes 
30.    Arrange for the patient to resume eating as soon as possible 8 19 No 
31.    Check renal function before restarting metformin  7 18 No 
32.    Restart regular diabetes medication when normal eating has been 
resumed 
8 16 No 
33.    Stop metformin before radiologic contrast examination  8 19 No 
34.    Encourage self-management of diabetes when appropriate  8 18 No 
35.    Preventively modify insulin therapy if there is a downward trend 
in blood glucose concentration or any other condition that predisposes 
to hypoglycemia 
8 14 No 
36.    Pre-emptively treat the patient with intravenous dextrose if 
feeding is interrupted  
7 9 No 
37.    Record episodes of hypoglycemia  8 9 No 
38.    Analyse cause of hypoglycemic episodes  8 5 No 
39.    Order subcutaneous basal-bolus insulin if hyperglycemia is 
reproducibly present and intravenous insulin infusion is not necessary 
7 7 No 
40.    Treat hyperglycemia during the hospital stay with insulin 7 4 No 
41.    Increase scheduled insulin dosage if correction doses are 
frequently required 
8 4 No 
Hospital discharge       
42.    Arrange a follow-up visit with the ambulant diabetes caregiver 8 NA Yes 
43.    Plan for appropriate follow-up in hyperglycemic patients who are 
not known to have diabetes 
8 NA Yes 
STRUCTURE INDICATORS       
44.    Presence of a multidisciplinary team to support and coordinate 
perioperative diabetes care  
This team consists of these caregivers: 
Internist 
Diabetes specialist nurse 
Dietician 
Surgical nurse 
Anesthesiologist 
8 NA Yes 
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INDICATORS Median 
panel rating 
Priority 
score 
Practice 
test 
Intensive care specialist 
Internal medicine resident specialising in the field of diabetology  
This team should: 
Develop and implement protocols  
Develop and implement standardised order sets 
Advise the caring team 
Coordinate staff education and train hospital staff   
Implement strategies to promote self-management of diabetes 
Plan for discharge and follow-up 
Provide support for using insulin infusion therapy  
Monitor the quality of the delivered perioperative diabetes care 
45.    Presence of a protocol for in-patient procedures and surgery for 
adults with diabetes, based on the most recent guidelines.  
This protocol should include:  
TASKS AND RESPONSIBILITIES OF THE VARIOUS CAREGIVERS 
GLYCEMIC MANAGEMENT POLICY: 
Target glucose levels  
Glucose measurement frequency  
Medication policy 
Hypoglycemia management 
Hyperglycemia management 
Procedure for administration of intravenous insulin  
ORGANISATION OF CARE: 
Surgery planned to prevent prolonged preoperative fasting 
Details of when to contact a diabetes specialist 
Postoperative diabetes management 
Discharge planning  
PREVENTION OF COMPLICATIONS: 
Contrast-induced nephropathy in patients with diabetic nephropathy 
Decubitus ulcers in patients with diabetic neuropathy 
Hypoglycemia 
8 NA Yes 
46.    The hospital has an algorithm to guide administration of 
intravenous insulin  
This algorithm should consider:  
The different maintenance insulin requirements of different patients 
Potential change in maintenance insulin requirements over the course 
of treatment  
Both current and previous glucose levels 
The rate of change of plasma glucose 
Current insulin infusion rate 
Nutrition, glucose infusions, and variations in them (bolus or 
continuous) 
7 NA Yes 
47.    Hospital provides staff education on perioperative diabetes care, 
tailored to the responsibilities of the caregivers.  
The following caregivers should receive education: 
Surgeons  
Anesthesiologists 
Internists 
Surgical ward nurses 
Recovery room nurses 
Residents and trainees in the professions just mentioned 
8 NA Yes 
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INDICATORS Median 
panel rating 
Priority 
score 
Practice 
test 
Physician assistants  
48.    The hospital has a glucose measurement manual that includes 
procedures for: 
Method of glucose measurement  
Glucose measurement in specific patient populations (e.g. critical care 
patients) 
Alert values 
Control of measurement quality 
Maintenance of measurement devices 
Administration responsibility                 
8 NA Yes 
49.    The hospital has a system for regular evaluation of the quality of 
perioperative diabetes care 
(Care quality is defined as the performance for the entire set of 
indicators 
7 NA Yes 
50.    The hospital has standardized order sets for perioperative 
glycemic management (e.g., for scheduled or correction dose insulin) 
7 NA Yes 
51.    The hospital provides nutrition according to the most recent 
nutritional guidelines  
7 NA Yes 
52.    The hospital ensures access to glucose measurements for all 
caregivers who are involved in the perioperative process  
8 NA Yes 
Grey bars: prioritised indicator set. These indicators were included in the practice test 
*NA: Not applicable. The ranking procedure was added to prioritise key indicators for categories of process 
indicators that contained more than four indicators. Other  indicators were included directly in the practice 
test. 
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Supplementary Table 3. Results for the Structure Indicators in Detail 
 
DESCRIPTION OF QUALITY INDICATOR Fraction of hospitals 
Multidisciplinary perioperative diabetes care team present 3/6 
The team consists of the following caregivers:  
Internist 3/3 
Diabetes nurse 2/3 
Dietician 0/3 
Surgical nurse 1/3 
Anesthesiologist 1/3 
Intensive care specialist 0/3 
Internal medicine resident specializing in diabetology 2/3 
The team has the following responsibilities:  
Development and implementation of a perioperative protocol  3/3 
Development and implementation of standardized order sets  2/3 
Advising the care team 2/3 
Coordination of staff education and training 3/3 
Promoting self-management of diabetes 1/3 
Planning for discharge and follow-up 1/3 
Providing support for treatment with intravenous insulin  1/3 
Monitoring the quality of delivered perioperative diabetes care 2/3 
Protocol for perioperative diabetes care present 6/6 
This protocol addresses the following care elements:  
TASKS AND RESPONSIBILITIES OF THE FOLLOWING CAREGIVERS:  
Internists 3/6 
Anesthesiologists 1/6 
Surgeons 1/6 
Nurses 3/6 
Intensive care specialists 0/6 
GLYCEMIC MANAGEMENT POLICY:   
Target glucose values 5/6 
Glucose measurement frequency 5/6 
Medication policy 6/6 
Hypoglycemia management 1/6 
Hyperglycemia management 4/6 
Procedure for administration of intravenous insulin 5/6 
ORGANISATION OF PERIOPERATIVE CARE:  
Surgery planning to prevent prolonged fasting 2/6 
Details of when to contact a diabetes specialist 4/6 
Postoperative diabetes management 4/6 
Discharge planning  2/6 
PREVENTION OF COMPLICATIONS:  
Contrast-induced nephropathy  5/6 
Decubitus ulcers in patients with diabetic neuropathy 5/6 
Hypoglycemia 1/6 
Dosing algorithm to guide intravenous insulin treatment present 0/6 
Staff education on perioperative diabetes care provided  3/6 
Education is provided for the following caregivers:  
Surgeons 0/3 
Anesthesiologists 0/3 
Internists 1/3 
Surgical ward nurses 2/3 
Recovery room nurses 0/3 
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DESCRIPTION OF QUALITY INDICATOR Fraction of hospitals 
Physician assistants 0/3 
Glucose measurement manual present 5/6 
This manual describes:   
Method of measuring glucose  4/5 
Glucose measurement for specific patient populations  5/5 
Procedure for alert values 2/5 
Procedure for control of measurement quality 4/5 
Procedure for maintenance of measurement devices 4/5 
Administration responsibility 2/5 
Quality of perioperative diabetes care regularly evaluated  1/6 
The hospital evaluates the following quality aspects:   
Average glycemic control  0/1 
Professional performance  1/1 
Patient orientedness of care  0/1 
Organisational structure  1/1 
Standardised order sets for perioperative glycemic management present  3/6 
Order sets are available for:   
Scheduled insulin 2/3 
Correction dose insulin 3/3 
Nutrition provided according to the most recent nutritional guidelines 5/6 
Access to glucose measurement results for all caregivers  4/6 
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ABSTRACT 
Background In this study, we assess the quality of current perioperative diabetes 
care throughout the hospital care pathway.  
Methods Multicenter observational study, including 389 participants with 
diabetes who underwent abdominal, cardiac, or large joint orthopedic surgery in 
six hospitals. We used 21 quality indicators for optimal perioperative diabetes 
care, including 3 outcome, 9 process, and 9 structure indicators, to assess the 
quality of current care.  
Results There were low scores for many quality indicators. Regarding patient 
outcome, only five percent of the participants had all postoperative blood glucose 
values within the recommended target range (6–10 mmol/l), and 91% had at least 
one hyperglycemic episode. Six of 9 process indicators scored less than 60%. For 
example, patient records revealed information about preoperative glycemic 
control for only 42% of the participants. Intraoperative blood glucose was 
measured according to the recommended frequency (once every 2 h) in 32% of the 
participants. Diabetes follow-up arrangements were tracked for 15%. Regarding 
organisational structure, perioperative diabetes care protocols lacked clear 
descriptions of the tasks and responsibilities of the caregivers in five of six 
hospitals. None of the hospitals had a multidisciplinary team in which all 
professionals involved in perioperative diabetes care were represented. There was 
considerable variation in indicator scores between the six hospitals.  
Conclusions The assessment shows major gaps between recommended 
perioperative diabetes care and current practice, and substantial variation in care 
delivery between hospitals. Interventions to improve perioperative diabetes care 
should focus on these specific gaps between recommended care and current 
practice. 
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INTRODUCTION 
Surgery for patients with diabetes is associated with longer hospital stay, more use 
of healthcare resources and increased perioperative morbidity and mortality 
compared to patients without diabetes.1-4 This may – in part – be explained by 
suboptimal perioperative diabetes care.  
 Perioperative diabetes care is a complex and multidisciplinary process. The 
hospital care pathway ranges from the preoperative evaluation up to hospital 
discharge, and is characterised by multiple care transitions and multiprofessional 
involvement. To achieve optimal perioperative diabetes care, all professionals 
involved should take the specific needs of the person with diabetes into account at 
all stages of the hospital care pathway from preoperative evaluation to hospital 
discharge.5  
 Several large professional organisations have developed recommendations for 
optimal perioperative diabetes care, but it is unknown whether this has resulted in 
optimal care delivery.5,6 In a previous study, we developed and tested quality 
indicators for optimal perioperative diabetes care to assess current care delivery.7 
These indicators are based on international guidelines and literature and were 
selected in a systematic Modified Delphi procedure.8-10  
In this study, we assessed the quality of current perioperative diabetes care 
throughout the hospital care pathway using these indicators.  
 
MATERIALS AND METHODS 
Design and study population 
We assessed the quality of current perioperative diabetes care for patients with 
diabetes who undergo major surgery in an observational study in six Dutch 
hospitals. There were two university hospitals (953-1042 beds), two medium-size 
teaching hospitals (543-576 beds), and two large non-university teaching hospitals 
(730-846 beds). All six hospitals performed orthopedic and abdominal surgery, 
and three of the six hospitals performed cardiac surgery. The hospitals 
participated in a study to test the effectiveness of an implementation strategy to 
improve perioperative diabetes care in daily clinical practice (trial no. 
NCT01610674). The Regional Review Board for Human Research Arnhem-
Nijmegen (CMO, no. 2008/333), approved the study for all hospitals. 
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Adult patients with diabetes were included if they met our criteria of major 
surgery: (1) the person was under general anesthesia during abdominal surgery or 
cardiac surgery, or under spinal or general anesthesia during large-joint 
orthopedic surgery and (2) the minimum operation time was 1 h. Patients who 
underwent out-patient surgery were excluded. If a participant underwent more 
than one surgical procedure, we included the first procedure. The survey included 
a one year observation period. We retrospectively identified the participants from 
data in the hospital prescription system, operating room management systems, 
preoperative screening records, and anesthesiology records. The participants were 
invited to participate in the study by mail and by phone.11 After informed consent 
had been obtained, information regarding the inclusion criteria was verified with 
the patient record. We aimed to include a minimum of 30 participants per surgical 
specialty (abdominal surgery, cardiac surgery, and large-joint orthopedic surgery) 
in each hospital.  
 
Quality indicators for perioperative diabetes care 
A modified Delphi method was used to achieve consensus on a valid set of quality 
indicators.8-10. Recommendations for optimal perioperative diabetes care were 
extracted from the literature (international guidelines, websites and PubMed 
database), translated into potential quality indicators, and presented to a 
multidisciplinary expert panel. This resulted in 36 quality indicators for optimal 
perioperative diabetes care throughout the hospital care pathway.7 The 
recommendations were categorised as ‘patient outcome’, ‘process’ or 
‘organisational structure’.12 Recommendations for process were categorised 
according to the various stages of the hospital care pathway: ‘preoperative 
evaluation’, ‘hospital admission’, ‘preoperative management’, ‘intraoperative 
management’, ‘postoperative management’, or ‘hospital discharge’. We tested the 
clinimetric properties of the indicators (measurability, applicability, reliability, 
improvement potential, and case-mix stability) in a practice test in six hospitals, 
and 21 indicators could be used to validly and reliably assess the quality of 
perioperative diabetes care.  
 In this multicenter observational study we report the results on 21 quality 
indicators for optimal perioperative diabetes care throughout the hospital care 
pathway including 3 outcome, 9 process, and 9 structure indicators.  
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Data collection 
The data relevant to process and outcome indicators were manually abstracted 
from the patient records and entered into a computerised database. The data were 
collected from medical and nursing records, anesthesiology records, medication 
records, and laboratory reports. Four trained research assistants and one 
researcher searched the patient records in the period August 2010–May 2011.  
 We assessed the quality indicators for the recommended organisational 
structure of perioperative diabetes care with a questionnaire. A diabetes specialist 
in each of the six participating hospitals completed the questionnaire. We asked 
the diabetes specialist to consult other caregivers if this was needed to answer the 
questions. For the questions about the content of the protocol, we asked the 
diabetes specialist to provide us with their local protocol. 
 
Statistical analysis 
Individual participant indicator scores (dichotomous variable) were computed for 
each participant and for each outcome and process indicator, and the scores 
described whether (value 1) or not (value 0 ) care was delivered as recommended. 
We computed overall indicator scores (in percentages) by dividing the number of 
participants who received the recommended care as described by the indicator 
(numerator) by the number of participants to whom the recommended care 
applied (denominator) To gain insight into the variation in indicator scores 
between the hospitals, we also calculated individual hospital scores and the 
median of these scores. SPSS 18.0 for Windows, Chicago, Ill was used for these 
descriptive analyses. 
 Because of the hierarchical structure of our study (patients nested within 
hospitals we performed multilevel logistic analysis (SAS for Windows V8.2) to 
study the relationship between the indicator scores and the following participant 
characteristics: age (≤ 70 years or > 70), gender, insulin treatment (yes = 
participant treated with insulin or a combination of insulin and oral hypoglycemic 
agents prior to hospitalisation), and type of surgery (cardiothoracic surgery, 
orthopedic surgery or abdominal surgery). A random intercept model with all 
other variables fixed was used. Participant characteristics with a significant 
influence on the indicator scores were included in a multilevel logistic regression 
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analysis to explain differences in indicator scores between hospitals.13 Significance 
for the multilevel analysis was set at p<0.05. 
 
RESULTS 
Study population  
Figure 1 shows the participant inclusion. A total of 389 participants participated in 
the current care assessment; 126 (32%) underwent abdominal surgery, 151 (39%) 
orthopedic surgery, and 112 (29%) cardiac surgery. Sixty-two percent were men 
and 38% were women. More than half of the participants (57%) were treated with 
oral hypoglycemic agents only before admission to hospital. Twenty-one percent 
of the participants used a combination of oral hypoglycemic agents and insulin, 
18% used insulin only, and 4% took dietary measures only.  
 
Figure 1. Participant inclusion 
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Outcome indicators 
Table 1 shows the results for the outcome indicators. For 5% of the participants, all 
postoperative blood glucose values were within the target range (6–10 mmol/l). 
Virtually all participants (91%) had at least one hyperglycemic episode (>10 
mmol/l) during the postoperative stay in the surgery ward. Ten percent of the 
participants needed unplanned readmission.  
 
Table 1.  Outcome indicator results and range of scores in the six hospitals 
 
 
Description of quality indicator 
Indicator 
score (%) 
 
Nc 
Range of hospital 
scores (%)  
All glucose values within target rangea in the surgical ward  5% 328 0-8 
Hyperglycemiab  in the surgical ward  91% 325 82-96 
Unplanned re-admission within 3 weeks  10% 388 6-14 
a Target range: 6-10 mmol/l.  
b Hyperglycemia: ≥1 or more glucose values >10 mmol/l 
c Number of evaluable participants (= indicator applicable, no missing data) 
 
Supplementary table 1 shows the influence of participant characteristics on the 
indicator scores. Fewer insulin-treated participants had all values within the target 
range compared to non-insulin-treated participants (OR 0.14 p=0.013) and more 
had at least one hyperglycemic episode (OR 2.14 p=0.033).  
 We also looked at differences in outcome indicator scores between the six 
hospitals. Figure 2 shows the individual hospital scores and the median of these 
scores. Individual hospital scores for the outcome indicators showed little 
variation between the hospitals. For example, the percentage of participants who 
had all postoperative blood glucose values within the recommended target range 
(6–10 mmol/l) was 0% in the lowest scoring hospital and 8% in the highest scoring 
hospital.  
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Process indicators 
Table 2 shows the process indicator scores. The indicator scores are described 
following the stages of the hospital care pathway that ranges from preoperative 
evaluation to hospital discharge.  
At the time of preoperative evaluation, information on preoperative glycemic 
control and microvascular complications was available for about half of the 
participants.  
Instructions for managing hypoglycemia and hyperglycemia were retrieved for 
about two thirds of the participants. For slightly more participants (70%) a policy 
was specified for hyperglycemia than for hypoglycemia (61%).  
 On the morning of surgery, fifty-six percent of the participants received 
intravenous insulin infusions.    
 At the start of surgery, a recent blood glucose value (<4 h preoperative) was 
available for 85% of the participants. In contrast, during surgery, blood glucose 
was rarely measured at the recommended frequency of at least once every 2 h 
(32%). Blood glucose levels were measured within one hour postoperative in 57% 
of the participants.  
 At discharge, follow-up arrangements for diabetes treatment with an ambulant 
diabetes caregiver were found for 15% of the participants. 
 
Table 2. Process indicator results and range of scores in the six hospitals 
 
 
Description of quality indicator 
Indicator 
score (%) 
 
na 
Range of  
hospital scores (%) 
Preoperative evaluation    
Microvascular complications evaluated 51 333 8-88 
Blood glucose control evaluated  42 327 19-83 
Hospital admission    
Policy specified for hypoglycemia  61 380 18-97 
Policy specified for hyperglycemia 70 380 29-97 
Preoperative management    
Intravenous insulin infusion initiated on the morning of surgery 56 371 6-97 
Intraoperative management    
Blood glucose measured within 4 h preceding surgery 85 293 50-85 
Blood glucose measured every 2 h during surgery 32 196 0-74 
Blood glucose measured within 1 h after surgery 57 348 23-74 
Hospital discharge    
Follow-up visit arranged with ambulant diabetes caregiver 15 372 2-19 
aNumber of evaluable participants (= indicator applicable, no missing data) 
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Supplementary table 1 shows the factors that influenced the process indicator 
scores. Participants who were treated with insulin or a combination of insulin and 
oral hypoglycemic agents prior to hospitalisation had higher scores for most 
process indicators. Participants who underwent cardiothoracic surgery or 
orthopaedic surgery had higher scores for most process indicator scores compared 
to those who underwent abdominal surgery. 
 
Process indicator scores varied considerably between the six hospitals (Figure 2). 
For most process indicators the range of individual hospital scores exceeded 50%, 
indicating large inter-hospital variations in care delivery throughout the hospital 
care pathway. The largest range of scores was found for the indicator ‘intravenous 
insulin infusion initiated on the morning of surgery’. Six percent of the 
participants in the lowest scoring hospital versus 97% of the participants in the 
highest scoring hospital received intravenous insulin infusions on the morning of 
surgery. Most of the variation in hospital indicator scores could not be explained 
by differences at the level of the participants. Intracluster correlation (ICC) varied 
between 0.03 – 0.60 after correction for participant characteristics. (Supplementary 
Table 2).  
 
Structure indicators 
Table 3 shows the results for the structure indicators. These results also varied 
considerably between the hospitals. 
 A multidisciplinary diabetes team to support and coordinate perioperative 
diabetes care was present in half of the hospitals (3/6); however, multidisciplinary 
participation was incomplete in all these teams. Internists were represented in all 
teams (3/3), diabetes specialist nurses in two (2/3), and both anesthesiologists and 
surgical nurses in one team (1/3).  
 All hospitals had a protocol for perioperative diabetes care (6/6). Protocols for 
perioperative diabetes care addressed tasks and responsibilities of internists and 
nurses in half of the hospitals (3/6), of anesthesiologists and surgeons in one 
hospital (1/6), and of intensive care specialists in none of the hospitals. 
Recommended items regarding glycemic management were addressed in most 
protocols except for hypoglycemia management, which was addressed in one 
protocol (1/6). Planning of surgery in order to prevent prolonged preoperative 
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fasting and discharge planning with respect to diabetes care policy were 
addressed in two of six protocols. 
 None of the hospitals had a decision support system (algorithm) to guide the 
administration of intravenous insulin (0/6).  
 Three hospitals (3/6) provided staff education on perioperative diabetes care; 
however, none of these hospitals provided education for all caregivers involved. 
In particular, surgeons and anesthesiologists did not receive any education (0/6).  
Standardised order sets were available in three of the six hospitals, access to 
glucose values for all caregivers involved was arranged in four hospitals, and 
nutrition according to current guidelines and a glucose measurement manual were 
both provided in five of the six hospitals.  
 One hospital (1/6) regularly assessed the quality of the perioperative diabetes 
care; this hospital assessed professional performance and organisation of 
perioperative diabetes care, but not the quality of perioperative glycemic control. 
 
Table 3. Structure indicator results  
 
DESCRIPTION OF QUALITY INDICATOR Fraction of hospitals 
1. Multidisciplinary perioperative diabetes care team present 3/6 
The team consists of the following caregivers:  
Internist 3/3 
Diabetes nurse 2/3 
Dietician 0/3 
Surgical nurse 1/3 
Anesthesiologist 1/3 
Intensive care specialist 0/3 
Internal medicine resident specialising in diabetology 2/3 
The team has the following responsibilities:  
Development and implementation of a perioperative protocol  3/3 
Development and implementation of standardised order sets  2/3 
Advising the care team 2/3 
Coordination of staff education and training 3/3 
Promoting self-management of diabetes 1/3 
Planning for discharge and follow-up 1/3 
Providing support for treatment with intravenous insulin  1/3 
Monitoring the quality of delivered perioperative diabetes care 2/3 
2. Protocol for perioperative diabetes care present 6/6 
This protocol addresses the following care elements: 
TASKS AND RESPONSIBILITIES OF THE FOLLOWING CAREGIVERS: 
 
 
Internists 3/6 
Anesthesiologists 1/6 
Surgeons 1/6 
Nurses 3/6 
Intensive care specialists 0/6 
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DESCRIPTION OF QUALITY INDICATOR Fraction of hospitals 
GLYCEMIC MANAGEMENT POLICY:   
Target glucose values 5/6 
Glucose measurement frequency 5/6 
Medication policy 6/6 
Hypoglycemia management 1/6 
Hyperglycemia management 4/6 
Procedure for administration of intravenous insulin 5/6 
ORGANISATION OF PERIOPERATIVE CARE:  
Surgery planning to prevent prolonged fasting 2/6 
Details of when to contact a diabetes specialist 4/6 
Postoperative diabetes management 4/6 
Discharge planning  2/6 
PREVENTION OF COMPLICATIONS:  
Contrast-induced nephropathy  5/6 
Decubitus ulcers in patients with diabetic neuropathy 5/6 
Hypoglycemia 1/6 
3. Dosing algorithm to guide intravenous insulin treatment present 0/6 
4. Staff education on perioperative diabetes care provided  3/6 
Education is provided for the following caregivers:  
Surgeons 0/3 
Anesthesiologists 0/3 
Internists 1/3 
Surgical ward nurses 2/3 
Recovery room nurses 0/3 
Physician assistants 0/3 
5. Glucose measurement manual present 5/6 
This manual describes:   
Method of measuring glucose  4/5 
Glucose measurement for specific patient populations  5/5 
Procedure for alert values 2/5 
Procedure for control of measurement quality 4/5 
Procedure for maintenance of measurement devices 4/5 
Administration responsibility 2/5 
6. Quality of perioperative diabetes care regularly evaluated  1/6 
The hospital evaluates the following quality aspects:   
Average glycemic control  0/1 
Professional performance  1/1 
Person centredness of care  0/1 
Organisational structure  1/1 
7. Standardised order sets for perioperative glycemic management present  3/6 
Order sets are available for:   
Scheduled insulin 2/3 
Correction dose insulin 3/3 
8. Nutrition provided according to the most recent nutritional guidelines 5/6 
9. Access to glucose measurement results for all caregivers  4/6 
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DISCUSSION 
In this study, we assessed the quality of perioperative diabetes care throughout 
the hospital care pathway with a set of 21 quality indicators. The assessment 
showed  ample room for improvement of perioperative diabetes care in all stages 
of the care pathway, gaps in the organisational structure of perioperative diabetes 
care, and poor postoperative glucose control. There were large variations in the 
organisation and delivery of perioperative diabetes care between the participating 
hospitals.  
 This is the first study to systematically assess the quality of perioperative 
diabetes care throughout the entire hospital care pathway. Some earlier studies 
assess the quality of diabetes care for hospitalised patients, including surgery 
patients. These studies were not designed to assess the quality of perioperative 
diabetes care along the entire patient pathway.14-17 In the UK, the ‘National 
Diabetes Inpatient Audit’ demonstrated that patients with diabetes, and those who 
are admitted for surgery in particular, experience high levels of medication and 
management errors during hospital stay.16 In the USA, Wexler et al. analysed the 
prevalence and management of hyper- and hypoglycemia among inpatients with 
diabetes in 44 hospitals.14 Severe hypoglycemia (glucose <2.2 mmol/l) was rare, 
but 77% of the participants had at least one hyperglycemic episode which was 
often managed inadequately. One study investigated preoperative glycemic 
control in surgical patients with diabetes. A preoperative HbA1c was available for 
only one third of the patients.18 This confirms our finding that glycemic control is 
often not addressed at the preoperative evaluation. 
 Despite the overall high quality of healthcare and diabetes care in the 
Netherlands, this study shows major gaps between recommended and current 
perioperative diabetes care.19-20 This probably reflects the difficulty of introducing 
evidence and clinical guidelines into the routine daily practice of a complex multi-
professional care process.21 The gaps in organisational structure raise the question 
whether the involved professionals are used to managing the diabetes as a team. 
Successful perioperative diabetes management requires a close working 
relationship between internists, surgeons, anesthesiologists, nurses, and patients 
with diabetes. However, none of the hospitals had a multidisciplinary team in 
which all professionals involved in perioperative diabetes care were represented, 
and the tasks and responsibilities for the various caregivers were poorly described 
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in protocols. There were large variations in the organisation and delivery of 
perioperative diabetes care between hospitals, even after correction for participant 
characteristics (ICC 0.03 – 0.60).22 The absence of a Dutch national guideline for 
perioperative diabetes care until recently may have contributed to these 
variations.23 Unfortunately, the number of hospitals was too small to study the 
influence of differences in the organisational structure of perioperative diabetes 
care between hospitals on the outcome and process indicator scores. Participant-
related factors explained only a small part of the inter-hospital variations in 
process indicator scores.  
 We described previously that patients with diabetes using insulin treatment 
prior to hospitalisation have more favorable experiences with perioperative 
diabetes care compared to patients with diabetes using oral treatment or a diet.11 
In line with these findings, the present study showed that more insulin treated 
participants received the recommended care as described by the process 
indicators. This could indicate that professionals perceive insulin-treatment as a 
marker of ‘more severe diabetes’ that deserves more attention than non-insulin-
treated diabetes.24 Strategies to improve perioperative diabetes care therefore need 
to pay specific attention to patients with non-insulin treated diabetes.   
 A strength of our study is that the assessment included all three components of 
the Donabedian quality of care framework: patient outcome, process and 
organisational structure of perioperative diabetes care.12 Our results are based on a 
large sample of participants with diabetes who had major surgery from six 
hospitals. The relationship between hyperglycemia and worse postoperative 
patient outcome has been clearly established for these patients.4,25-27 A limitation of 
this study is that the set of 21 quality indicators did not include indicators to assess 
the quality of care for the stage ‘postoperative management’ in our six hospitals. 
The initial set of 36 quality indicators, as developed based on guidelines and 
literature, included two quality indicators for this stage. Unfortunately, the 
practice test in our six hospitals showed that these indicators were unmeasurable 
because data to fill the indicator algorithms were missing for a large proportion of 
the participants.7 Improvements in administrative policy and data registration 
may facilitate the collection of these data in the future. A second limitation is that 
we could not study the influence of diabetes type on the indicator scores, as it was  
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often not recorded in the medical record. We analysed the influence of diabetes 
treatment instead.  
 As a next step, we have planned to evaluate the relationship between the 
process indicator scores and patient outcome. To gain insight into this, we used 
these baseline data to investigate the relationship between the process indicator 
scores and the length of hospital stay. For five of nine process indicators, there was 
a trend towards shorter hospital stay in case of adherence to the indicator. These 
included all three quality indicators regarding the measurement of blood glucose 
in the perioperative period (indicator no. 6, 7 and 8). The association was 
significant for one quality indicator, concerning intraoperative glucose 
measurement (indicator no. 7). We are waiting for the data from the after 
measurement for the improvement study to confirm these results.   
 In conclusion, our assessment identified major gaps between recommended 
perioperative diabetes care and current practice, and large variations in care 
delivery between the hospitals. The indicator scores reveal multiple opportunities 
for improvement of perioperative diabetes care throughout the hospital care 
pathway. Interventions to improve the quality of perioperative diabetes care 
should focus on these specific gaps between recommended care and current daily 
practice. Further research is needed to clarify the determinants of the variation in 
care delivery and to determine the optimal strategy to improve perioperative 
diabetes care.  
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SUPPLEMENT 
 
Supplementary Table 1. Factors that influence outcome and process indicator scores 
 
 Participant characteristic 
 Insulin 
treated 
 
Age>70 yrs 
 
Female 
Orthopedic 
surgery* 
Cardiothoracic 
surgery* 
Description of quality indicator OR P OR P OR P OR OR P** 
All glucose values within target 
range* in the surgical ward  
0.14 0.013 0.45 0.144 0.73 0.571 0.96 0.09 0.072 
Hyperglycemia † in the surgical 
ward  
2.14 0.033 1.08 0.033 0.59 0.454 0.58 1.27 0.062 
Unplanned readmission within 3 
weeks  
2.00 0.002 0.29 0.002 0.65 0.002 0.24 0.29 0.002 
Microvascular complications 
evaluated 
5.12 <.001 1.46 0.237 0.52 0.054 2.03 0.78 0.093 
Blood glucose control evaluated  2.14 0.010 0.80 0.407 1.00 0.999 0.76 0.08 <.001 
Policy specified for hypoglycemia  1.84 0.026 1.45 0.163 1.27 0.383 1.95 2.13 0.067 
Policy specified for hyperglycemia 1.79 0.042 1.24 0.424 0.93 0.791 1.27 6.96 <.001 
Intravenous insulin infusion 
initiated on the morning of surgery 
4.09 <.001 0.93 0.812 1.20 0.559 1.10 14.98 <.001 
Blood glucose measured within 4 h 
preceding surgery 
2.43 0.002 0.65 0.099 0.72 0.224 2.44 1.50 0.019 
Blood glucose measured every 2 h 
during surgery 
1.45 0.422 0.72 0.476 0.35 0.035 1.00 6.20 0.006 
Blood glucose measured within 1 h 
after surgery 
1.59 0.103 0.88 0.625 1.31 0.342 1.85 19.40 <.001 
Follow-up visit arranged with 
ambulant diabetes caregiver 
0.97 0.020 0.97 0.930 0.94 0.859 0.38 0.32 0.003 
* Comparison of orthopedic surgery and cardiothoracic surgery with abdominal surgery 
**  Overall p-value categorical variable Orthopedic surgery  vs Cardiothoracic surgery vs abdominal 
surgery 
 
Supplementary Table 2. Variation in hospital indicator scores after correction for participant 
characteristics.  
 
Indicator description ICCa 
1. All glucose values within target range (6-10 mmol/l) in the surgical ward  0.23 
2. Hyperglycemia (>10 mmol/l) in the surgical ward  0.56 
3. Unplanned readmission within 3 weeks  0.35 
4. Microvascular complications evaluated 0.33 
5. Blood glucose control evaluated  0.60 
6. Policy specified for hypoglycemia  0.09 
7. Policy specified for hyperglycemia 0.32 
8. Intravenous insulin infusion initiated on the morning of surgery 0.19 
9. Blood glucose measured within 4 h preceding surgery 0.08 
10. Blood glucose measured every 2 h during surgery 0.04 
11. Blood glucose measured within 1 h after surgery 0.03 
12. Follow-up visit arranged with ambulant diabetes caregiver 0.00 
a Intracluster Correlation calculated after correction for participant characteristics. 
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ABSTRACT 
Aims Person centredness is an important principle for delivering high-quality 
diabetes care. In this study, we assess the level of person  centeredness of current 
perioperative diabetes care.  
Methods We conducted a survey in six Dutch hospitals, among 690 participants 
with diabetes who underwent major abdominal, cardiac, or large-joint orthopedic 
surgery. The survey included questions regarding seven dimensions of person-
centred perioperative diabetes care.  
Results Complete data were obtained from 298 participants. The survey scores 
were low for many of the dimensions of person centredness. The dimensions 
‘information’, ‘patient involvement’, and ‘coordination and integration of care’ 
had the lowest scores. Only half the participants had received information about 
perioperative diabetes treatment, and approximately one-third had received 
information about the effect of surgery on blood glucose values, target glucose 
values, and glucose measurement times. Similarly, half the participants had an 
opportunity to ask questions preoperatively, and only one-third of the participants 
felt involved in the decision-making regarding diabetes treatment. Most 
participants knew neither the caregiver in charge of perioperative diabetes 
treatment nor whom to contact in case of diabetes-related problems during their 
hospital stay.  
Conclusions Current perioperative diabetes care is characterised by a lack of 
patient information and limited patient involvement. These results indicate that 
there is ample room for improving the person centredness of perioperative 
diabetes care.  
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INTRODUCTION 
Current guidelines for diabetes care advocate a person centred approach to 
treating people with diabetes.1 Person centred care is an important principle for 
delivering high-quality diabetes care.2 The Institute of Medicine defines person 
centred care as “providing care that is respective of and responsive to individual 
patient preferences, needs and values, and ensuring that patient values guide all 
clinical decisions”.3 Individualised treatment regimens and self-management 
support are therefore the fundamentals of contemporary diabetes care.1 This 
implies that adequate glucose control cannot be achieved without active 
participation of the person with diabetes. 
 The prevalence of diabetes among surgical patients ranges from 20% for general 
surgery to nearly 35% for cardiac surgery.4,5 Limited information about the person 
centredness of perioperative diabetes care in daily clinical practice is available: are 
the persons’ needs and preferences for perioperative diabetes care met, and do 
their values guide all clinical decisions? Previous studies that have assessed 
patient experiences in various populations of inpatients suggest that people with 
diabetes feel rather disempowered with respect to their diabetes when admitted to 
hospital for intercurrent disease, such as a surgical procedure.6,7,8 However, these 
studies do not focus on the needs and preferences of surgical patients with 
diabetes along the entire hospital care pathway. The present study aims to assess 
the level of person centredness in current perioperative diabetes care. To meet this 
goal, we conducted a survey among a large group of patients undergoing major 
surgery, and we determined the clinical characteristics that influenced person 
centredness. 
 
PARTICIPANTS AND METHODS 
Development of a survey on person centred perioperative diabetes care 
We based our survey on the Picker dimensions of person centredness and the 
questions from the Picker Adult Inpatient Survey.9,10 The Picker Institute, an 
organisation that is dedicated to developing a person centred approach to 
healthcare, defines eight universal dimensions of person centredness of hospital 
care that appear relevant for Europe and the USA (Table 1).11,12  
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Box 1. Picker dimensions of person centredness 
 
 Access to care 
 Information, communication, and education 
 Respect for patient values, preferences, and needs 
 Physical comfort 
 Coordination and integration of care 
 Emotional support and alleviation of fear and anxiety 
 Involvement of family and friends 
 Transition and continuity 
 
We used a focus group discussion to tailor relevant questions from the Picker 
Adult Inpatient Survey to the setting of perioperative diabetes care. We asked the 
participants to reflect on their needs and preferences for diabetes care from 
preoperative evaluation to hospital discharge. We selected the participants in 
consultation with their ambulant diabetes caregiver on the basis of the following 
criteria: (1) surgery within the previous 2 years, (2) insulin treatment, and (3) 
experience with self-management of diabetes. We aimed for a group of four to 
eight participants.13 We invited ten people, of whom eight accepted the invitation. 
Two people could not participate because of time constraints, and the six 
remaining participated in the focus group discussion. Three of the six participants 
were men, and the mean age was 50 years (range 41–62 years). Five participants 
had type 1 diabetes; the mean duration of diabetes was 25 years (range 7–41 
years).  
 The tape-recorded focus group discussion was transcribed verbatim. We 
analysed the interview qualitatively using Atlas.ti software. Two researchers 
extracted all transcripts that had to do with a person’s needs and preferences 
regarding perioperative diabetes care. All transcripts were classified to the 
corresponding Picker dimensions of person centredness (Box 1). Disagreements 
were solved by discussion.  
 We extracted a total of 48 transcripts that related to six dimensions of person 
centredness. Many transcripts centred on ‘information’ and ‘patient involvement’. 
These appeared to be key areas for people with diabetes who have to undergo 
surgery. Therefore, we split the dimension ‘information, communication, and 
education’ into ‘information’ (16 items) and ‘communication and education’ (5 
items; Table 1). We renamed the dimension ‘respect for the person’s values, 
preferences, and needs’ ‘patient involvement’ (11 items). Eight items related to 
‘coordination and integration’. Fewer transcripts related to the dimensions ‘access 
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to care’ (3 items), ‘physical comfort’ (2 items), and ‘transition and continuity’ (3 
items). We did not identify transcripts for ‘emotional support’ and ‘involvement of 
family and friends’.  
 We translated all 48 transcripts into questions that ask people with diabetes to 
rate their experiences with perioperative diabetes care on a four-point Likert scale 
(1 = never; 2 = sometimes; 3 = usually; 4 = always) or on a YES or NO scale.  
 
Participants 
We used the survey to assess the person centredness of current perioperative 
diabetes care in six Dutch hospitals. These hospitals participated in a project to 
improve the quality of perioperative diabetes care for people who undergo major 
surgery (trial no. NCT01610674). The survey was part of the baseline measurement 
for the improvement project. There were two university hospitals with 953 and 
1042 beds and four non-university teaching hospitals with a bed capacity varying 
from 543 to 846. All six hospitals performed orthopaedic and abdominal surgery, 
and three of the six hospitals performed cardiac surgery. We aimed to include a 
minimum of 30 participants per surgical specialty in each hospital and invited a 
minimum of 60 participants per surgical specialty whenever sufficient numbers 
were available. The participants were recruited retrospectively from data in the 
hospital prescription system, operating room management systems, preoperative 
screening records, and anaesthesiology records. The data concerned surgery that 
took place during the period 2009-2010. Adults with diabetes were included if they 
met the following criteria for major surgery: (1) they were under general 
anesthesia during abdominal surgery or cardiac surgery or under general or spinal 
anaesthesia during large-joint orthopedic surgery and (2) the minimum operation 
time was 1 h. People who underwent outpatient surgery were excluded. We 
invited the participants to participate in the survey by post.  
 Informed consent was obtained from all participants because the baseline 
measurement for the improvement project included a medical record search. After 
informed consent had been obtained, information regarding the inclusion criteria 
was verified with the patient record. The Regional Review Board for Human 
Research (CMO), Arnhem-Nijmegen (CMO no. 2008/333), assessed and approved 
the study for all hospitals.  
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Variables 
Person centredness of perioperative diabetes care  
The participants answered 48 questions regarding seven dimensions of person-
centred perioperative diabetes care. Their responses to the survey questions were 
recoded as dichotomous scores: ‘yes’ (answer categories ‘yes’, ‘usually’, or 
‘always’) or ‘no’ (answer categories ‘no’, ‘sometimes’, or ‘never’). We computed 
frequencies to describe the experiences. Questions that applied to subgroups of 
participants (≤70%) were excluded from further analysis. 
 
Determinants of person centredness  
We collected data about clinical characteristics that might influence person 
centredness. Age, gender, type of surgery, and length of hospital stay were 
extracted from the medical records. Questions about other potential determinants 
of person centredness were added to the survey. These questions included the 
type of diabetes, treatment, whether the surgery was elective or emergency, self-
testing of blood glucose, and self-administration and self-adjustment of insulin.  
 We studied the influence of hospital and clinical characteristics on the mean 
scores for the dimensions of person centredness. Before starting this analysis, we 
tested the dimensions for internal consistency by calculating Cronbach’s alpha 
coefficients. The dimensions ‘access’, ‘physical support’, and ‘follow-up’ contained 
too few questions to produce a meaningful Cronbach’s alpha, so we excluded 
them from further analysis. The dimensions ‘information’, ‘patient involvement’, 
‘communication and education’, and ‘coordination’ had Cronbach’s alpha 
coefficients of 0.7 or more, which implies that the questions within these 
dimensions are reliably related to each other (Table 1). We first calculated mean 
scores for these four dimensions for each participant and then for the total study 
population. Participants for whom 50% or more values were missing for the 
questions within one dimension were excluded. The mean scores of these four 
dimensions were used as independent variables for the analysis of determinants.  
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Table 1. Survey results for each dimension of patient-centered perioperative diabetes care 
 
Item (no. of participants in which item is applicable) Score 
% 
Rangea 
% 
n Alpha 
Access to care     –– 
Glucose measurement occurred in a timely way 78 72–88 286  
Diabetes medication was administered in a timely way (287) 92 85–97 269  
Participant had an opportunity to contact his/her own internist (56) 52 36–100 56 --- 
Information     0.81 
Preoperatively, the participant received information about:       
The influence of surgery on glucose valuesb 31 25–36 294 --- 
Bringing along diabetes medication (287) 64 57–77 279  
Preoperative use of his/her own diabetes medication (287) 53 48–66 278  
Perioperative adjustments of his/her own medication (287) 44 33–49 280  
Glucose measurement frequency 27 24–33 292  
Target glucose values 20 10–22 291  
Perioperative diabetes treatment 49 32–56 290  
Perioperative diabetes treatment, written (141) 7 2–21 141 --- 
Participant received clear answers to questions (127)c  58 17–71 127 --- 
Postoperatively, the participant received information about:       
Intraoperative glucose values  20 10–31 291  
Glucose measurement times 34 29–40 293  
Glucose values during admission  72 61–77 268  
Adjustments of diabetes medication (213) 59 51–80 205  
Intraoperatively administered insulin (154)c 15 0–30 154 --- 
Participant received clear answers from nurses (148) c 75 71–88 148 --- 
Participant received clear answers from specialists (121) c 68 60–85 121 --- 
Patient involvement     0.84 
Specialists shared preoperative decision-making with participant  31 20–37 271  
Nurses shared preoperative decision-making with participant 33 25–38 268  
Participant’s own knowledge and experience taken into account 62 50–68 258  
The participant had an opportunity to:      
Ask questions preoperatively  52 43–67 269  
Ask questions at the surgical ward  69 64–77 261  
Have meals he/she was used to 67 58–78 270  
Have the snacks he/she was used to 61 50–70 267  
Testing blood glucose him/herself (172)c 61 45–70 153 --- 
Use his/her own blood glucose measurement device (150)c 61 43–100 138 --- 
Self-administer insulin (113)c 79 60–100 107 --- 
Self-adjust insulin dosage (82)c 70 57–88 74 --- 
Communication and education    0.87 
Participant trusted intraoperative specialist’s decisions  90 86–97 269  
Participant trusted specialist’s decisions during stay at ward 85 79–89 271  
Participant trusted nurses’ decisions  85 80–91 273  
Participant trusted nurses to adequately measure blood glucose 85 79–90 274  
Participant trusted nurses knowledge about his/her own glucometer (172)c  78 71–83 155 --- 
Physical comfort     --- 
Participant received help with blood glucose measurement (108)c 69 57–100 100  
Participant received help with diabetes medication (119)c 66 50–75 109  
Coordination and integration of care     0.77 
One professional was in charge of diabetes treatment 13 9–19 292  
One contact was present for questions about diabetes treatment  17 14–21 288  
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Item (no. of participants in which item is applicable) Score 
% 
Rangea 
% 
n Alpha 
Caregivers knew about participant’s diabetes treatment 68 66–71 256  
Caregivers did not provide contradictory information c 5 3–8 276  
Nurses adequately transferred diabetes-related information  70 63–73 236  
Specialists adequately transferred diabetes-related information  64 50–69 217  
Participant could reach the caregiver in charge of inpatient diabetes care 
(37)c 
90 75–100 31 --- 
Participant could reach inpatient diabetes care contact (49)c 17 88–100 43 --- 
Transition and continuity    --- 
Participant knew diabetes medication regime at discharge (284) 92 85–97 274  
Family doctor knew about diabetes treatment policy upon discharge 49 45–52 291  
Home care knew about diabetes treatment policy upon discharge (125)  72 65-82 125  
aRange for the six hospitals 
b Poor reliability to the other questions in the same dimension  
c Excluded from calculation of Cronbach’s alpha and mean dimension score because of small number 
 
RESULTS 
Participants 
Figure 1 shows the inclusion of the participants.  
 
Figure 1. Flowchart showing participant inclusion 
 
 
 
Surveys were sent to 690 people with diabetes who underwent surgery, and 362 
returned a completed questionnaire (52%). In total, 64 people were excluded for 
the following reasons: 24 people did not provide informed consent for a medical 
record search (the baseline measurement for the improvement project included a 
Room for improving the person centredness 
81 
medical record search, see methods) 17 medical records showed that the inclusion 
criteria had not been met, and in 23 cases, data extraction was not feasible, e.g., 
because the patient record was unavailable. Table 2 shows the characteristics of 
the 298 participants who were included in the final analysis. 
 
Table 2. Characteristics of the participants 
 
 n % 
Age    
 ≤70 years 157 53 
 >70 years 141 47 
Gender   
 Male 181 61 
 Female 117 39 
Diabetes type   
 Type 1 20 7 
 Type 2 217 75 
 Unknown 53 18 
Diabetes treatment   
 Diet only 11 4 
 Oral hypoglycemic agent  171 57 
 Insulin 61 21 
 Combination treatment 55 19 
Type of surgery   
 Abdominal 96 32 
 Cardiac 86 29 
 Large-joint orthopedic 116 39 
Elective/emergency surgery   
 Elective 266 90 
 Emergency 30 10 
Length of hospital stay   
 ≤7 days 173 58 
 >7 days 124 42 
 
Person centredness of perioperative diabetes care  
Table 1 shows the survey results. The results show room for improvement for 
most dimensions of person centredness. For more than half the survey items, less 
than 65% of the participants had reported care as described for each item.  
 The scores for the dimension ‘access to care’ varied from 52% to 92%. Fifty-two 
percent of the participants had an opportunity to contact his/her internist.  
 Overall, the scores for the dimension ‘information’ were low. Thirteen of 16 
items had scores below 65%. For example, preoperatively, few participants 
received information about the effect of surgery on blood glucose values (31%) 
and about target blood glucose values during the perioperative period (20%). 
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Postoperatively, few participants were informed of their intraoperative blood 
glucose values and the insulin administered (20% and 15%, respectively). 
 The scores for the dimension ‘patient involvement’ were also low. Seven of 11 
scores were lower than 65%. For example, one-third of the participants reported 
that they had been involved in the decision-making regarding their diabetes 
treatment and half the participants had an opportunity to ask questions about 
perioperative diabetes treatment.  
 Most scores for the dimension ‘communication and education’ were 85% or 
higher. This indicates that most participants received the care as described for the 
items. The scores for the dimension ‘physical comfort’ were fair; both items had 
scores higher than 65%.  
 Overall, the scores for the dimension ‘coordination and integration of care’ were 
low. Five of eight items had scores below 65%. For example, most participants 
(13%) did not know who their caregiver in charge of diabetes treatment was, nor 
whom to contact in case of diabetes-related problems during their hospital stay 
(17%).  
 The scores for the dimension ‘transition and continuity’ varied from 49% to 
92%. Forty-nine percent of the participants indicated that their family doctor knew 
about their diabetes treatment policy when they were discharged.  
 The variation between hospitals was generally small, with a range of less than 
20% between the lowest and highest scores. The variation was greater for several 
questions in the dimension ‘patient involvement’. For example, 60% of the 
participants in the hospital with the lowest score and 100% of the participants in 
the hospital with the highest score were given the opportunity to self-administer 
insulin during their hospital stay. These results suggest that the level of patient 
involvement depends partly on local policies.  
 
Determinants of person centredness  
Table 3 shows the mean scores for the four dimensions of person centredness that 
had good internal consistency. Table 3 also shows the influence on the four mean 
dimension scores for each clinical characteristic that had significant multivariate 
associations with one or more dimensions. Insulin treatment prior to hospital 
admission was associated with higher mean scores for the dimensions ‘patient 
involvement’ (p<0.001), and ‘coordination’ (p<0.005). Older participants had lower 
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mean scores for the dimensions ‘information’ (p=0.002), ‘patient involvement’ (p= 
0.001) and ‘coordination’ (p=0.012). Older participants who were treated with oral 
hypoglycaemic agents or a diet prior to hospital admission had the lowest scores 
for the dimension ‘information’ (p=0.023). Longer hospital stay was associated 
with higher scores for the dimension ‘coordination’ (p=0.003). Univariate analysis 
showed no influence of the hospital on the survey scores (p>0.15), hence the 
influence of hospital characteristics was not further tested.  
 
Table 3. Determinants of patient-centered perioperative diabetes carea  
 
 Dimensions of patient-centred care 
  
Information 
Patient 
involvement 
Communication 
and education 
 
Coordination 
Determinant Mean (SD) P Mean (SD) P Mean (SD) P Mean (SD) P 
         
Overall mean 2.29 (0.88)  2.52 (0.88)  3.42 (0.79)  2.22 (0.84)  
         
Age          
≤70 years 2.42 (0.89) 0.002 2.70 (0.81) 0.001 3.37 (0.77) 0.492 2.34 (0.81) 0.012 
>70 years 2.15 (0.85)  2.31 (0.90)  3.45 (0.81)  2.07 (0.86)  
Treatment          
No insulin 2.14 (0.81) 0.281 2.34 (0.86) <0.001 3.41 (0.83) 0.987 2.09 (0.81) 0.005 
Insulin 2.51 (0.92)  2.79 (0.83)  3.40 (0.71)  2.40 (0.85)  
Length of stay         
≤1 week 2.32 (0.85) 0.753 2.55 (0.93) 0.999 3.38 (0.82) 0.590 2.10 (0.77) 0.003 
>1 week 2.26 (0.91)  2.49 (0.80)  3.44 (0.74)  2.37 (0.84)  
         
Interaction Age*Treatmentb        
≤70 years, no insulin  2.35 (0.87) 0.027       
≤70 years, insulin 2.49 (0.90)        
>70 years, no insulin 1.95 (0.71)        
>70 years, insulin 2.56 (0.95)        
aThe mean scores for the dimensions range from 1 (low) to 4 (high) 
bInteraction Age*Treatment was significant only for the dimension ‘information’ 
 
DISCUSSION 
Principal findings 
In this study, we present a survey to assess the person centredness in 
perioperative diabetes care, throughout the entire hospital care pathway. The 
survey includes questions regarding seven dimensions of person centredness of 
care. Our assessment shows that there is ample room to improve the person 
centredness of perioperative diabetes care. The survey scores were low for many 
of the dimensions, including the dimensions ‘information’ and ‘patient 
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involvement’. These dimensions reflected key areas for surgical patients with 
diabetes in our focus group discussion.  
 
Strengths and limitations 
We based our survey on the Picker dimensions of person centredness. These 
dimensions appear to be central aspects of hospital care for people in Europe and 
the USA.9,10 Picker surveys have been used to evaluate patient experiences with 
hospital care since 1987 in hospitals in the USA and since 1998 in several European 
countries. Modified versions of the Picker dimensions and surveys have been used 
to assess patient experiences with other specific care settings such as the care for 
people with Parkinson’s disease and people with myocardial infarction.14,15 The 
literature suggests that measuring patient experiences elicits more factual data 
than measuring patient satisfaction; thus, we asked participants for their 
experiences rather than their satisfaction with care. 11 In our study, we set up a 
focus group consisting of people with diabetes and used their discussion to tailor 
the Picker dimensions of person centredness to the setting of perioperative 
diabetes care. Their needs and preferences overlapped considerably with the 
questions from the Picker Adult Inpatient Survey.10-12  
 The current survey does not include questions regarding the patient-centred 
dimensions ‘emotional support’ and ‘involvement of family and friends’. We may 
have developed transcripts for these dimensions if a larger number of focus 
groups were studied. An alternative explanation could be that the participants 
were less likely to mention items regarding these dimensions, as the diabetes was 
not the primary reason for admission. 
 To our knowledge, this is the first study to assess the person centredness of the 
entire hospital care pathway for people with diabetes who undergo a surgical 
procedure. The results are based on a large sample of participants from six 
hospitals, including participants with type 1 or type 2 diabetes, undergoing major 
surgery, who were treated with oral diabetes medication, insulin, a combination 
treatment or a diet. As patients undergoing minor or day case surgery were not 
included in our study, our results cannot be generalised to this group.  
 Our survey did not include the level of general nor diabetes specific education. 
It may be assumed that people with a higher degree of education would have 
higher expectations and if these were not met would score lower on their 
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questionnaires. While this possibility cannot be excluded based on our own 
results, the fact that insulin-treated patients, who have generally received more 
diabetes education, and have longer diabetes duration, have better experiences 
compared to oral treatment users, strongly argues against this possibility. 
 As the study took place in the Netherlands, the results may not necessarily 
apply to other geographical regions. However, we feel that the results can be 
applied to similar western countries. For example, in the United Kingdom, studies 
in mixed populations of inpatients with diabetes have suggested similar or even 
lower person centredness. In the ‘Inpatient Diabetes Audit 2012’, only 21% of the 
participants stated that they were involved in the diabetes care plan.6 Half the 
participants were permitted to self-administer insulin while in hospital, and 17% 
were permitted to test their own blood glucose values. Problems with meal choice 
and timing were frequently reported.7,8,16 These data suggest that a lack of person 
centredness also characterises diabetes care in other inpatient settings and other 
countries.  
 The response rate for the survey was 52%, which is similar to that in other 
studies.6 Sixty-four participants were excluded because they did not provide 
informed consent for the baseline measurement of the improvement study or 
because they did not meet the inclusion criteria. The exclusion of these 
participants did not seem to influence the survey results (data not shown). The 
results from the current care study can be used for further refinement of the 
survey to improve its applicability in clinical practice.  
 
Meaning of the study 
In this study, we assessed the level of person centredness of current perioperative 
diabetes care, based on patient experiences. Person-centred care is defined as 
“providing care that is respective of and responsive to individual patient 
preferences, needs and values, and ensuring that patient values guide all clinical 
decisions”. The survey results show that, despite the overall high quality of 
healthcare and diabetes care in the Netherlands, there is ample room for 
improvement of the person centredness of perioperative diabetes care.17-19 It 
should be noted that we did not audit agreed care recommendations or care 
standards. The needs and preferences of the people with diabetes who 
participated in our focus group discussion were leading for the tailoring of our 
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survey questions. These people with diabetes were not aware of quality indicators 
or guidelines for perioperative diabetes care. Besides person centredness, many 
other aspects of perioperative diabetes care are crucial from a quality and safety 
perspective. For example, the preferred use of own blood glucose measurement 
devices during hospital stay poses a safety concern that should be addressed when 
these are used. In addition, patient experiences are by definition subjective. For 
example, it is difficult to know whether the patient perception of the timeliness of 
glucose measurement reflects what is the clinical necessity. However, from a 
person centredness perspective, all participants should have received the care as 
described in the questionnaire. The specific needs of the person with diabetes 
should be taken into account by all caregivers at all stages of the patient 
pathway.20  
 Information’ and ‘patient involvement’ reflect key dimensions of person-
centred perioperative diabetes care in our study. Patient involvement and self-
management support are cornerstones of contemporary diabetes care.1,3 Involving 
patients in perioperative diabetes care is an important part of the strategy to 
improve the safety of insulin use in the hospital.21 Hospitals should develop 
information about perioperative diabetes treatment for their patients and 
implement strategies to improve the involvement of patients in perioperative 
diabetes management. 
 This survey was part of the baseline measurement for an improvement study 
that focuses on perioperative diabetes care for people who undergo major surgery. 
The relationship between hyperglycemia and worse postoperative patient 
outcome has been clearly established for these people. However, currently, the 
population who have day case surgery are the largest proportion of people 
undergoing surgery. Many of the processes along the perioperative care pathway 
are also shared by these people. Adequate information, communication and 
optimal patient involvement may be even more important for these people.  
 Older age and diabetes treatment with oral hypoglycemic agents prior to 
hospital admission were associated with less favourable patient experiences. The 
negative association between patient experience scores and older age is consistent 
with those in other studies.15,22 The negative association with oral diabetes 
treatment could indicate that professionals perceive oral treatment as a marker of 
‘less severe diabetes’ that deserves less attention than insulin-treated diabetes.23 
Room for improving the person centredness 
87 
Such a perception could have important implications if it also leads to suboptimal 
practice performance regarding other aspects of perioperative diabetes 
management. Strategies to improve the person centredness of perioperative 
diabetes care need to pay specific attention to older people and people who use 
oral diabetes treatment.  
 Care along the perioperative pathway is complex. From referral and 
preoperative evaluation to hospital discharge, the responsibility for perioperative 
diabetes care shifts across several caregivers and involves multiple care 
transitions. The Joint British Diabetes Societies’ guideline for perioperative 
management of adults with diabetes provides a strategy to try and improve 
overall diabetes care for perioperative patients.20 This guideline includes several 
patient centred recommendations. Our descriptions of optimal person-centred 
perioperative diabetes care can be used as an extension to this guideline. 
 In conclusion, person centredness is essential for delivering high-quality 
perioperative diabetes care. The needs and preferences of the person with diabetes 
should be taken into account by all caregivers at all stages of the patient pathway. 
This study shows that there is ample room to improve the person centredness of 
current perioperative diabetes care. Our study results offer a concrete starting 
point for interventions to effect such improvement.  
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ABSTRACT 
Background As perioperative hyperglycemia is associated with poor 
postoperative patient outcomes, clinical guidelines provide recommendations for 
optimal perioperative glucose control. It is unclear to what extent recommended 
glucose levels are met in daily practice, and little is known about factors that 
influence these levels. 
Methods We describe blood glucose levels throughout the hospital care pathway 
in 375 non-critically ill patients with diabetes who underwent major surgery 
(abdominal, cardiac, or orthopedic) in six hospitals, examine determinants of these 
levels including adherence to nine quality indicators for optimal perioperative 
diabetes care, and perform qualitative interviews to identify barriers for optimal 
care.  
Results Virtually all patients (95%) experienced at least one hyperglycemic value 
(>10 mmol/l); 9% had at least one value <4 mmol/l. Mean glucose increased from 
preoperative to postoperative day (POD) 1 (+2.3 mmol/l, 5-95% CI 1.9-2.7), and 
then gradually decreased on POD 2-14 (+1.8 mmol/l, 5-95% CI 1.4-2.2). Insulin-
treated patients (with or without oral agents) had higher glucose levels (+1.7 
mmol/l, 5-95% CI 0.5-3.0, and +1.2 mmol/l, -0.1-2.5) than patients using oral 
agents only. Indicator adherence tended to be associated with higher glucose 
levels. Barriers for optimal care included a lack of formalised agreements on target 
glucose levels, absence of directly obvious disadvantages of hyperglycemia, and 
concern about inducing hypoglycemia.  
Conclusions Hyperglycemia is common after major surgery, in particular on 
POD1 and in insulin-treated patients. Our results suggest that perioperative 
diabetes care is reactive rather than pro-active, and that current emphasis of 
professionals is on treating instead of preventing postoperative hyperglycemia. 
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INTRODUCTION 
Perioperative hyperglycemia is associated with poor postoperative patient 
outcomes for various surgical procedures.1 Perioperative hyperglycemia increases 
the risk of developing postoperative infections, renal failure and myocardial 
infarction, and length of hospital stay.1-6 Therefore, optimal perioperative diabetes 
care is important. 
 The delivery of optimal perioperative diabetes care is complex. Perioperative 
blood glucose regulation is influenced by fluctuations in nutritional intake, 
physical activity, emotional stress, and insulin sensitivity that result from the 
surgery.7 In addition, multiple professionals are involved throughout the hospital 
care pathway and there are several care transitions. Hyperglycemia can easily be 
overlooked and is often inadequately addressed, as the diabetes is generally not 
the primary reason for hospital admission.8,9 Clinical inertia (not initiating or 
intensifying therapy when indicated) and concern about inducing hypoglycemia 
are well-known barriers for physicians to optimal diabetes care during 
hospitalisation.8,9  
 Several professional organisations provide recommendations for glycemic 
targets in hospitalised patients. The National Health Service in the UK and the 
Netherlands Society of Internal Medicine recommend a blood glucose target of 6-
10 mmol/l.,10,11 The American Diabetes Association recommends a premeal blood 
glucose <7.8 mmol/l and random blood glucose <10 mmol/l.12 It is unclear 
whether the recommended blood glucose targets are met throughout the 
perioperative period in daily clinical practice, and little information is available on 
factors that influence perioperative blood glucose control.  
 In this study we (1) describe blood glucose levels throughout the entire 
perioperative hospital care pathway, (2) examine determinants of these levels, 
including the adherence to nine quality indicators for optimal perioperative 
diabetes care, and (3) identify barriers hindering optimal perioperative diabetes 
care among professionals.  
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MATERIALS AND METHODS 
Perioperative blood glucose and determinants   
Study population  
We conducted an observational study to gain insight into current perioperative 
glucose control for patients with diabetes who undergo major surgery. Patients 
with diabetes who underwent major surgery were included from six Dutch 
hospitals; two academic hospitals (953-1042 beds), two regional teaching hospitals 
(543-576 beds), and two tertiary teaching hospitals (730-846 beds). All six hospitals 
performed orthopedic and abdominal surgery, and three of the six hospitals 
performed cardiac surgery. The six hospitals participated in a study to test the 
effectiveness of a strategy to improve perioperative diabetes care.13 A previously 
developed set of quality indicators for optimal perioperative diabetes care was 
used to assess the effectiveness.14 The data that are presented in the current 
manuscript are part of the baseline data for the improvement study. At baseline, 
all hospitals provided usual care, using their own unique protocols to regulate 
blood glucose. The patients were identified from data in the hospital prescription 
system, operating room management systems, preoperative screening records, 
and anesthesiology records. Adult patients with diabetes were included if they 
met the following criteria of major surgery: (1) the patient was under general 
anesthesia during abdominal surgery or cardiac surgery or under spinal or general 
anesthesia during large joint orthopedic surgery, (2) the minimum observed 
operation time was 1 h. We excluded patients who had no available perioperative 
glucose measurements, and patients who underwent out-patient surgery. For 
patients with more than one procedure, we included only the first procedure. 
Informed consent for the medical record search was obtained from all patients.  
 The Regional Review Board for Human Research (CMO), Arnhem-Nijmegen 
(CMO no. 2008/333) approved the  study for all hospitals. 
 
Blood glucose values 
From patient records, we extracted pre-, intra- and postoperative blood glucose 
values up to postoperative day (POD) 14 that were measured during the stay at 
the surgery ward, operating room or recovery. The blood glucose values were 
categorised according to the stages of the perioperative period: ‘preoperative’, 
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‘intraoperative’, ‘recovery room’, ‘postoperative day 0-1’, and ‘postoperative days 
2-14’.  
 
Determinants of blood glucose levels 
Data on potential determinants were also extracted from the patient records, and 
included clinical characteristics (i.e. age, gender, diabetes treatment, type of 
surgery), a recent HbA1c value (no older than 3 months preceding the surgery), 
and process of care data.  
 The process of care data were used to assess quality indicator adherence. The 
quality indicators were developed during a previous study, based on international 
guidelines and literature and a systematic RAND Modified Delphi procedure.14 
The set includes nine process indicators that describe optimal perioperative 
diabetes care throughout the hospital care pathway that should be provided to all 
patients with diabetes who undergo major surgery. Table 2 presents the quality 
indicators. The clinimetric properties of the quality indicators were tested in the 
six hospitals that participated in the present study. For each patient and each 
process indicator, we computed individual patient indicator scores (dichotomous 
0,1). These scores described whether or not care was delivered as recommended, 
for example whether the patient’s glycemic control was evaluated preoperatively, 
or whether the patient’s blood glucose was measured within 4 h preceding 
surgery.  
 Four trained research assistants and one researcher manually abstracted the 
relevant data from the medical and nursing records, anesthesiology records, 
medication records, and laboratory reports. 
 
Statistical analysis 
The number of glucose measurements per patient and per stage of the 
perioperative process were calculated (mean number of measurements, SD). We 
computed mean blood glucose levels per stage of the perioperative process for 
each patient (mean blood glucose, SD) and the means of the patients’ means, the 
percentage of patients with at least one glucose value >10 mmol/l, the percentage 
of patients with at least one glucose value <4 mmol/l and the percentage of 
patients with all blood glucose values 6-10 mmol/l.  
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We used mixed models with three levels (measurement, patient, hospital) to study 
bivariate associations between clinical characteristics (i.e. age, gender, diabetes 
treatment, type of surgery), the stages of the perioperative period, and the process 
indicators (independent variables) on the one hand and the blood glucose levels 
(dependent variables) on the other hand. Independent variables that were 
associated (p<0.15) with the perioperative blood glucose level in the bivariate 
analysis were included in a multivariate mixed model to explain differences in 
perioperative glucose levels. The log likelihood ratio test was used to compare 
models with and without these variables. If the difference in the log likelihood 
ratio between models with and without a variable was statistically significant 
(p<0.05), then the variable was included in the final multivariate model.  
 Results from the mixed model analysis are expressed as regression coefficients 
with the corresponding 5-95% confidence intervals. The regression coefficients 
indicate the increase (or decrease) in blood glucose in mmol/l per unit change in 
the independent variable/determinant. SPSS 22.0 for Windows (SPSS, Chicago, 
Ill.) was used.  
 
Barriers 
We performed semi-structured interviews with the various caregivers involved in 
perioperative diabetes care (surgeons, anaesthesiologists, internists and nurses) to 
identify barriers to optimal perioperative diabetes care. To structure the 
interviews, an interview guide was developed for each group of professionals. The 
interview guide included questions regarding perceived barriers to the delivery of 
optimal perioperative diabetes care as described with the quality indicators.14 
Additional interviews were held until no new information was gleaned. The tape-
recorded interviews were transcribed verbatim. Two researchers (IH and MH) 
extracted all transcripts that had to do with barriers for optimal perioperative 
diabetes care. The transcripts were classified into categories of potential barriers to 
physician adherence according to a conceptual model, i.e. influencing factors 
regarding features of the target group of professionals who should deliver the 
recommended care (attitude towards the indicator, knowledge, skills); features of 
the social setting and social network (e.g. colleagues of the involved professionals 
and patients) and features of the organisational and administrative context.15 
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RESULTS  
Perioperative blood glucose and determinants   
Study population 
We included 375 participants with a total number of 6545 available blood glucose 
measurements. Supplementary Figure 1 shows the inclusion of the participants. 
Sixty-two percent were male, and median age was 70 years. Thirty-one percent 
underwent abdominal surgery, 30% cardiac surgery, and 40% large joint 
orthopedic surgery. The diabetes treatment regimen prior to hospital admission 
included insulin in 39% of the participants. Supplementary Table 1 shows 
additional characteristics. A recent HbA1c value (no older than 3 months 
preceding the surgery) was available for only 35% of the participants.  
 Table 1 shows the proportions of participants with available glucose 
measurements per stage of the perioperative process, and the numbers of 
measurements per stage. The median number of glucose measurements per 
participant was 14 (5-95th percentile range 1-51). Preoperative measurements were 
available for 67% of the participants. Postoperative glucose measurements on the 
recovery, POD 0 and 1, and POD 2-14 were available for about 80% of the 
participants. Intraoperative measurements were available for few patients (22%).  
 
Table 1.  Available measurements per stage of the perioperative period 
 
Stage Total number of 
measurements  
n 
Number of patients 
with measurements  
n (%)* 
Mean number of 
measurements per patient 
mean (SD) 
Preoperative 313 250 (67) 1.3 (0.61) 
Intraoperative 179 83 (22) 2.2 (1.22) 
Recovery 351 290 (77) 1.2 (0.41) 
Postoperative day 0&1 1334 286 (76) 4.7 (2.20) 
Postoperative day 2-14 4368 301 (80) 14.5 (13.92) 
* Percentage of the total study population (n=375) 
 
Perioperative blood glucose levels 
Ninety-five percent of the patients experienced at least one hyperglycemic value 
(>10 mmol/l), and 9% had at least one value <4 mmol/l. Eleven percent of the 
patients had all blood glucose values 6-10 mmol/l. Figure 1 shows the mean blood 
glucose range for each stage of the perioperative process. The mean blood glucose 
values were highest on POD 0 and 1. Supplementary Figures 2a and 2b show these 
results by type of diabetes treatment.  
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Figure 1. Mean blood glucose levels according to the perioperative stage  
 
 
* Blood glucose levels represent the means of the patients’ mean blood glucose levels per perioperative 
stage 
  
Supplementary Table 2 presents the mean blood glucose and the proportion of 
patients with hyperglycemia (≥ 1 value >10 mmol/l by perioperative stage and 
diabetes treatment. Patients on insulin treatment had higher mean blood glucose 
values in all stages of the perioperative process, and more had at least one value 
>10 mmol/l compared to patients on a diet or oral hypoglycemic agents only.  
 
Determinants of perioperative blood glucose levels, bivariate analysis 
In the bivariate analysis, the stages of the perioperative period, age, and the 
diabetes treatment regimen prior to hospital admission were significantly 
associated with the blood glucose levels (p<0.15), and were included in the 
multivariate model (Table 2).  
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Table 2.  Bivariate associations between the potential determinants and the glucose levels 
  
 Beta p-value 
Clinical characteristics   
Age -0.04 0.001 
Gender -0.30 0.177 
Diabetes treatment   
Diet -2.24 0.001 
 Oral treatment -1.18 0.000 
 Insulin -0.48 0.141 
 Combination treatment -  
Type of surgery   
Abdominal surgery -0.10 0.696 
Cardiothoracic surgery 0.35 0.239 
Orthopedic surgery -  
Stages of the perioperative period   
Preoperative  -1.84 0.000 
Intraoperative -1.69 0.000 
Recovery room -0.81 0.000 
Postoperative day 0-1 0.47 0.000 
Postoperative day 2-14 -  
Quality indicators   
Microvascular complications evaluated 0.76 0.014 
Preoperative blood glucose control evaluated 0.25 0.354 
Policy specified for hypoglycemia 0.69 0.009 
Policy specified for hyperglycemia 0.58 0.038 
Intravenous insulin infusion on morning of surgery 0.31 0.232 
Blood glucose measured within 4 h preceding surgery 0.15 0.569 
Blood glucose measured every 2 h during surgery 0.97 0.008 
Blood glucose measured within 1 h after surgery 0.24 0.315 
Follow-up visit arranged with ambulant diabetes caregiver 1.75 0.000 
 
For all nine quality indicators, adherence was associated with higher glucose 
levels. In other words, the delivery of recommended care was associated with 
higher glucose levels. Five quality indicators were significantly associated with the 
blood glucose levels (p<0.15), and were included in the multivariate model.  
 
Determinants of perioperative blood glucose levels, multivariate analysis 
Table 3 shows the results of the multivariate model to explain differences in 
perioperative glucose levels. The perioperative stage was the major determinant of 
the perioperative blood glucose levels. Blood glucose increased from preoperative 
to POD 0&1 (+2.3 mmol/l, 5-95% CI 1.9 to 2.7), and then gradually declined on 
POD 2 (+1.8 mmol/l, 5-95% CI 1.4 to 2.2). Patients treated with insulin (with or 
without oral hypoglycemic agents) had higher glucose levels (+1.7 mmol/l, 5-95% 
CI 0.5-3.0 and +1.2 mmol/l, 5-95% CI -0.1-2.5 resp.) than patients using oral agents 
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only. Providing care as recommended in two quality indicators was positively 
associated with the perioperative blood glucose levels: ‘Policy specified for 
hypoglycemia’ (+0.7, 5-95% CI 0.2-1.1) and ‘follow-up arrangement with ambulant 
diabetes caregiver’ (+1.6 mmol/l, 5-95% CI 1.0-2.1).  
 
Table 3.  Factors that are associated with glucose levels in the multivariate model 
 
Factor  β (5-95% CI)* 
Stage of the perioperative process  
Preoperative -  
Intraoperative 0.15 (-0.46-0.75) 
Postoperative, recovery 1.05 (0.55-1.54) 
Postoperative, day 0&1 2.27 (1.88-2.67) 
Postoperative, day 2-14 1.78 (1.41-2.15) 
  
Treatment  
Diet only - 
Oral 0.62 (-0.60-1.83) 
Insulin  1.19 (-0.08-2.47) 
Combination oral and insulin  1.74 (0.48-2.99)  
  
Quality indicators  
Policy specified for hypoglycemia 0.65 (0.22-1.07) 
Follow-up visit arranged with ambulant diabetes caregiver 1.55 (1.00-2.10) 
* The regression coefficients indicate the increase (or decrease) in blood  
glucose in mmol/l per unit change in the independent variable/predictor. 
 
Barriers 
We held a total of 41 interviews with the professionals involved in perioperative 
diabetes care. Four predominant barriers were identified that obstructed the 
delivery of optimal perioperative diabetes care at the level of multiple quality 
indicators for multiple professionals: a lack of priority for perioperative diabetes 
care, a lack of multidisciplinary ownership, a lack of knowledge about 
perioperative diabetes care, and limited person centeredness (see box 1).  
 With regard to adherence with the recommended glucose targets, the most 
prominent barriers at the professional level were a lack of formalised agreements 
on target glucose levels, a lack of evidence for specific perioperative glucose 
targets, absence of directly obvious disadvantages of higher blood glucose values, 
and concern about inducing hypoglycemia.  
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Box 1. Predominant barriers hindering optimal perioperative diabetes care 
 
 
 
DISCUSSION AND CONCLUSIONS 
Suboptimal perioperative glucose control, particularly hyperglycemia, is common 
after major surgery, and most pronounced on POD 1 and in insulin treated 
patients. The results of the present study suggest that perioperative diabetes care 
is reactive rather than pro-active, and that current emphasis of professionals is on 
treating instead of preventing postoperative hyperglycemia. This interpretation is 
based on the findings that adherence to quality indicators becomes better in case 
of poor perioperative glucose control, a preoperative HbA1c was available for only 
few patients and, finally, the interviews confirmed that perioperative diabetes care 
lacks priority.  
 We report that hyperglycemia is common in hospitalised patients, as has been 
shown by other studies.1.2,17,18 Most studies, however, did not focus on surgical 
patients in particular, or concentrated on postoperative complications as potential 
consequences of perioperative hyperglycemia.1-7 Kwon et al assessed perioperative 
glucose regulation and found that 70% of general surgical patients with diabetes 
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had at least one blood glucose value >10 mmol/l at any point between the day of 
surgery and day 2 postoperative, which is completely in line with our findings.7 
Our study further adds information on the course of the blood glucose levels 
throughout the perioperative period, and the determinants of these levels.  
 Several authors have listed barriers for optimal inpatient diabetes care, but not 
for perioperative diabetes care specifically.18,19 Perioperative diabetes care is 
characterised by the involvement of multiple caregivers from different 
professions, including internists, anesthesiologists, surgeons and nurses. We 
systematically identified barriers for optimal perioperative diabetes care by semi-
structured interviews with all these professionals. Our data confirm earlier listed 
barriers, including lack of priority for preoperative diabetes care and a lack of 
knowledge about optimal care, and add lack of multidisciplinary ownership and 
lack of patient centeredness as barriers not previously mentioned. Strategies to 
improve perioperative diabetes care need to include interventions to address these 
specific barriers.  
 The fact that the recommended blood glucose targets are often not achieved 
during the perioperative period could indicate that many patients are at increased 
risk of postoperative complications.1-6 Several studies have established a 
relationship between hyperglycemia and increased rates of postoperative 
complications has been established for both for patients with and without 
diabetes, although this relationship was commonly stronger for patients without 
diabetes.1-3 One recent large observational study showed a relationship between 
perioperative hyperglycemia and postoperative complications for patients without 
diabetes, but not for patients with diabetes.20 While the observational relationship 
between peri-operative hyperglycemia and post-operative complications hence 
seems quite well established, it should be noted that it is currently unclear 
whether the lowering of blood glucose in the perioperative period actually 
improves postoperative outcomes for patients with diabetes.21-22 A recent 
Cochrane review on the effects of intensive perioperative glucose control in 
diabetic patients undergoing surgery did not support the use of intensive 
glycaemic control protocols with near-normal blood glucose targets for these 
patients.22 While evidence is limited, current guidelines on perioperative diabetes 
care do recommend that hyperglycemia in the perioperative period should be 
treated if this can be done safely, which means with an acceptable risk of 
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hypoglycaemia.10-12 Timely evaluation and adequate management of diabetes in 
the pre- and perioperative period has been found to improve perioperative 
glucose control.23,24 For example, availability of HbA1c could trigger more pro-
active diabetes care. This could be done by testing in the hospital, but HbA1c 
would also be easily retrievable from GP offices. Thus, it would be more ideal 
when optimal care would start in the preoperative period to prevent 
hyperglycemia. We noticed a trend with increased adherence to optimal 
perioperative diabetes care being associated with higher glucose levels, i.e. better 
perioperative diabetes care in case of hyperglycemia. This could imply that 
recommended perioperative diabetes care results in higher blood glucose levels. 
However, a more logical explanation is that perioperative hyperglycemia, and/or 
clinical characteristics that predispose to hyperglycemia such as insulin treatment, 
trigger professionals to provide stricter perioperative diabetes care according to 
the guideline.  
 We showed earlier that professional adherence to optimal perioperative 
diabetes care is better for insulin treated patients than for non-insulin treated 
patients.25,26 This could indicate that professionals perceive insulin treatment as a 
marker of ‘more severe diabetes’ that deserves more attention than diabetes 
treated with oral agents. Nevertheless, our results show that perioperative 
hyperglycemia is also common in patients on oral hypoglycemic agents.  
 Adherence to quality indicators had a minor contribution to perioperative blood 
glucose levels, with only two indicators, ‘policy specified for hypoglycemia’  and 
‘follow-up arrangement with ambulant diabetes caregiver’ showing a significant 
relationship in the multivariate model. This suggests that many other factors 
including the type of diabetes treatment and the perioperative stage are relevant 
for perioperative glucose control. For example, we did not collect detailed 
information on insulin treatment of hyperglycemia, insulin dosage and treatment 
regimens as the indicator set did not provide recommendations on these subjects. 
 While we find that perioperative glucose control is suboptimal, it might still 
have been improved compared to one or two decades ago. There are no data that 
support this notion. In 1996, one of the authors (AdB) performed a smaller but 
similar study as the current study in one academic center (see supplementary 
Figure 3, unpublished data). The results show that current glucose levels are 
probably slightly lower, but otherwise quite similar outcomes and a similar trend 
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of substantial hyperglycemia in the perioperative period, suggesting only small 
improvements of perioperative glucose control over the last 20 years.   
 
Strengths and limitations 
Our study has been performed in Dutch hospitals; hence results may not be 
applicable to hospitals in other countries. From an international perspective, the 
level of diabetes care in the Netherlands is the second highest in Europe, 
rendering it less likely that perioperative glucose control will be better in other 
hospitals.27 We believe that the findings of our study are of international 
relevance.  
 A limitation of our study is that the analysis was based on data that were 
collected as part of the normal routines. For example, we were not able to 
determine the influence of preoperative HbA1c on the perioperative glucose 
levels, as HbA1c was available for only one third of the patients. Also, glucose 
measurements could have been prompted by expectation of abnormal values, 
leading to information bias.  
 A strength of this study is that our results are based on a large number of 
glucose values throughout the entire perioperative care pathway and are collected 
from different hospitals, ranging from regional teaching hospitals to academic 
hospitals. To our knowledge, this is the first study to examine the relationship 
between adherence to a validated set of quality indicators for optimal 
perioperative diabetes care and perioperative blood glucose. Another strength is 
that we only included patients who underwent major surgery which is the 
clinically relevant population for whom the relationship between hyperglycemia 
and worse postoperative outcome has been clearly established.  
 
CONCLUSIONS 
Suboptimal perioperative glucose regulation, particularly hyperglycemia, was 
highly prevalent in our population of major surgery patients with diabetes. This 
indicates that many patients are at increased risk of postoperative complications. 
Our data suggest that professionals tend to be reactive rather than proactive in 
their approach to diabetes care in the perioperative period. An approach explicitly 
aimed at shifting towards more proactive diabetes management in the 
preoperative period may help to avert postoperative hyperglycemia. This includes 
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improving professional adherence to current guideline recommendations. The 
quality indicator set describes optimal perioperative diabetes care that should be 
provided to all patients with diabetes who undergo major surgery, regardless of 
the type of diabetes treatment and glycemia. Alternative approaches are also 
welcome. We are currently testing a centralised data extraction from Electronic 
Health Records to identify patients at risk for deterioration of glucose control at an 
early stage. An approach explicitly aimed at shifting towards more proactive 
diabetes management in the preoperative period may help to avert postoperative 
hyperglycemia. 
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SUPPLEMENT 
 
Supplementary Figure 1. Participant inclusion 
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Supplementary Figure 2a. Mean blood glucose levels according to the perioperative stage by 
type of diabetes treatment (non-insulin) 
* Blood glucose levels represent the means of the patients’ mean blood glucose levels per perioperative 
stage 
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Supplementary Figure 2b.  Mean blood glucose levels according to the perioperative stage by 
type of diabetes treatment (insulin) 
 
 
* Blood glucose levels represent the means of the patients’ mean blood glucose levels per perioperative 
stage 
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Supplementary Table 1. Characteristics of the patients (n=375) 
 
 %  
Gender  
 Male 62 
 Female 38 
Diabetes treatment  
 Diet only 
Oral hypoglycemic agent  
Insulin only 
4 
 57 
 18 
 Combination treatment 21 
Type of surgery  
 Abdominal 
Cardiac 
Large joint orthopedic 
31 
 30 
 40 
Elective/emergency surgery  
 Elective 
Emergency 
89 
 11 
HbA1c available 35 
Hospital length of stay (median 7 days)   
 ≤10 days 
>10 days 
70 
 31 
Percentages may not add to 100 due to rounding 
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Supplementary table 2. Mean glucose and number of patients with ≥1 value >10 mmol/l per 
perioperative stage 
 
 All patients Non-insulin treatment Insulin treatment  
 Mean glucose 
mmol/l (SD) 
≥1 value >10 
mmol/l 
N (%) 
Mean glucose 
mmol/l (SD) 
≥1 value >10 
mmol/l 
N (%) 
Mean glucose 
(SD) 
mmol/l (SD) 
≥1 value >10 
mmol/l 
N (%) 
Perioperative stage       
Preoperative 8.2 (3.0) 49 (20) 7.7 (2,1) 20 (15) 8,7 (3.6) 29 (26) 
Intraoperative 8.8 (2.3) 31 (37) 8.6 (2,3) 17 (34) 9.2 (2.3) 14 (42) 
Recovery room 9.1 (3.2) 95 (33) 8.6 (2,8) 48 (27) 9.9 (3,7) 47 (42) 
POD 0-1 10.5 (3.7) 219 (77) 9.8 (3.2) 126 (72) 11.3 (4.2) 93 (84) 
POD 2-14 10.2 (3.7) 244 (81) 9.9 (3.3) 133 (75) 10.5 (4.1) 111 (90) 
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Supplementary Figure 3. Mean perioperative blood glucose levels in a cohort of 38 patients in 
1993 (unpublished data) 
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ABSTRACT 
Aims To assess the impact of a multifaceted strategy to improve perioperative 
diabetes care throughout the hospital-care pathway. 
Methods Controlled before-and-after study in six hospitals. The purpose of the 
strategy was to target four predominant barriers that obstructed optimal care 
delivery. We provided feedback about baseline indicator performance, developed 
a multidisciplinary protocol and patient information, and provided professional 
education. After a 6-month intervention, we determined the performance changes 
against three outcome indicators and nine process indicators using data 
concerning 811 patients with diabetes who had major surgery. The progress of the 
interventions was monitored closely.   
Results Two process indicators improved significantly in the intervention 
hospitals; the proportion of patients for whom glycemic control had been 
evaluated preoperatively increased by 9% (p<0.002), and the proportion of 
patients with blood glucose measurements within 1 h after surgery increased by 
29% (p<0.0001). Four other process indicators and all three outcome indicators 
improved more in the intervention hospitals than in the control hospitals, but the 
differences were not statistically significant. These included the proportion of 
patients with all glucose values at 6–10 mmol/l (+3%) and the proportion of 
patients with hyperglycemia (-8%). The implementation of the multidisciplinary 
protocol was still ongoing after the 6-month intervention period.  
Conclusions The multifaceted improvement strategy had a limited impact on the 
quality of perioperative diabetes care. This study demonstrates the complexity of 
improving perioperative diabetes care throughout the multiprofessional hospital-
care pathway.  
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INTRODUCTION 
Patients with diabetes are prone to develop complications after surgery, which 
relates in part to the long-term micro- and macrovascular complications of the 
diabetes.1-3 In addition, perioperative hyperglycemia is associated with worse 
postoperative patient outcomes for patients with diabetes, and even more so for 
patients who were not previously known to have diabetes.1,4 Appropriate diabetes 
treatment in the perioperative period could decrease diabetes-associated 
morbidity and mortality.1,2 
 The perioperative hospital-care pathway begins with preoperative evaluation 
and ends with hospital discharge. It involves multiple teams of caregivers and 
multiple transitions of care, as well as the person with diabetes him/herself. 
Achieving optimal care requires all involved professionals to take the specific 
needs of the person with diabetes into account at all stages of the care pathway.5 
However, clinical practice audits show that providing optimal diabetes care for 
hospitalised patients is challenging.6 In previous studies, we assessed the quality 
of current perioperative diabetes care and identified multiple opportunities for 
improving patient outcomes, processes, organisational structure and the person 
centeredness of such care.7,8 
 In the present study we assess the impact of a multifaceted strategy to improve 
perioperative diabetes care throughout the hospital-care pathway in a controlled 
before-and-after study in six Dutch hospitals.  
 
PARTICIPANTS AND METHODS 
Design and study population 
We conducted a controlled before-and-after feasibility study in six hospitals. We 
used the strategy in three hospitals, and three other hospitals served as matched 
controls. The intervention group and the control group each consisted of one 
university hospital (953–1042 beds), one large non-university teaching hospital 
(730–846 beds), and one medium-size teaching hospital (543–576 beds). The 
intervention group included eight surgery departments (three orthopedic, three 
abdominal, and two cardiac), and the control group included six surgery 
departments (three orthopedic, two abdominal, and one cardiac).  
 We included adults with diabetes who met the criteria for major surgery: (1) 
general anesthesia during abdominal surgery or cardiac surgery, or spinal or 
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general anesthesia during large-joint orthopedic surgery and (2) minimum 
operation time 1 h. Patients who underwent out-patient surgery were excluded. If 
a participant underwent more than one surgical procedure, we included the first 
procedure. For the baseline measurement, the surgery took place in the period 
March 2009–March 2010. For the after measurement, the surgery took place in the 
period June 2011–June 2012. We retrospectively identified the patients from data 
in the hospital prescription system, operating room management systems, 
preoperative screening records, and anaesthesiology records. We invited the 
patients to participate in the study by mail and by phone.8 We first obtained 
informed consent from all potential participants. Then we checked the information 
about the inclusion criteria against the patient records. We aimed to include a 
minimum of 30 participants per surgical specialty (abdominal surgery, cardiac 
surgery, and large joint orthopedic surgery) in each hospital at baseline and after 
the intervention (i.e. aiming at 420 participants). The Regional Review Board for 
Human Research (CMO), Arnhem-Nijmegen (CMO no. 2008/333), approved the 
study for all hospitals. 
 
Variables and data collection 
We determined the performance changes against 12 quality indicators for optimal 
perioperative diabetes care throughout the hospital-care pathway. The quality 
indicators were developed during a previous study, and are based on 
international literature and a systematic consensus procedure. A practice test in 
the six hospitals participating in the current study showed that 21 quality 
indicators could be used to validly and reliably assess the quality of care, and 
hence, change in the quality of care in these hospitals.8 The set includes three 
outcome indicators, nine process indicators and nine structure indicators 
 Data needed to calculate the indicator scores were retrieved from medical and 
nursing records, anesthesiology records, medication records, and laboratory 
reports. Trained research assistants collected the data, and entered the data into a 
computerised database. In addition, we abstracted data from these original 
sources about relevant clinical characteristics, including age, gender, diabetes 
medication, type of surgery (abdominal, cardiac, or large joint orthopedic), and 
length of hospital stay. At baseline, electronic medical records were available in 
two hospitals (one intervention hospital and one control hospital). After the 
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intervention, electronic medical records were available in five hospitals (three 
intervention hospitals and two control hospitals). Hospital characteristics were 
collected at baseline.  
 
Improvement strategy 
The purpose of the strategy was to target barriers that obstructed optimal care 
delivery. Barriers to and facilitators for optimal care were identified by semi-
structured interviews with professionals involved in perioperative diabetes care in 
the intervention hospitals. We also surveyed patients with diabetes who had 
undergone major surgery to gain insight into their experiences with perioperative 
diabetes care.7 Four predominant barriers that obstructed the delivery of optimal 
perioperative diabetes care were identified1: a lack of priority for perioperative 
diabetes care, a lack of multidisciplinary ownership, a lack of knowledge about 
perioperative diabetes care, and limited person centeredness that included a lack 
of patient information and a lack of patient involvement. Based on these findings, 
a multifaceted strategy to resolve these barriers was developed. The strategy 
included the following interventions (Supplementary Figure 1):   
1) Feedback about the baseline indicator performance 
2) Development of a multidisciplinary protocol, including a chapter about 
diabetes self-management during hospital stay 
3) Education for professionals about the importance of optimal perioperative 
diabetes care and the new multidisciplinary protocol   
4) Development of patient information about perioperative diabetes care.  
The multidisciplinary protocol, patient information, and education were tailored 
to the local preferences and routines. In each intervention hospital, we contacted a 
diabetes specialist, an anesthesiologist, a diabetes nurse, and senior nurses from 
the participating surgery departments. These professionals took the lead for 
driving the change. There was a close working relationship between the researcher 
and the professionals to achieve agreement about the multidisciplinary protocol, 
patient information, and the educational meetings. 
 Perioperative diabetes care in the control hospitals was delivered according to 
their usual care routines. They were free to undertake activities to improve 
perioperative diabetes care.  
                                                     
1 The authors will be happy to provide the exact details of this barrier analysis. 
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Progress of the interventions  
The progress of the interventions was monitored by documenting participation in 
all activities: e.g. who attended the feedback meeting, and who attended an 
educational meeting. Further, the professionals in the intervention hospitals 
completed a questionnaire about the progress of the interventions. For example, 
the questionnaire asked when the multidisciplinary protocol and patient 
information were put into use, and whether anything other than applying the four 
intervention components of the multifaceted strategy was done to improve 
perioperative diabetes care. To explain potential changes in scores in the control 
hospitals, the professionals in these hospitals completed a questionnaire about the 
interventions that were undertaken to improve perioperative diabetes care during 
or after the intervention period.  
 The intervention period started with a feedback meeting in each of the three 
intervention hospitals. A multidisciplinary protocol for perioperative diabetes care 
and information for patients were developed with all three hospitals. The protocol 
included a chapter on diabetes self-management for hospitalised patients with 
diabetes. Six to 12 researcher outreach visits and multiple e-mail and telephone 
contacts were needed to achieve consensus about the protocol and patient 
information. All hospitals held educational meetings about the importance of 
optimal perioperative diabetes care and the new multidisciplinary protocol for 
nurses at the surgical wards and for residents internal medicine. Hospitals 1 and 2 
held meetings for anaesthesiologists. The attendance rates for the educational 
meetings neared 80-100%. The surgeons were notified of the new protocol by e-
mail and during a staff meeting. All hospitals developed information for patients. 
 Figure 1 shows the timelines for the intervention activities in the intervention 
hospitals. We planned a 6-month timetable (March 2011–September 2011) for the 
interventions. The questionnaires completed by all the hospitals revealed that the 
implementation of the multidisciplinary protocol and patient information were 
still in progress after the 6-month intervention period. Hospital 1 undertook 
additional activities to implement the multidisciplinary protocol, which included 
educational meetings. Hospital 2 did not introduce the multidisciplinary protocol 
and patient information until several months after the intervention period because 
the hospital board requested additional changes. In hospital 3, the intervention 
period was postponed to account for a delay in performing the baseline 
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measurement and developing the multidisciplinary protocol (May 2011-December 
2011). As a result of all delays, part of the educational meetings took place after the 
intervention period. Furthermore, the patient information had not been put to use 
by the end of the observation period. 
 
Figure 1. Timelines for the improvement activities in the intervention hospitals 
 
Two control hospitals held educational meetings about perioperative diabetes 
regulation for nurses. One of these hospitals instituted a position for a clinical 
diabetes nurse. Both control hospitals revised the protocol for perioperative 
diabetes care. 
 
Statistical analysis 
We computed individual participant indicator scores (dichotomous 0,1 variable)  
to describe whether or not care was delivered as recommended. We calculated the 
score for each participant and for each outcome and process indicator. For each 
indicator, we constructed an algorithm that revealed how the indicator score had 
been deduced from the original data.8 For each hospital group (intervention or 
control), we computed the percentage of indicator adherence.  
 We used SAS version 9.2 to analyse all data. We used a mixed model to assess 
the impact of the improvement strategy. We tested the changes in performance 
against the 12 quality indicators for optimal perioperative diabetes care. For each 
indicator, the basic model included the effects on the intervention group versus 
the control group and on the timing of the measurement (pre-intervention vs. 
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post-intervention). The model also included the interaction between these two 
variables. The type of hospital was included as a level in the multilevel analysis. 
 To gain insight into potential confounders of the effect of the intervention, we 
studied the single correlations between clinical characteristics (independent 
variables) and the indicator scores, using univariate analyses (chi-square test). We 
determined all the independent variables that 1) showed enough variation among 
our participants and 2) were univariately significantly associated with one or more 
indicator scores (p<0.15). Then we included them in a multilevel, stepwise, logistic 
regression analysis to correct for differences in the distribution of clinical 
characteristics over the groups and measurements. If we detected a correlation 
between two independent variables, we included only one variable in the 
multilevel analysis. The type of surgery and diabetes treatment influenced most 
indicator scores. Three indicator scores were influenced by age, and one was 
influenced by sex (Supplementary Table 1). The significance for the multilevel 
analysis was set at p<0.05.  
 To gain insight into the effect modification by type of surgery, we analysed each 
subgroup. The type of surgery did not have a consistent influence on the effect of 
the intervention. 
 
RESULTS  
Participants 
Table 1 shows the hospital characteristics, including the organisational structure of 
perioperative diabetes care (i.e. the nine structure indicators) in the intervention 
hospitals and the control hospitals at baseline. Figure 2 shows the inclusion of the 
participants. Table 2 shows the characteristics of the participants. The department 
of orthopedic surgery of one intervention hospital declined to participate in the 
interventions because of time constraints. Therefore, we present analyses both 
including and excluding this department, i.e. an intention-to-treat analysis and a 
per-protocol analysis, respectively. 
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Table 1.  Hospital characteristics at baseline, including organisational structure of perioperative 
diabetes care 
 
 Control 
hospitals (n=3) 
Intervention 
hospitals (n=3) 
Teaching hospital  3 3 
Multidisciplinary perioperative diabetes care team present 2 1 
The team consists of the following caregivers:   
Internist 2 1 
Diabetes nurse 2 0 
Dietician 0 0 
Surgical nurse 1 0 
Anaesthesiologist 1 0 
Intensive care specialist 0 0 
Internal medicine resident specialising in endocrinology 1 1 
The team has the following responsibilities:   
Development and implementation of a perioperative protocol  2 1 
Development and implementation of standardised order sets  2 0 
Advising the care team 1 1 
Coordination of staff education and training 2 1 
Promoting self-management of diabetes 1 0 
Planning for discharge and follow-up 1 0 
Providing support for treatment with intravenous insulin  1 0 
Monitoring the quality of  the perioperative diabetes care 1 1 
Protocol for perioperative diabetes care present 3 3 
This protocol addresses the following care elements: 
TASKS AND RESPONSIBILITIES OF THE FOLLOWING CAREGIVERS: 
 
 
 
Internists 2 1 
Anesthesiologists 1 0 
Surgeons 0 0 
Nurses 1 0 
Intensive care specialists 0 0 
GLYCEMIC MANAGEMENT POLICY:    
Target glucose values 3 2 
Glucose measurement frequency 3 2 
Medication policy 3 3 
Hypoglycemia management 3 2 
Hyperglycemia management 3 1 
Procedure for administration of intravenous insulin 2 3 
ORGANISATION OF PERIOPERATIVE CARE:   
Surgery planning to prevent prolonged fasting 1 1 
Details of when to contact a diabetes specialist 3 1 
Postoperative diabetes management 3 1 
Discharge planning  2 0 
PREVENTION OF COMPLICATIONS:   
Contrast-induced nephropathy  3 2 
Decubitus ulcers in patients with diabetic neuropathy 2 2 
Hypoglycemia 1 0 
Dosing algorithm to guide intravenous insulin treatment present*  0 0 
Staff education for the perioperative diabetes care provided  2 1 
Glucose measurement manual present 3 2 
Quality of perioperative diabetes care evaluated regularly  1 0 
Standardised order sets for perioperative glycemic management 
present 
2 1 
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 Control 
hospitals (n=3) 
Intervention 
hospitals (n=3) 
Nutrition according to the most recent nutritional guidelines 3 2 
Access to glucose measurement for all caregivers 3 1 
  *For non-critically ill surgical patients 
 
Table 2.  Characteristics of the participants in the control and intervention hospitals, at baseline and 
after the intervention 
 
 Control  Intervention  
 Percentage of 146 
participants 
at baseline 
Percentage of 147 
participants after 
intervention 
Percentage  of 243 
participants  at 
baseline 
Percentage of 275 
participants after 
intervention 
Age      
 ≤70 years 51 50 52 62 
 >70 years 49 50 48 38 
Sex     
 Male 58 57 65 59 
 Female 42 43 35 41 
Diabetes treatment     
 Dietary measures 
Hypoglycemic agent  
Insulin  
3 2 4 2 
 68 58 50 57 
 12 17 22 13 
 Combination treatment 16 23 24 28 
Type of surgery     
 Abdominal 
Cardiac 
Large joint orthopedic 
25 34 37 38 
 25 29 31 33 
 50 37 32 29 
Elective/emergency surgery     
 Elective 
Emergency 
85 95 90 95 
 15 5 10 5 
Hospital length of stay     
 ≤7 days 
>7 days 
57 52 55 66 
 43 48 45 34 
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Figure 2. Patient inclusion 
 
 
Impact of the improvement strategy 
Table 3 presents the changes in indicator scores after the intervention period for 
the intervention group and the control group. Supplementary figure 2  shows the 
individual hospital indicator scores in the three intervention hospitals and the 
three control hospitals before and after the intervention.  
 Several indicator scores improved in both groups. The intention-to-treat 
analysis showed for two out of nine process indicators statistically significant 
differences in improvement in favour of the intervention group. An additional six 
indicators improved more in the intervention hospitals than in the control 
hospitals, but these differences were not statistically significant. The indicator 
score regarding ‘microvascular complications evaluated’ improved more in the 
control group than in the intervention group.  
 The per-protocol analysis – which excluded the participants from the 
department of orthopedic surgery declining participation in the interventions – 
showed that two other indicators had improved statistically significant in the 
intervention group: ‘intravenous insulin infusion on the morning of surgery’ (18% 
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increase, p=0.018), and ‘blood glucose measured every 2 h during surgery’ (26% 
increase, p=0.036).  
 
Table 3.  Indicator scores before and after the intervention 
 
 Control, Intervention ∆Con-Int 
INDICATOR change% change% P-value1 
Presence of microvascular complications evaluated 30 1 <0.00012 
Preoperative glycemic control evaluated -10 9 0.0014 
Policy specified for hypoglycemia 0 -3 NS 
Policy specified for hyperglycemia -4 -6 NS 
Intravenous insulin infusion initiated 10 18 NS 
Blood glucose measured within 4 h preoperatively 4 5 NS 
Blood glucose measured every 2 h intraoperatively 17 26 <0.0001 
Blood glucose measured within 1 h postoperatively -19 29 NS 
Follow-up visit arranged with diabetes caregiver 2 9 NS 
All glucose values 6-10 mmol/l on surgical ward 1 3 NS 
Hyperglycemia3 on the surgical ward -2 -8 NS 
Unplanned readmission within 3 weeks 0 -3 NS 
1 All P-values were corrected for type of surgery, diabetes treatment, age and sex. 
2 More improvement in the control group 
3 Hyperglycemia: ≥1 glucose values >10 mmol/l  
 
DISCUSSION 
The multifaceted intervention strategy had a limited impact on the quality of 
perioperative diabetes care. Two (intention-to-treat analysis) or four (per protocol 
analysis) out of nine process indicators improved significantly more in the 
intervention group. While in essence our study demonstrates that a targeted 
strategy can improve perioperative diabetes care, our results show at the same 
time that the changes are quite modest, which illustrates the complexity of 
improving perioperative diabetes care throughout the entire multiprofessional 
hospital-care pathway. 
 To our knowledge, this is the first study to systematically assess the impact of a 
multifaceted improvement strategy on the quality of perioperative diabetes care in 
a multicenter, controlled, before-and-after feasibility trial. Controlled before-and-
after studies are among the broader range of appropriate study designs for the 
Cochrane Effective Practice and Organisation of Care (EPOC) group reviews that 
address questions about the effects of improvement strategies.9 In line with 
contemporary theories of effective improvement, we based our strategy on an 
analysis of barriers and facilitators for optimal perioperative diabetes care.10,11 Our 
interventions were directed towards the various professionals involved in 
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perioperative diabetes care along the entire hospital-care pathway. The American 
Association of Clinical Endocrinologists and the American Diabetes Association 
recommend a systems approach to inpatient diabetes care that includes the 
institution of a multidisciplinary steering committee, achievable glycemic goals 
with the use of protocols and order sets, and professional education.12,13 These 
interventions were components of our improvement strategy. 
 Studies have reported on various interventions for improving inpatient diabetes 
care, including the institution of diabetes management protocols,14,15 the provision 
of professional education,16-18 standardised insulin order sets,19-20 the institution of 
a diabetes inpatient specialist nurse service or a dedicated inpatient care team,21-23 
or a combination of interventions.24-26 The studies were all single centre studies, 
and the designs, target populations, and effect measures that were used varied, 
which limits the comparisons. In line with our study, Underwood et al. reported 
improvements in obtaining preoperative HbA1c tests as the result of an 
improvement strategy,27 but did not focus on perioperative diabetes care 
throughout the entire hospital-care pathway. This is one of the strengths of our 
study.  
 As stated, while our intervention yielded positive results, at the same time the 
observed changes were quite limited. There may be several reasons for the limited 
impact of our improvement strategy. First, more time may be needed for optimal 
strategy performance. The implementation of the multidisciplinary protocol and 
patient information were still in progress after the intervention period. We 
achieved multidisciplinary consensus for the tasks and responsibilities of the 
caregivers and the patients with diabetes regarding perioperative diabetes care; 
however, the implementation of these agreements was not complete at the time of 
the after measurement. To improve perioperative diabetes care, all caregivers who 
are involved in this pathway must show commitment, and these caregivers should 
act together as a team. The patient with diabetes also needs commitment. 
Involving patients in inpatient diabetes care is an important part of the strategy to 
improve the safety of insulin use in the hospital.28 At baseline, lack of 
multidisciplinary ownership and lack of priority for perioperative diabetes care 
were important barriers to the delivery of optimal care. These barriers may also 
have contributed to the delay in implementing the multidisciplinary protocol in 
daily clinical practice. Second, the strategy targeted barriers that obstructed the 
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delivery of optimal perioperative diabetes care at the level of multiple quality 
indicators. Barriers to optimal care at the level of individual indicators were only 
partly addressed. Augmenting the strategy with interventions to target these 
specific barriers could enhance the effect. Third, the organisational structure of 
perioperative diabetes care was better in place in the control hospitals than in the 
intervention hospitals. For example, at baseline more control hospitals than 
intervention hospitals provided education for professionals, had standardised 
order sets, and had a multidisciplinary diabetes team to coordinate perioperative 
diabetes care. This may have facilitated further improvement in these hospitals, 
which in turn attenuated the impact of the improvement strategy in the 
intervention hospitals. 
 The present paper has limitations. The differences in baseline organisational 
structure constitute a first limitation of this study. Given the small number of 
participating hospitals, it was impossible to control for the potential influence of 
differences in organisational structure of perioperative diabetes care in the 
hospitals. Still, while the number of hospitals was small, so far no other study on 
this topic has been performed in more than one hospital and neither has ever a 
controlled set-up been used with matched hospitals. A second limitation is that 
there were also large differences in process indicator scores between the six 
hospitals at baseline. Our inclusion criteria were strict, so these differences cannot 
solely be explained by differences in the clinical characteristics of the patients. 
Daily clinical practice is characterised by wide variations that have no basis in 
clinical science.30 We accounted for these variations by including the hospital as a 
level in the multilevel analysis, and we corrected for baseline process and outcome 
indicator scores. Another limitation is that the intervention period coincided with 
changes in the administrative policy for patient data. The number of hospitals 
with electronic patient records increased from two (one intervention hospital and 
one control hospital) to five hospitals (three intervention hospitals and two control 
hospitals).  
 The present study has a number of strengths: we used a set of quality indicators 
to assess the impact of the improvement strategy. The quality indicators were 
developed in a rigorous selection procedure, and the clinimetric properties were 
tested in the six participating hospitals. Only measurable, applicable, reliable 
indicators that showed improvement potential were used as effect measures. As 
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noted, an important strength of our study is the fact that we focused on the entire 
perioperative hospital-care pathway.  
 
In conclusion, the multifaceted improvement strategy that we developed and 
tested in this study had a limited impact on the quality of perioperative diabetes 
care. This study demonstrates the complexity of improving perioperative diabetes 
care throughout the hospital-care pathway that is characterised by multiple care 
transitions and multiprofessional involvement. 
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SUPPLEMENT 
 
Supplementary Table 1. Determinants of indicator scores regarding process and outcome 
 
 DETERMINANT 
 Group 
(Int/Con1) 
Period 
(Pre/Post) Effect 
Type of 
surgery Age 
 
Treatment 
 
Sex INDICATOR 
Professional performance        
Microvascular complications evaluated  0.2450 <.0001 <.00012 0.0159 0.3258 <.0001 0.4874 
Blood glucose control evaluated  0.8323 0.5435 0.0014 <.0001 0.2838 0.0068 0.0189 
Policy specified for hypoglycemia  0.2537 0.7757 0.8022 0.0081 0.5658 0.0011 0.1704 
Policy specified for hyperglycemia 0.0395 0.0987 0.6719 <.0001 0.8199 0.0004 0.8016 
Intravenous insulin infusion on 
morning of surgery 
0.4812 0.0009 0.0821 <.0001 0.6812 <.0001 0.5700 
Blood glucose measured within 4 h 
preceding surgery 
0.8516 0.0899 0.4279 0.0047 0.0060 0.0056 0.5030 
Blood glucose measured every 2 h 
during surgery 
0.9090 <.0001 0.1353 0.0001 0.9101 0.1921 0.2308 
Blood glucose measured within 1 h 
after surgery 
0.3100 0.1695 <.0001 <.0001 0.1728 0.1293 0.3638 
Follow-up visit arranged with 
ambulant diabetes caregiver 
0.3753 0.0705 0.2030 <.0001 0.9536 <.0001 0.6105 
Patient outcome        
All glucose values within target range3 
in surgical ward 
0.1038 0.3285 0.9918 0.2554 0.0053 0.0003 0.7860 
Hyperglycemia4 in surgical ward  0.4648 0.0856 0.5038 0.1719 0.0078 <.0001 0.1962 
Unplanned re-admission within 3 
weeks  
0.0774 0.3509 0.7140 <.0001 0.2600 0.0111 0.2285 
1Con = control; Int = intervention 
2Improvement in the control group 
3 6-10 mmol/l 
4At least one value >10 mmol/l 
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Optimal perioperative diabetes care throughout the hospital care pathway is 
essential to obtain the most favourable results in surgery for people with diabetes. 
In this thesis, we applied a stepwise implementation model to improve the quality 
of perioperative diabetes care throughout the hospital care pathway. First, we 
defined optimal perioperative diabetes care from both the professional and 
patient’s perspective. Subsequently, we assessed the quality of current 
perioperative diabetes care, perioperative glucose control, and the level of person 
centredness in current perioperative diabetes care, and explored barriers for 
optimal care. Finally, we used this information to develop and test a strategy to 
improve the quality of perioperative diabetes care throughout the hospital care 
pathway. In this chapter we first summarise and discuss our main findings 
chapter by chapter and subsequently put the results into a broader perspective.  
 
Development of quality indicators  
In the study described in chapter 2, we aimed to develop a valid set of quality 
indicators for optimal perioperative diabetes care throughout the hospital care 
pathway. We developed 36 quality indicators, based on international guidelines 
and literature and a systematic Modified Delphi procedure. The results from our 
practice test showed that it is essential to subject indicators to a practice test before 
applying them for quality improvement purposes in a specific setting, as a number 
of indicators turned out to be not feasible. The practice test resulted in a total of 21 
quality indicators that subsequently could be used to assess the quality of 
perioperative care in our study hospitals, including 3 outcome indicators, 9 
process indicators, and 9 structure indicators. 
 
Quality indicators are preferably based on evidence-based guidelines. When we 
started the study in 2009, no national or international evidence-based guideline 
was available with perioperative diabetes care as a topic. Recommendations for 
optimal perioperative diabetes care were dispersed over several mono-
disciplinary guidelines and scientific literature. The extraction of all 
recommendations from these sources resulted in a comprehensive list of potential 
quality indicators. The use of a systematic Modified Delphi method enabled us to 
single out those quality indicators that are relevant for assessing the quality of 
perioperative diabetes care in the opinions of experts. The resulting quality 
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indicator set includes indicators for patient outcome, process and organisational 
structure of perioperative diabetes care; all three components of the Donabedian 
quality of care framework.1 The set includes indicators to assess the quality of care 
processes throughout the entire hospital care pathway.  
 Our practice test showed that several quality indicators were not suitable to be 
used as tools to guide and monitor quality improvement in our six study 
hospitals. This was primarily due to a lack of measurability (9 indicators) and low 
improvement potential (5 indicators), while one indicator was inapplicable. The 
fact that indicators cannot be measured should not necessarily be a reason to 
discard such indicators. Data registration and administrative policy can be 
adapted to facilitate the measurability of these indicators. Similarly, low 
improvement potential renders indicators less suitable in quality improvement 
efforts, but again this should not be the sole reason to discard indicators. If the 
recommended care has a strong relationship with improved patient outcomes, it 
should be monitored whether adherence to these indicators continues to be high. 
The clinimetric properties of the indicators may vary upon the healthcare setting 
in which the indicators are used. It is recommended that a new practice test is 
performed before applying the quality indicator set to other healthcare settings. In 
the end, twenty-one quality indicators could be used to assess the quality of 
perioperative diabetes care in our study hospitals. The final indicator set included 
3 outcome indicators, 9 process indicators, and 9 structure indicators and thus 
predominantly consisted of process indicators and structure indicators.  
 Recent reports have criticised the use of these types of indicators as measures 
for the quality of care.2,3 Several studies have reported that higher process 
indicator scores were not associated with better outcomes.4-6 However, this does 
not necessarily indicate that care as described with the quality indicators is not 
important, as the quality indicators were derived from evidence based 
recommendations for optimal care. A more plausible explanation is that in daily 
practice numerous additional factors and care processes that cannot all be assessed 
are also important for achieving optimal outcomes. Therefore, it is important that 
focussing on process indicator scores does not result in lack of attention for other 
processes that contribute to achieving optimal outcomes. In this thesis, we 
reported a trend towards shorter hospital stay for patients whose blood glucose 
was measured according to the recommended frequency. There is also criticism 
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towards the increasing administrative burden that comes about with the scoring of 
process indicators. The collection of data indeed turned out to be a laborious 
exercise in our study, as is described in the next paragraph. Kringos et al 
investigated the reliability, validity and usefulness of two sets of quality indicators 
for Dutch hospital care.2 They reported problems with regard to the interpretation 
of indicator definitions, the availability of data and differences in the registration 
and reporting of data. These problems limited the validity of the data, and 
increased the administrative burden for professionals. Moreover, they reported 
that professionals questioned the usefulness of scoring the indicators, and that the 
indicators were not used in programs to improve the quality of care. 
 These criticisms have resulted in a tendency towards advocating the use of 
outcome indicators instead of structure and process indicators. Outcomes are the 
ultimate result of provided care in all dimensions, and the ultimate result that 
matters to patients. Therefore, outcome indicators may be more useful for external 
comparisons, e.g. for negotiations with insurers, or to aid patients in choosing a 
hospital. However, as described above (higher process indicator scores are not 
always associated with better outcomes) worse outcomes do not necessarily 
indicate that care delivery is less optimal. For example, treating patients with more 
complex disease could result in worse outcomes. Careful correction for case-mix is 
needed when comparing the results of different healthcare settings.7,8 Often, a 
larger sample size is required for meaningful comparisons of outcomes than for 
comparisons of process and structure. Another disadvantage of using outcome 
indicators could be that it is not directly clear what should be improved in case of 
lower indicator scores. Process and structure indicators on the other hand describe 
exactly what needs to be improved, and therefore could be more helpful in quality 
improvement programs like in our thesis. In summary, there are advantages and 
disadvantages to measuring each type of indicators, and the best choice depends 
on the aims of the research, assessment or improvement process. In our thesis, we 
used a combination of all three types of indicators. 
 Our quality indicator set includes a limited number of outcome indicators, 
including two indicators with regard to achieved perioperative blood glucose 
levels, and one with regard to the rate of unplanned readmissions. The lack of 
outcome indicators in our set is inherent to the development of quality indicators 
based on guidelines. Guidelines generally focus on the management of a condition 
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and the organisational structures that need to be in place, but do not define 
optimal outcome of care. Studies are needed to identify suitable outcome 
indicators for optimal perioperative diabetes care. In addition, further research is 
needed to determine which process indicators have an association with optimal 
patient outcomes -such as the length of hospital stay and the number of 
postoperative infections- and with costs.  
 
Assessment of the quality of current perioperative diabetes care  
In chapter 3, our objective was to assess the quality of current perioperative 
diabetes care. We used the quality indicators as developed in chapter 2 for this 
purpose and included data from 389 participants with diabetes who underwent 
major surgery (abdominal, cardiac, or large joint orthopedic) in six hospitals. The 
assessment showed ample room for improvement of perioperative diabetes care 
throughout the hospital care pathway. Information regarding preoperative 
glycemic control was available for only few patients, intraoperative blood glucose 
was measured sparsely, and postoperative glucose control was poor. There were 
large variations between hospitals in both the delivery of perioperative diabetes 
care and the organizational structure of perioperative diabetes care. Perioperative 
diabetes care protocols lacked clear descriptions of the tasks and responsibilities of 
the caregivers in most hospitals, and none of the hospitals had a multidisciplinary 
team in which all professionals involved in perioperative diabetes care were 
represented. There was considerable variation in process indicator scores between 
the six hospitals. Participants who were treated with insulin prior to 
hospitalisation and participants who underwent cardiac surgery received more 
optimal care as described with the process indicators. Participant-related factors 
could explain only a limited part of the inter-hospital variation.  
 
Health care and diabetes care in the Netherlands are of very high quality. The 
Euro Health Consumer Index (EHCI) is a comparison of European health care 
systems from a consumer viewpoint based on the design of “systems policy”, 
consumer choice, service level and access to information. Overall, the Netherlands 
ranked first in the 2015 EHCI.9 With regard to diabetes care, the Netherlands 
ranked second after Sweden.10 According to the EHCI report, the Netherlands are 
famous for having the best multidisciplinary team approach and coordinated 
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efforts to deal with diabetes. The results of our assessment seem to indicate that 
this does not hold true for diabetes care for patients who undergo surgery. None 
of the hospitals had a multidisciplinary team in which all professionals involved in 
perioperative diabetes care were represented, and perioperative diabetes care 
protocols lacked clear descriptions of the tasks and responsibilities of the 
caregivers in most participating hospitals. The multiprofessional availability of 
data with regard to the perioperative management of diabetes was also poor. The 
indicator set describes essential aspects of care delivery for patients with diabetes 
who undergo surgery, and information with regard to these aspects should be 
easily accessible for all caregivers involved. Nevertheless, multiple data sources 
were needed to retrieve this information. We doubt that in daily practice, 
caregivers would have the time to undertake this effort. The introduction of 
electronic patient records in many hospitals over the past few years provides an 
opportunity to improve the multidisciplinary availability of data with regard to 
perioperative diabetes care.  
 Participant-related factors could explain only a limited part of the variation in 
process indicator scores between the hospitals. The number of hospitals was too 
small to study the influence of the reported differences in the organizational 
structure of perioperative diabetes care between hospitals on the outcome and 
process indicator scores. The lack of a Dutch guideline for perioperative diabetes 
care until recently may have contributed to the inter-hospital variation found in 
this study. There were several differences between the protocols for perioperative 
diabetes care in the participating hospitals. For example, in some hospitals the 
protocol recommended intravenous insulin for all patients with diabetes, while in 
other hospitals, intravenous insulin was recommended only for patients using 
insulin treatment prior to hospital admission. The new Dutch guideline provides 
guidance on this topic. Many other factors could have led to the variations, 
including professional related factors. Clarifying the determinants of the variation 
in care delivery will need further research.  
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Person centredness of current perioperative diabetes care  
In chapter 4, we determined the level of person centredness of current 
perioperative diabetes care. For this purpose, we developed a survey based on the 
Picker dimensions of person centredness and the Picker Adult Inpatient Survey. 
We obtained survey results from 298 participants with diabetes who underwent 
major abdominal, cardiac, or large-joint orthopedic surgery in six hospitals. The 
results of the patient experience survey showed that there is plenty of room for 
improving the person centredness of perioperative diabetes care: survey scores 
were low for many of the dimensions of person centredness, with the dimensions 
‘information’, ‘patient involvement’, and ‘coordination and integration of care’ 
having the lowest scores. These dimensions reflected key areas for surgical 
patients with diabetes in our study. Insulin treated participants reported better 
experiences with perioperative diabetes care.  
 
The 2012 American Diabetes Association’s Position Statement called for a more 
patient-centred approach in the management of type 2 diabetes.11 It recommends 
that treatment decisions should be made using a shared decision-making 
approach, with the caregiver and patient mutually exchanging information and 
deliberating on treatment options. This shared decision-making approach should 
be continued when patients with diabetes are admitted to hospital for a surgical 
procedure. There may be less to choose about treatment, but the caregiver still has 
the duty to inform patients about this treatment, and to gauge the patient’s 
preferred level of involvement. For caregivers, involving patients in the 
management of the diabetes during hospital admission can be an area of 
uncertainty, in particular with regard to respectively their and the patient’s tasks 
and (legal) responsibilities. The Netherlands Society of Internal Medicine and the 
Joint British Diabetes Societies for Inpatient Care Group provide guidance on this 
topic in their guidelines.12,13 We recommend that hospitals develop information 
about perioperative diabetes treatment for their patients and implement strategies 
to improve the involvement of patients in perioperative diabetes management, 
based on these guidelines and our survey items.  
 Patient experience is increasingly recognised as one of the three pillars of 
quality in healthcare next to clinical effectiveness and patient safety.14 In the 
Netherlands, Patient Reported Experience Measures (PREMs) are currently being 
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developed to assess patient experiences.15 PREMs are standardised, validated 
questionnaires to assess patients’ experiences with healthcare. The questionnaires 
are based on questions from the Consumer Quality Index (CQ index). The 
Consumer Quality Index (CQ index) is a broadly used questionnaire to assess 
patient experience that includes questions regarding patient involvement, 
information and the coordination of care. Other instruments that help to include 
the patients’ perspective into assessments of the quality of care are Patient 
Reported Outcome Measures (PROMs). PROMs are standardised, validated 
questionnaires to assess perceived health status, functional status or health-related 
quality of life.16 PROMs can be used to determine the effectiveness of a treatment, 
or to assess the quality of care. Patients’ experience of care processes and their 
perceived outcomes of healthcare can provide additional valuable insights into the 
quality of healthcare, and may help to provide a ‘whole-system’ perspective of the 
quality of care. 
 
Perioperative blood glucose levels and determinants 
In chapter 5 we describe the results and determinants of blood glucose levels 
throughout the hospital care pathway, including adherence to the developed 
quality indicators. In addition, we performed qualitative interviews to identify 
barriers for the delivery of optimal care. The results showed that hyperglycemia is 
common after major surgery, in particular on postoperative day 1 and in insulin 
treated participants. Interestingly, there was a trend towards higher perioperative 
blood glucose levels in case of better adherence to the recommended care for all 
process indicators. Four predominant barriers obstructed the delivery of optimal 
perioperative diabetes care at the level of multiple quality indicators and multiple 
professionals: a lack of priority for perioperative diabetes care, a lack of 
multidisciplinary ownership, a lack of knowledge about perioperative diabetes 
care, and limited person centredness. Perceived barriers to currently 
recommended blood glucose targets included a lack of formalised agreements on 
target glucose levels, absence of directly obvious disadvantages of hyperglycemia, 
and concern about inducing hypoglycemia. Our date suggests that professionals 
tend to be reactive rather than proactive in their approach to perioperative 
diabetes care, and that current emphasis of professionals is on treating instead of 
preventing postoperative hyperglycemia. 
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The high rates of perioperative hyperglycemia indicate that many patients are at 
increased risk for postoperative complications.17-21 Our results are in line with 
previous studies that have reported that the management of hyperglycemia in 
hospitalized patients was reactive rather than proactive.22-26 A reactive sliding-
scale insulin approach instead of a proactive approach that includes basal, bolus, 
and correction insulin has been used to control hyperglycemia in hospitalised 
patients with diabetes for decades.  
 We assume that higher blood glucose levels or clinical characteristics that 
predispose to hyperglycemia, such as insulin treatment, trigger professionals to 
provide the recommended care. Indeed, indicator adherence was better for insulin 
treated patients than for patients using oral treatment, and they reported better 
experiences with perioperative diabetes care. This could indicate that professionals 
regard insulin treated diabetes as more severe diabetes that needs more attention 
than non-insulin treated diabetes. Previous reports have shown that professional 
adherence to guideline recommendations is indeed better for patients who are 
more severely ill.27 The barrier interviews that were also performed in this study 
confirmed that professionals expected that glucose regulation would be less of a 
problem in patients using oral treatment. This opinion is not supported by our 
results as these show that perioperative hyperglycemia was also common in 
patients on oral treatment.  
 
Barriers for optimal perioperative diabetes care 
In chapter 5 we also describe barriers for the delivery of optimal care among 
professionals involved in perioperative diabetes care. We identified four 
predominant barriers that obstructed the delivery of optimal perioperative 
diabetes care at the level of multiple quality indicators and multiple professionals. 
These barriers included a lack of priority for perioperative diabetes care, a lack of 
multidisciplinary ownership, a lack of knowledge about perioperative diabetes 
care, and limited person centredness. Perceived barriers to currently 
recommended blood glucose targets included a lack of formalised agreements on 
target glucose levels, absence of directly obvious disadvantages of hyperglycemia, 
and concern about inducing hypoglycemia.   
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Our results confirm previously reported barriers, being lack of priority for 
preoperative diabetes care and a lack of knowledge about optimal care, and add 
the lack of multidisciplinary ownership and lack of person centredness as new 
barriers.22-26 Our findings add further insight into factors that may contribute to 
the clinical inertia that has been reported previously as a barrier for optimal 
diabetes care during hospitalisation. 22-24 Clinical inertia means not initiating or 
intensifying treatment when indicated. The strategy to improve perioperative 
diabetes care, as described in the next paragraph, was developed to address the 
four predominant barriers mentioned above.   
 
Effectiveness of the improvement strategy  
Based on the results of the assessment of current care and the barrier analysis, as 
described above, we investigated the effectiveness of a multifaceted strategy to 
improve perioperative diabetes care throughout the hospital care pathway. The 
strategy included the following components: feedback about baseline indicator 
performance, development of a multidisciplinary protocol and patient 
information, and the provision of professional education. We assessed the impact 
of the strategy in a controlled before-and-after study, with three hospitals serving 
as intervention hospitals, and three as their matched controls. The results are 
described in Chapter 6. The impact of the strategy on the quality of perioperative 
diabetes care was limited. Two out of nine process indicators improved 
significantly more in the intervention group than in the control group in the 
intention-to-treat analysis, and four out of nine in the per protocol analysis. Four 
other process indicators and all three outcome indicators improved more in the 
intervention hospitals than in the control hospitals, but the differences were not 
statistically significant.  
 
Our study results illustrate the complexity of improving perioperative diabetes 
care throughout the whole multiprofessional hospital care pathway. In particular 
the development and implementation of a hospital-wide multidisciplinary 
perioperative diabetes care protocol turned out to be a laborious effort. 
Perioperative diabetes care is a complex multiprofessional care setting, involving 
various multiprofessional teams of caregivers and several transitions of care. The 
quality of perioperative diabetes care depends crucially on the performance and 
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teamwork of all professionals who are involved. To improve the quality of care, all 
professionals involved should take into account the specific needs of patients with 
diabetes who undergo surgery at all stages of the hospital care pathway. Lack of 
multidisciplinary ownership and lack of priority for perioperative diabetes care 
were important barriers for optimal care at baseline, and, unfortunately, also 
hindered improving perioperative diabetes care within a relatively short 
timeframe. The implementation of the protocol required changes in clinical 
routines, better collaboration among disciplines, and changes in the organisation 
of care throughout the hospital care pathway. These are all factors that are known 
to be difficult to target in improvement efforts.28  
 The improvement strategy consisted of three intervention components. It is a 
commonly held view that multifaceted interventions are more effective than 
single-component interventions, although a review by Squires et al did not 
provide evidence to support this view.28,29 Still, a multifaceted strategy was in our 
opinion the appropriate choice in our study as supported by the American 
Association of Clinical Endocrinologists and the American Diabetes Association. 
These societies also recommend a multifaceted approach to inpatient diabetes care 
that includes the institution of a multidisciplinary steering committee, achievable 
glycemic goals with the use of protocols and order sets, and professional 
education.30,31 Multifaceted interventions, by their nature, require more resources 
and are more complex to deliver and sustain.32  
 The beneficial effects of the strategy may have been underestimated, 
considering the incomplete implementation of the multidisciplinary protocol and 
patient information. We experienced that numerous factors and care processes 
needed to be considered in order to improve the quality of perioperative care. We 
were able to improve some of these care processes, however, our efforts did not 
directly translate into improvements of indicator scores. We expect that a longer 
period is needed for optimal strategy performance.  
 
In summary, we aimed to improve perioperative diabetes care throughout the 
entire hospital care pathway, but the studies in this thesis show that this is not 
easily accomplished. We developed quality indicators defining optimal 
perioperative diabetes care, reported ample room for improvement of the quality 
of current perioperative diabetes care, perioperative glucose control, and the level 
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of person centredness. Finally, we mentioned the limited success of a multifaceted 
strategy to improve the quality of care. Below, we provide a more in-depth 
discussion of the methods used, problems encountered during the study, the 
clinical implications of our findings and future research directions. 
 
Methodological considerations  
Development of quality indicators  
The evidence level for most quality indicators provided in the guidelines, was ‘D’, 
meaning: a formal combination of expert views or other information, e.g., Delphi 
study, expert opinion or informal consensus. Like in many fields of medicine, 
there is only a limited scientific basis for recommendations regarding 
perioperative diabetes care.33,34 The use of a systematic Modified Delphi method 
enabled us to combine the evidence from guidelines and the scientific literature 
with the opinions of experts to develop a set of quality indicators.35 This consensus 
method has been used in other studies.33,36-39 Our procedure for quality indicator 
development follows the common steps of guideline based quality indicator 
development that were recommended by Kötter et al, and is compatible with the 
practical guidelines for using this method to select quality indicators that were 
formulated by Boulkedid et al.40,41 
Quality indicator data collection 
Data collection turned out to be laborious. We thoroughly searched multiple 
information resources, including medical and nursing records, anesthesiology 
records, medication records, and laboratory reports to retrieve the data that were 
needed to compute the indicator scores. At the moment of the second (“after”) 
measurement, the number of hospitals with electronic patient records had 
increased from two (one intervention hospital and one control hospital) to five 
hospitals (three intervention hospitals and two control hospitals). This influenced 
the availability of data in these hospitals, and therefore, may have influenced the 
indicator scores in these hospitals.  
Development of a survey to assess patient experiences  
We based our survey on the Picker dimensions of person centredness. These 
dimensions appear to be central aspects of hospital care for people in Europe and 
the USA.42,43 The focus group interview did not yield transcripts regarding the 
patient centred dimensions ‘emotional support’ and ‘involvement of family and 
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friends’, so our survey does not include questions regarding these dimensions. 
The participants in our focus group may not have mentioned items with regard to 
these dimensions because the diabetes was not the primary reason for hospital 
admission. The survey is quite lengthy in its current form. The results from the 
current care study can be used for further refinement of the survey to improve its 
applicability in clinical practice. A ranking procedure to single out those items that 
are most relevant to patients could be added to reduce the number of questions.  
Study design improvement study 
The intervention described in this thesis is the first multicentre study to 
systematically investigate the effects of a multifaceted strategy to improve 
perioperative diabetes care in a controlled before and after design. Controlled 
before-and-after studies are among the broader range of appropriate study 
designs for the Cochrane Effective Practice and Organisation of Care (EPOC) 
group reviews that address questions about the effects of improvement 
strategies.44 We used the improvement strategy in three hospitals, and three other 
hospitals served as matched controls. The controls were matched based on 
hospital type; university hospital, large non-university teaching hospital, or 
medium-size teaching hospital. Despite this matching, there were large variations 
in both the organisational structure of perioperative diabetes care and in the 
delivery of care between the participating hospitals at baseline. However, these 
large variations reflect the reality of current perioperative diabetes care in the 
Netherlands, and it is impossible to match for all these variations. We accounted 
for the variations by including the hospital as a level in the multilevel analysis, 
and corrected for baseline process and outcome indicator scores.  
 
Implications for clinical practice 
 Quality indicators should be developed using a systematic procedure. Indicator 
sets should be updated regularly, to ensure that they are based on the latest 
evidence.  
 Our quality indicator set can be used to assess the quality of perioperative 
diabetes care. It is essential to perform a practice test with the indicators before 
using them in other healthcare settings.  
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 The studies in this thesis reveal major gaps between recommended care and 
current perioperative diabetes care. Interventions to improve the quality of care 
should focus on bridging these specific gaps.  
 We recommend that hospitals systematically collect information about 
perioperative diabetes treatment for their patients to assess the quality of care, 
including patient experiences.  
 Developments in hospital organisation, particularly the introduction of 
electronic health records and the potential to electronically connect and 
centralize measurements may facilitate the collection of this information. 
 Based on this information, specific targets for quality improvement strategies 
can be selected.  
 Our patient experience survey can be used to evaluate patient experiences with 
perioperative diabetes care. Embedding a selection of our survey items in 
existing CQ index or PREM questionnaires may facilitate the collection of data 
and limit the burden of filling out multiple questionnaires for patients.  
 Strategies that aim to improve the quality of perioperative diabetes care need to 
take into account the multiprofessional setting and the entire perioperative care 
pathway from the preoperative evaluation up to hospital discharge. We 
recommend that hospitals develop a multidisciplinary protocol for 
perioperative diabetes care, based on the Netherlands Society of Internal 
Medicine guideline, and the recommendations for optimal care as described 
with our indicator set. An example of our protocol can be provided upon 
request.  
 We recommend that hospitals develop information about perioperative diabetes 
treatment for their patients and implement strategies to improve the 
involvement of patients in perioperative diabetes management, based on the 
guidelines from the Netherlands Society of Internal Medicine the Joint British 
Diabetes Societies for Inpatient Care Group, and our survey items. An example 
of our patient information can be provided upon request. 
 Given the complex multiprofessional care setting of perioperative diabetes care, 
improvement strategies should allow for sufficient time for complete 
implementation.   
 Strategies to improve perioperative diabetes care need to pay specific attention 
to patients with diabetes using oral treatment or a diet.   
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 An approach explicitly aimed at shifting towards more proactive diabetes 
management in the preoperative period may help to avert postoperative 
hyperglycemia. 
 
Implications for research 
 Further research needs to clarify the determinants of the variation in delivery of 
perioperative diabetes care. 
 Studies are also needed to clarify the determinants of the variation in the 
involvement of patients in perioperative diabetes care between hospitals. 
 It should be determined which process indicators have the strongest association 
with optimal patient outcomes such as the length of hospital stay and the 
number of postoperative infections, and costs.  
 Studies are needed to identify suitable outcome indicators for perioperative 
diabetes care.  
 Studies are needed to investigate the optimal strategy to improve the 
involvement of patients in perioperative diabetes care.  
 
In summary  
People with diabetes are more likely to require surgery than people without 
diabetes, and more often suffer from complications after surgery. Although 
guidelines have been developed for optimal perioperative diabetes care, 
implementation in real practice appears insufficient. The studies in this thesis first 
define optimal perioperative diabetes care from the professional and patient 
perspective. They subsequently report ample room for improving the quality of 
current perioperative diabetes care, perioperative glucose control and the level of 
person centredness. In addition, barriers for the delivery of optimal care are 
described. Finally, with our multifaceted improvement strategy we took a small 
step towards improving the outcomes of patients with diabetes undergoing 
surgery, but evidently more work is needed to advance optimal perioperative 
diabetes care.  
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Hoofdstuk 1: algemene inleiding   
Diabetes is een chronische aandoening die gekenmerkt wordt door chronisch 
verhoogde bloedglucosewaarden als gevolg van een relatief of absoluut 
insulinetekort. Diabetes kan op de langere termijn leiden tot ernstige complicaties 
zoals retinopathie, neuropathie en nefropathie, en een sterk verhoogd risico op het 
krijgen van cardiovasculaire aandoeningen. De prevalentie van diabetes is sterk 
toegenomen in de laatste decennia en zal naar verwachting in de komende jaren 
verder toenemen als gevolg van stijging van het aantal mensen met obesitas en de 
vergrijzing. In Nederland hebben meer dan 1.000.000 mensen diabetes, wat gelijk 
staat aan een prevalentie van ongeveer 6 procent. Mensen met diabetes hebben  
een grotere kans om een chirurgische ingreep te moeten ondergaan dan mensen 
zonder diabetes vanwege de complicaties en comorbiditeit die geassocieerd zijn 
met diabetes. Schattingen van de diabetesprevalentie onder patiënten op een 
chirurgische afdeling variëren van 20% van de patiënten op een afdeling algemene 
chirurgie tot bijna 35% op een afdeling hartchirurgie. Mensen met diabetes krijgen 
ook vaker complicaties na een chirurgische ingreep. Het verhoogde risico op 
postoperatieve complicaties is deels gerelateerd aan de aanwezigheid van 
complicaties van de diabetes zoals coronairlijden en nierfalen. Daarnaast hebben 
verscheidene onderzoeken aangetoond dat verhoogde bloedglucosewaarden in de 
periode rondom een operatie geassocieerd zijn met een verhoogd risico op 
postoperatieve complicaties. Er zijn aanwijzingen uit wetenschappelijk onderzoek 
dat hyperglycemie een beïnvloedbare, onafhankelijke voorspeller is van slechtere 
postoperatieve resultaten, en mogelijk ook een oorzakelijke factor. Optimale 
regulatie van de bloedglucosewaarden in de perioperatieve periode zou derhalve 
het risico op postoperatieve complicaties kunnen verlagen. Gezien de toenemende 
prevalentie van diabetes en het verhoogde risico op het krijgen van postoperatieve 
complicaties bij mensen met diabetes is optimale perioperatieve diabeteszorg van 
groot belang.  
 De dagelijkse praktijk laat echter zien dat het nog niet zo eenvoudig is om te 
komen tot een optimale regulatie van de bloedglucosewaarden in de periode 
rondom een operatie. De insulineproductie, insulinegevoeligheid, inname van 
voeding en mate van lichamelijke activiteit veranderen voortdurend tijdens een 
ziekenhuisopname vanwege een operatie. Daarnaast wordt hyperglycemie 
gemakkelijk over het hoofd gezien en vaak niet goed behandeld, omdat de 
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diabetes over het algemeen niet de primaire reden is voor de ziekenhuisopname. 
Het perioperatieve diabeteszorgtraject is een complex multidisciplinair proces, dat 
loopt van de preoperatieve beoordeling op de polikliniek tot en met ontslag uit het 
ziekenhuis.  Binnen dit traject zijn diverse multiprofessionele teams van 
zorgverleners betrokken bij de diabeteszorg, en zijn er diverse overdrachten van 
zorg tussen de verschillende betrokken afdelingen.  
 
In hoofdstuk 1 geven we een samenvatting van de beschikbare literatuur over de 
invloed van diabetes en perioperatieve hyperglycemie op postoperatieve 
uitkomsten, glucose streefwaarden in de perioperatieve periode, en de kwaliteit 
van de huidige perioperatieve diabeteszorg vanuit het perspectief van de 
professional en van de patiënt. In dit proefschrift hanteerden we een stapsgewijs 
implementatiemodel om de perioperatieve diabeteszorg te verbeteren. De eerste 
stap was het ontwikkelen van kwaliteitsindicatoren voor optimale perioperatieve 
diabeteszorg. Kwaliteitsindicatoren zijn meetbare zorgelementen die een 
aanwijzing geven over de kwaliteit van de geleverde zorg. Vervolgens brachten 
we de huidige kwaliteit van de perioperatieve diabeteszorg in kaart, zowel vanuit 
het perspectief van de professional als dat van de patiënt.  Daarnaast hielden we 
interviews met betrokken professionals om barrières te identificeren die hen 
hinderden bij het verlenen van optimale zorg. Tenslotte ontwikkelden we op basis 
van deze informatie een strategie om de perioperatieve diabeteszorg over het 
gehele zorgtraject te verbeteren, en onderzochten de effectiviteit van deze 
strategie.  
 
Hoofdstuk 2: indicatorontwikkeling  
In de studie die beschreven wordt in hoofdstuk 2 ontwikkelden we een set 
kwaliteitsindicatoren voor optimale perioperatieve diabeteszorg gedurende het 
gehele zorgtraject in het ziekenhuis. We zochten in internationale literatuur en 
richtlijnen naar aanbevelingen voor optimale perioperatieve diabeteszorg. Deze 
aanbevelingen werden voorgelegd aan een multidisciplinair panel van experts met 
betrekking tot perioperatieve diabeteszorg. We pasten een modified Delphi 
methode toe om een set van kernaanbevelingen samen te stellen. De daar uit 
volgende kernaanbevelingen werden omgezet in 36 kwaliteitsindicatoren. 
Vervolgens verrichten we een praktijktest met de indicatoren in 6 Nederlandse 
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ziekenhuizen om de kwaliteitscriteria (meetbaarheid, reproduceerbaarheid, 
toepasbaarheid, verbeterpotentieel, onderscheidend vermogen, en de noodzaak 
tot correctie van case-mix) van de indicatoren in de dagelijkse praktijk te 
evalueren. De praktijktest liet zien dat het essentieel is om een praktijktest uit te 
voeren met indicatoren voordat ze worden toegepast in een specifieke zorgsetting; 
21 van de 36 ontwikkelde indicatoren, waaronder 3 uitkomstindicatoren, 9 
procesindicatoren en 9 structuurindicatoren bleken geschikt om de kwaliteit van 
de perioperatieve diabeteszorg te evalueren in onze studieziekenhuizen.  
 
Hoofdstuk 3: meting van de huidige zorgkwaliteit  
In hoofdstuk 3 brachten we de huidige kwaliteit van de perioperatieve 
diabeteszorg in kaart aan de hand van de in hoofdstuk 2 ontwikkelde 
kwaliteitsindicatoren. De indicatorscores werden berekend over de gegevens van 
389 mensen met diabetes uit 6 Nederlandse ziekenhuizen, die een grote 
buikoperatie, hartoperatie of een orthopedische operatie aan de grote gewrichten 
hadden ondergaan. De resultaten lieten zien dat er over het gehele zorgtraject veel 
ruimte is voor verbetering van de perioperatieve diabeteszorg. Zo werd er in de 
meeste dossiers geen informatie over de preoperatieve diabetesinstelling 
gevonden,  werden bloedglucosewaarden slechts mondjesmaat gecontroleerd, en 
was de postoperatieve glucoseregulatie slecht. In de meeste ziekenhuizen ontbrak 
in de protocollen voor perioperatieve diabeteszorg een duidelijke beschrijving van 
de taken en verantwoordelijkheden van de betrokken zorgverleners. Geen van de 
ziekenhuizen beschikte over een multidisciplinair team waarin alle bij de 
perioperatieve diabeteszorg betrokken professionals vertegenwoordigd waren. Er 
waren grote verschillen tussen de ziekenhuizen in de wijze waarop de 
perioperatieve diabeteszorg georganiseerd was, en er waren ook grote verschillen 
in de scores op de procesindicatoren tussen de ziekenhuizen. Studiedeelnemers 
die insuline gebruikten in de thuissituatie en studiedeelnemers die een 
hartoperatie ondergingen ontvingen vaker zorg conform de aanbevelingen in de 
procesindicatoren. Slechts een klein deel van de verschillen in indicatorscores 
tussen de ziekenhuizen was te verklaren door verschillen in de karakteristieken 
van de studiedeelnemers uit deze ziekenhuizen.  
 
Samenvatting 
155 
Hoofdstuk 4: persoonsgerichtheid van de perioperatieve diabeteszorg 
In hoofdstuk 4 onderzochten we de persoonsgerichtheid van de perioperatieve 
diabeteszorg. Om de persoonsgerichtheid te onderzoeken ontwikkelden we een 
vragenlijst om de ervaringen van mensen met diabetes met de perioperatieve 
diabeteszorg te meten. De vragenlijst was gebaseerd op de acht dimensies van 
persoonsgerichte zorg zoals deze door het Picker Instituut gedefinieerd werden, 
een vragenlijst van het Picker Instituut om de ervaringen met ziekenhuiszorg te 
meten, en informatie uit een focusgroep interview met mensen met diabetes die in 
het verleden een operatie hadden ondergaan. De vragenlijst werd ingevuld door 
298 mensen met diabetes uit 6 Nederlandse ziekenhuizen, die een grote 
buikoperatie, hartoperatie of orthopedische operatie aan de grote gewrichten 
hadden ondergaan. De resultaten toonden dat er veel ruimte is voor het 
verbeteren van de persoonsgerichtheid van de perioperatieve diabeteszorg. Er 
werden lage scores gevonden binnen meerdere dimensies van persoonsgerichte 
zorg. De dimensies ‘informatie’, ‘betrekken van de patiënt’, en ‘coördinatie en 
integratie van zorg’ bevatten de laagste scores. Tijdens het focusgroep interview 
waren juist deze dimensies naar voren gekomen als de belangrijkste gebieden van 
persoonsgerichtheid voor mensen met diabetes die een operatie ondergaan. 
Studiedeelnemers die insuline gebruikten in de thuissituatie rapporteerden betere 
ervaringen met perioperatieve diabeteszorg dan studiedeelnemers die behandeld 
werden met tabletten.  
 
Hoofdstuk 5: perioperatieve glucoseregulatie en determinanten 
In hoofdstuk 5 beschreven we de glucoseregulatie over de gehele 
ziekenhuisopname vanwege een operatie en determinanten van deze regulatie, 
waaronder de invloed van het verlenen van optimale perioperatieve diabeteszorg 
zoals gedefinieerd in de kwalteitsindicatoren. Daarnaast hielden we kwalitatieve 
interviews met professionals die betrokken zijn bij perioperatieve zorg om 
barrières te identificeren die het verlenen van optimale zorg kunnen hinderen. De 
resultaten  lieten zien dat hyperglycemie vaak voorkomt na een grote operatie, 
vooral op de eerste dag na de operatie en bij studiedeelnemers die insuline 
gebruikten in de thuissituatie. Opvallend was dat voor alle procesindicatoren het 
verlenen van optimale zorg samen leek te hangen met hogere 
bloedglucosewaarden gedurende de ziekenhuisopname. We identificeerden vier 
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overkoepelende barrières die het verlenen van optimale zorg hinderden op het 
niveau van meerdere kwaliteitsindicatoren en meerdere professionals. Deze 
barrières waren een gebrek aan prioriteit dat professionals gaven aan het verlenen 
van optimale perioperatieve diabeteszorg, een gebrek aan multidisciplinaire 
samenwerking, een gebrek aan kennis over perioperatieve diabeteszorg, en een 
gebrek aan persoonsgerichtheid van deze zorg. Wat betreft de aanbevolen 
glucosestreefwaarden identificeerden we de volgende barrières voor het bereiken 
van deze streefwaarden: een gebrek aan formele afspraken over 
glucosestreefwaarden, het afwezig zijn van direct duidelijke negatieve gevolgen 
van hyperglycemie en angst voor het veroorzaken van hypoglycemie. Wij 
concludeerden uit deze gegevens dat de zorgverlening van professionals met 
betrekking tot de perioperatieve diabeteszorg meer reactief is dan proactief, en dat 
het focus in de huidige perioperatieve diabeteszorg meer ligt op het behandelen 
dan het voorkomen van postoperatieve hyperglycemie.  
 
Hoofdstuk 6: effectiviteit van de verbeterstrategie  
In hoofdstuk 6 ontwikkelden we een veelzijdige strategie om de perioperatieve 
diabeteszorg te verbeteren over het gehele ziekenhuiszorgtraject van de 
perioperatieve diabeteszorg. We baseerden de strategie op de resultaten van de 
meting van de huidige zorgkwaliteit en de barrière analyse zoals hierboven 
beschreven. De strategie bestond uit de volgende interventiecomponenten: 
feedback over de indicatorscores van de meting van de huidige zorgkwaliteit, het 
ontwikkelen van een multidisciplinair protocol en patiënteninformatie, en het 
geven van scholing aan de betrokken professionals. We onderzochten de 
effectiviteit van de strategie in een gecontroleerd before-and-after design. De 
verbeterinterventies werden uitgevoerd in 3 interventieziekenhuizen en 3 
ziekenhuizen fungeerden als controleziekenhuizen. De impact van de strategie op 
de kwaliteit van de perioperatieve diabeteszorg was beperkt. In de intention-to-
treat analyse was bij 2 van de 9 procesindicatoren de verbetering in indicatorscore 
significant groter in de interventiegroep dan in de controlegroep. In de per 
protocol analyse was dat het geval bij 4 van de 9 indicatorscores. Vier andere 
procesindicatoren en alledrie de uitkomstindicatoren verbeterden meer in de 
interventieziekenhuizen dan in de controleziekenhuizen, maar de verschillen 
waren niet statistisch significant.  
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Mensen met diabetes hebben een grotere kans om een chirurgische ingreep te 
moeten ondergaan dan mensen zonder diabetes, en ze krijgen vaker complicaties 
na een operatie. Internationale literatuur en richtlijnen bevatten aanbevelingen 
voor optimale perioperatieve diabeteszorg, maar de implementatie van deze 
aanbevelingen in de dagelijkse praktijk blijkt onvoldoende. In dit proefschrift 
beschreven we wat de definitie is van optimale perioperatieve diabeteszorg vanuit 
het perspectief van de professional en vanuit het perspectief van de patiënt. 
Vervolgens lieten we zien dat er veel ruimte is voor het verbeteren van de 
kwaliteit van perioperatieve diabeteszorg, de perioperatieve glucoseregulatie, en 
de persoonsgerichtheid van perioperatieve diabeteszorg. Tenslotte leverden we 
met onze veelzijdige verbeterstrategie een kleine bijdrage aan het verbeteren van 
de operatieresultaten bij patiënten met diabetes, maar het is duidelijk dat er meer 
nodig is om de perioperatieve diabeteszorg te optimaliseren. 
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Allereerst ben ik vreselijk dankbaar dat ik mijn onderzoek eindelijk heb kunnen 
afronden. Het viel niet mee om alle banen en petten met elkaar te combineren. Het 
is een heerlijk gevoel om voor in ieder geval de komende jaren te weten waar ik 
werk, en daar ook weer vol voor te kunnen gaan zonder de hete adem van een 
promotie-agenda in mijn nek.  
 
Zonder de medewerking van een heel leger aan professionals in de deelnemende 
ziekenhuizen hadden we niets kunnen beginnen. Ik wil al deze mensen bedanken 
voor hun inspanningen, in het bijzonder de internisten, diabetesverpleeg-
kundigen, anesthesiologen, chirurgen, orthopeden, verpleegkundigen en 
leidinggevenden. Daarnaast wil ik de deelnemers aan het focusgroep interview en 
alle mensen die de vragenlijsten hebben ingevuld en toestemming gegeven 
hebben voor het lichten van hun dossier bedanken. 
 
Mijn promotoren en copromotoren wil ik hartelijk danken voor hun begeleiding in 
de afgelopen jaren. Lieve Marlies, je begon als copromotor en eindigde als 
promotor, een welverdiende leerstoel! Dit was vast één van de langstlopende 
promotietrajecten die je hebt begeleid. Aan je niet aflatende steun was het niet te 
merken. Je hebt me altijd beloofd dat het goed zou komen, en dat was nog waar 
ook. Kenmerkend zijn je perfectionisme en je voortschrijdende inzicht (zucht…). 
Als je je ergens in vastbijt laat je niet meer los. Losmaken is meer iets voor 
fysiotherapeuten. Het onderzoek heeft je zeker een aantal slapeloze nachten 
gekost; bij ongeveer elke stap kwamen er weer nieuwe beren op de weg. 
Uiteindelijk heb je overal weer een draai aan weten te geven. In ruil daarvoor heb 
ik af en toe verse pasta voor je gedraaid. Naast je beroepsmatige kwaliteiten ben je 
ook nog eens een erg leuk mens met het hart op de goede plek. Heel erg bedankt 
voor je begeleiding in de afgelopen jaren! Lieve Petra, het begon allemaal met de 
vraag naar een stage om meer te leren over kwaliteit van zorg, en het eindigde met 
een promotieonderzoek. In het voortraject hebben we flink gestoeid met het 
schrijven van diabetesprotocollen en de implementatie daarvan op de afdelingen 
interne geneeskunde. We hebben aan den lijve ondervonden dat dit niet zo 
eenvoudig is als het mag lijken.  Ik vond het fijn dat je er was om een brug te staan 
tussen het onderzoek, kwaliteit van zorg, en de dagelijkse praktijk. Daarnaast was 
je ook de beschermengel die mij een beetje uit de wind hield. Ondanks je overvolle 
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agenda sta je altijd klaar met raad en daad, ook voor carrière- en andere vragen. 
Heel erg bedankt voor je begeleiding en betrokkenheid! Beste Hub, het was jouw 
idee om van mijn vraag aan Petra een promotieonderzoek te maken. Je schetste 
een indeling van de hoofdstukken, introduceerde Marlies om mee te schrijven aan 
de subsidieaanvraag, en in 2009 konden we starten. Dat scheelde maar een haartje, 
aangezien we de aanmeldingsdatum voor de subsidie bijna misten omdat we de 
procedure niet goed kenden. Dank voor je begeleiding, vooral bij het reviseren van 
de stukken. Jouw handgecorrigeerde setje (Hub -> Inge), in mijn postvak bij IQ of 
met de fiets afgeleverd in mijn thuisbrievenbus, blijven bewaard voor het 
nageslacht. De terminologie rondom het patient/person/participant gebeuren is 
een dingetje. Ik hoop dat de taalstelling in het proefschrift aansluit bij de meest 
recente trend. Beste Cees, dit was wel een heel andere tak van sport. Van ‘harde 
wetenschap’ naar kwaliteit van zorg. Daarnaast bleek het verbeteren van de 
klinische diabeteszorg, waar het allemaal om begon, een meerjarenproject. 
Hopelijk biedt het nieuwe D-team uitkomst, en is hiermee de juiste manier 
gevonden om de kwaliteit van de klinische diabeteszorg in het Radboud verder te 
verbeteren en monitoren. Ik vond het erg leerzaam om met je achter de computer 
te zitten. Je zorgde er altijd precies op het goede moment voor dat de goede zinnen 
in een brief of artikel kwamen die de reviewers tevreden konden stellen. Dank 
voor je begeleiding! 
 
Beste Janine, zonder jouw ondersteuning was er geen enkel artikel gekomen. Het 
onderzoek was een enorme logistieke en administratieve klus. Jouw ervaring met 
vergelijkbare projecten was onmisbaar. Je was eigenlijk van alles tegelijk, van 
onderzoeksassistent tot statisticus en alles daartussenin. We hebben samen 
dagenlang achter de computer gezeten en bergen werk verzet om 
onderzoeksinstrumenten te ontwikkelen, de dataverzameling te coördineren, data 
te cleanen, indicatoralgoritmen te maken, etcetera. Gelukkig was dit ook gezellig! 
Het is jammer dat het allemaal wat langer geduurd heeft dan geraamd, waardoor 
de afronding van het project zich wat buiten je gezichtsveld heeft voltrokken. Je 
hebt me enorm geholpen met het project, en ook om het te overleven, grote dank 
daarvoor! Beste student-assistenten, heel erg bedankt voor jullie hulp bij het 
verzamelen van gegevens uit de medische dossiers! Laura, bedankt voor je hulp 
Dankwoord 
162 
bij het coördineren en uitvoeren van de nameting! Hartelijke dank ook aan de 
medewerkers van het secretariaat van IQ healthcare.   
 
Dan wil ik een aantal nog niet genoemde coauteurs bedanken, waaronder drie 
statistici. Jan, je slaagde er regelmatig in om mij wat van statistiek te laten 
begrijpen, en dat is heel knap. Zelfs na je pensioen mocht ik nog bij je langs komen 
bij tandheelkunde om de puntjes op de i te zetten. Ik neem aan dat de 
verschuiving van statistiek naar je hobby’s gaandeweg steeds verder zal 
toenemen, en wens je daar veel plezier bij. Dank voor je hulp! Femke, dank voor je 
bijdrage aan het statistische gedeelte en vooral ook voor je geduld! Het heeft wat 
tijd en voortschrijdende inzichten gekost, maar uiteindelijk is het glucose-artikel er 
gekomen. Reinier, een kleine bijdrage, maar niet minder bedankt! Alfons, dank 
voor je hulp bij het glucose-artikel!  
 
Na alle beren die op mijn weg kwamen was ik heel blij dat er ook iets heel 
voorspoedig verliep. Beste Jolanda, je hebt er in ijltempo voor gezorgd dat het 
manuscript verstuurd kon worden, en hebt me de verdere afhandeling uit handen 
genomen. Heel erg bedankt daarvoor!  
 
Zonder de steun van familie en vrienden was ik de afgelopen jaren niet 
doorgekomen. Lieve pap en mam, jullie staan al mijn hele leven klaar om me bij 
alles te ondersteunen. Ook grote kinderen hebben dat nog steeds nodig. Het blijft 
fijn om na een drukke werkdag in de auto even lekker (handsfree) met je moeder 
te kunnen bellen. Het is ook een grote luxe om altijd een oppas-back-up te hebben. 
Onmisbaar in geval van promotieonderzoek. Bedankt dat ik altijd op jullie kan 
rekenen! Pap, neem je wel weer een hondje? Lieve zus Marieke, het zou leuk zijn 
om jou als paranimf achter me te hebben staan op de promotie-dag! Alle begrip 
natuurlijk als het niet lukt, maar hopelijk is er wat te regelen. We zien het wel. En 
ja, je moet inderdaad het hele boekje lezen voor het geval er een vraag komt die ik 
niet weet. We vonden het heel gezellig om een paar dagen bij jou, Nard, Tom, Sien 
en Luuk in Salisbury te mogen logeren. Superleuk huis (met game-room) en leuk 
stadje, geweldige grasvelden en lekkere fish & chips. Als het niet lukt om hier te 
komen willen we nog wel een keer rond de kerst? Lieve Anny en Wim, 
schoonouders heb je niet echt voor het kiezen, maar als dat had gekund dan had ik 
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jullie gekozen. Bedankt voor jullie steun in de afgelopen jaren. Dat we nog maar 
veel mee mogen maken met elkaar in goede gezondheid. 
 
Lieve Margot, wat leuk dat je mijn paranimf bent vandaag! Het is ook fijn dat je 
psycholoog bent, want misschien heb ik dat nog nodig na vandaag. Die EMDR wil 
ik misschien nog even over praten. Ik vind het fijn om Frank en jou tot mijn 
vrienden te kunnen rekenen. Samen skiën, eten, en tennissen is leuk, maar als je 
zelfs op vakantie in Frankrijk mag langskomen met je problemen dan heb je echte 
vrienden. Lieve Marco, eerst buurman, nu buurtman en vriend. Superlief dat je 
mijn nood-paranimf wil zijn. Family is altijd first, dus je bent zeker geen tweede 
keus! En nee hoor, je hoeft het boekje niet helemaal te lezen, achter me staan en 
mooi wezen is voldoende. Beloof me dat je net zo goed voor jezelf zorgt als voor 
anderen want we willen nog heel lang met je meegenieten van het goede leven!  
 
Last but not least, dit onderzoek was zeker nooit afgekomen zonder de steun van 
mijn man Jeroen. Lieve Jeroen, het is me een raadsel hoe je het uithoudt met mij. 
We ontmoetten elkaar als buren in het studentenhuis op de Tweede Oude 
Heselaan en vielen van niets meteen in het alles. Dat was niet altijd even 
makkelijk, maar we zijn inmiddels alweer 22 jaar samen. Je bent een supervader, 
kunt heerlijk koken en zet ook nog eens elke week de vuilniszakken buiten. Ik ben 
blij dat het gelukt is om 2 ontzettend mooie en slimme kinderen op de wereld te 
zetten. Loek en Mats, jullie zijn de beste kinderen ter wereld. Na deze promotie 
kan het alleen nog maar leuker worden met ons viertjes!  
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Inge Hommel werd geboren op 7 november 1974 in Helmond. Na het behalen van 
haar VWO-diploma aan het Knippenberg College (1993) verhuisde ze naar 
Nijmegen om Geneeskunde te studeren aan de Radboud Universiteit. In 2000 
behaalde ze haar arts-examen, waarna ze aan haar eerste baan begon als arts-
assistent longziekten in het Sint Maartens Gasthuis in Venlo (nu VieCurie). Een 
half jaar later stapte ze over naar het Jeroen Bosch Ziekenhuis en startte daar een 
aantal maanden later met de opleiding tot internist. De academische fase van de 
opleiding doorliep ze in het Radboudumc, waar ze in 2007 de opleiding tot 
algemeen internist afrondde.     
 
Na de opleidingsfase bleef ze in dienst van het Radboudumc en was daar onder 
andere betrokken bij het opstellen en implementeren van protocollen met 
betrekking tot de diabeteszorg voor in het ziekenhuis opgenomen patiënten. De 
intentie tot het verbeteren van de klinische diabeteszorg vormde de aanleiding 
voor haar promotie-traject dat in 2009 van start ging, onder begeleiding van prof. 
Marlies Hulscher (afdeling IQ healthcare), dr. Petra van Gurp (afdeling Algemeen 
Interne Geneeskunde), dr. Hub Wollersheim (afdeling IQ healthcare) en prof. Cees 
Tack (afdeling Algemeen Interne Geneeskunde).  
 
Tijdens de eerste onderzoeksjaren werkte ze op de diabetespolikliniek in het 
Radboudumc en vanaf 2011 tot en met 2016 als waarnemend internist en chef de 
clinique in verschillende ziekenhuizen, waaronder Gelre ziekenhuizen locatie 
Zutphen. Daarnaast werkt ze sinds 2011 als consulterend internist in de Sint 
Maartenskliniek in Nijmegen in de avond- en weekenddiensten. Sinds januari 
2017 werkt ze daar ook twee dagen per week overdag. Even zo veel dagen per 
week werkt ze sinds 2015 in Medisch Centrum de Veluwe in Apeldoorn.  
 
Inge is getrouwd met Jeroen en heeft twee kinderen, Loek (2008) en Mats (2010). 
 

